Sentence,class,file
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 389–400Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  389Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S9985 5Concentrated insulins: the new basal insulins elizabeth M Lamos1 Lisa M Y ounk2 Stephen N Davis3 1Division of endocrinology, Diabetes  and Nutrition, 2Department of  Medicine, University of Maryland  School of Medicine, 3Department  of Medicine, University of Maryland  Medical Center, Baltimore, MD, USAIntroduction:  Insulin therapy plays a critical role in the treatment of type 1 and type 2 diabetes  mellitus.",Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
"This can result in  unpredictable absorption, increased pain, discomfort, and leakage.Correspondence: Stephen N Davis University of Maryland Medical Center,  22 South Greene Street, N3w42,  Baltimore, MD 21201, USA Tel +1 410 328 2488 Fax +1 410 328 8688 email sdavis@medicine.umaryland.ed uJournal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Lamos et al Running head recto: New concentrated basal insulins DOI: http://dx.doi.org/10.2147/TCRM.S99855",Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2015/206538lbl.pd f. Accessed November 05, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01195 454?term =NCT01195454&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
Available from: https://clinicaltrials.gov/ct2/show/NC T01959529?term =NCT01959529&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
"Available from:  http://www.drugs.com/price-guide/humulin-r-concentrate d. Accessed  December 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
Available from: http://www.goodrx.,Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
Available from: http://www.drugs.,Non-OADS,/arxiv_data1/oa_pdf/a1/e6/tcrm-12-389.PMC4790523.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5b/44/ijn-11-977.PMC4790524.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 977–990International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  977OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9537 5antimicrobial performance of mesoporous titania  thin films: role of pore size, hydrophobicity, and  antibiotic release Saba Atefyekta1 Batur ercan2,3 Johan Karlsson1 Erik Taylor2 Stanley Chung2 Thomas J Webster1,4 Martin andersson1 1Department of Chemistry and  Chemical Engineering, Chalmers  University of T echnology, Gothenburg,   sweden; 2Department of chemical  Engineering, Northeastern University,   Boston, MA, USA; 3Department  of Metallurgical and Materials  Engineering, Middle East Technical  University, Ankara, T urkey; 4center  of excellence for advanced Materials  Research, King Abdulaziz University,   Jeddah, Saudi ArabiaAbstract:  Implant-associated infections are undesirable complications that might arise after  implant surgery.",Non-OADS,/arxiv_data1/oa_pdf/5b/44/ijn-11-977.PMC4790524.pdf
"This is due to the fact that the body’s defense systems are  much weaker in the presence of a foreign material and that the surface of the implant  generally is unable to suppress bacterial growth.1–3 These microbial colonization- derived infections, often referred to as biomaterial associated infections (BAI), are  some of the most common causes of implant failure.4–7 For example, it has been  observed that BAI occurs in 1.5%–2.5% of primary hip and knee replacements, which  in 3.2%–5.6% of cases result in surgical revisions.8 The key pathogenic factor responsible for infection is the development of bacterial  colonies embedded in a matrix, consisting of proteins, polysaccharides, and DNA,  called a biofilm on the implant surface.9–11 Such adhesive biofilms are very resistant  toward the body’s defense mechanisms and antibiotic treatments.1,12 The eradication of  infections after the formation of a biofilm often necessitates removal and replacement  of the implant, which results in high costs and trauma for the patient.13–15 Moreover,  biofilms increase resistance to antibiotic treatments and raise the need for increased correspondence: Martin andersson Department of Chemistry and Chemical  Engineering, Chalmers University of  Technology, Kemivägen 10, 41296  Gothenburg, Sweden Tel +46 31 772 2966 Fax +46 31 160 062 email martina@chalmers.s e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Atefyekta et al Running head recto: Antimicrobial performance of mesoporous titania thin films DOI: http://dx.doi.org/10.2147/IJN.S95375",Non-OADS,/arxiv_data1/oa_pdf/5b/44/ijn-11-977.PMC4790524.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5b/44/ijn-11-977.PMC4790524.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/44/ijn-11-977.PMC4790524.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/24/ee/tcrm-12-379.PMC4790525.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 379–385submit your manuscript | www.dovepress.co m Dove press  379 http: //dx.doi.org/10.2147/TCRM.S9401 9Dove press ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article effect of Ascaris  lumbricoides  infection on T helper  cell type 2 in rural egyptian children naglaa M shalaby1 nehad M shalaby2 1Department of Parasitology, Faculty  of Medicine, 2Mansoura University  Children hospital, Mansoura  University, Mansoura, egyptAbstract:  Ascaris lumbricoides  is a neglected parasite that induces changes in host immune  response.",Non-OADS,/arxiv_data1/oa_pdf/24/ee/tcrm-12-379.PMC4790525.pdf
"It is  estimated that ~1.5 billion infections are caused by A. lumbricoides alone.3 Such  infections are associated with significant morbidity.4 It is reported that the prevalence of soil-transmitted helminth (STH) parasites is  commonly high in conditions of poor hygiene and sanitation with more affection in  children than adults.5 The mammalian host is infected with A. lumbricoides  orally by  ingestion of infective ova.6,7 Ascariasis is common in areas where defecation occurs  in open latrines and stool is disposed arbitrarily in the surrounding environment.4  Therefore, contamination of food and water is so easy, the most common sources of  infection.8 Human infection with A. lumbricoides  has been associated with eosinophilia, fever,  dyspnea, and cough what is known as Loeffler’s syndrome during the larval migratory  phase through the lung and abdominal pain during the intestinal phase.9 Ascariasis  is characterized by eosinophilia, mast cell hyperplasia, and high levels of circulating  immunoglobin E (IgE).10Correspondence: nehad M shalaby Mansoura University Children hospital,  Mansoura University, algomhoria street,  Mansoura, 35516, egypt email amahalawy2002@yahoo.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Shalaby and Shalaby Running head recto: Effect of A. lumbricoides  infection on Th cell DOI: http://dx.doi.org/10.2147/TCRM.S94019",Non-OADS,/arxiv_data1/oa_pdf/24/ee/tcrm-12-379.PMC4790525.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/24/ee/tcrm-12-379.PMC4790525.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/ee/tcrm-12-379.PMC4790525.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/ea/ott-9-1327.PMC4790526.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1327–1337OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1327Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9195 3Metabolism-related enzyme alterations identified by  proteomic analysis in human renal cell carcinoma Zejun lu1,* Yuqin Yao2,* Qi song3 Jinliang Yang4 Xiangfei Zhao1 Ping Yang1 Jingbo Kang1 1Department of radiation Oncology,   naval general hospital of People’s  liberation army, Beijing, 2research  center for Public health and  Preventive Medicine, West china  school of Public health/ no 4 West  china Teaching hospital, sichuan  University, chengdu, 3Department  of gynaecology and Obstetrics,   The general hospital of chinese  People’s armed Police Force, Beijing,   4state Key laboratory of Biotherapy/ collaborative innovation center  for Biotherapy, West china hospital,   sichuan University, chengdu, People’s  republic of china *These authors contributed equally  to this workAbstract:  The renal cell carcinoma (RCC) is one of the most common types of kidney neoplasia  in Western countries; it is relatively resistant to conventional chemotherapy and radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/f1/ea/ott-9-1327.PMC4790526.pdf
"6, Beijing 100048,  People’s republic of china email kjbnet@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lu et al Running head recto: Protein disorders in human renal cell carcinoma by proteomic analysis DOI: http://dx.doi.org/10.2147/OTT.S91953",Non-OADS,/arxiv_data1/oa_pdf/f1/ea/ott-9-1327.PMC4790526.pdf
The pkl files were analyzed using the MASCOT  search engine ( http://www.matrixscience.co m).,OADS,/arxiv_data1/oa_pdf/f1/ea/ott-9-1327.PMC4790526.pdf
"Pathway data were obtained from the Kyoto Encyclopedia  of Genes and Genomes ( http://www.genome.jp/keg g) –  a collection of online databases dealing with genomes, enzy - matic pathways, and biological chemicals.13 Protein–protein  interactions were identified with the search tool STRING  database.",OADS,/arxiv_data1/oa_pdf/f1/ea/ott-9-1327.PMC4790526.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f1/ea/ott-9-1327.PMC4790526.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/ea/ott-9-1327.PMC4790526.pdf
"dovepress.com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/07/30/imcrj-9-057.PMC4790530.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Medical Case Reports Journal 2016:9 57–60International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  57Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S10242 3Leg ischemia post-varicocelectomy abdullah M al-Wahbi1 shaza elmoukaied2 1Division of Vascular surgery,   Department of surgery, King  abdulaziz Medical City, Riyadh,   saudi arabia; 2Department of surgery,   Dr sulaiman al Habib Hospital,   Riyadh, saudi arabia Correspondence: abdullah M al-Wahbi   Division of Vascular surgery, Department  of surgery, King abdulaziz Medical City,  po Box 22490, Riyadh 11426, saudi  arabia   tel +966 11 801 1111 ext 15442   email wahbia@ngha.med.s a;   amw8855@gmail.co mAbstract:  Varicocelectomy is the most commonly performed operation for the treatment of  male infertility.",Non-OADS,/arxiv_data1/oa_pdf/07/30/imcrj-9-057.PMC4790530.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/07/30/imcrj-9-057.PMC4790530.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/30/imcrj-9-057.PMC4790530.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/49/jaa-9-037.PMC4790533.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Asthma and Allergy 2016:9 37–43submit your manuscript | www.dovepress.co m Dove press  37 http: //dx.doi.org/10.2147/JAA.S8873 9Aspirin-exacerbated respiratory disease:  pathophysiological insights and clinical   advances John w Steinke Jeff M wilson Asthma and Allergic Disease  Center, Carter immunology  Center, Department of Medicine,   University of virginia Health System,   Charlottesville, vA, USA Correspondence: John w Steinke   Asthma and Allergic Disease Center, Box  801355, University of virginia Health  System, Charlottesville,  v A 22908, USA   T el +1 434 982 3270   Fax +1 434 924 5779   email js3ch@virginia.ed uAbstract:  Asthma and chronic rhinosinusitis are heterogeneous airway diseases of the lower  and upper airways, respectively.",Non-OADS,/arxiv_data1/oa_pdf/62/49/jaa-9-037.PMC4790533.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/62/49/jaa-9-037.PMC4790533.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/49/jaa-9-037.PMC4790533.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/7f/prbm-9-031.PMC4790534.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/e2/7f/prbm-9-031.PMC4790534.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Psychology Research and Behavior Management 2016:9 31–39Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  31ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S10104 0The perception of intuition in clinical practice by  iranian critical care nurses: a phenomenological  study Parkhide hassani1 alireza abdi1 Rostam Jalali2 nader salari3 1Faculty of nursing and Midwifery,   shahid Beheshti University of Medical  sciences, T ehran, iran; 2Faculty of  nursing and Midwifery, Kermanshah  University of Medical sciences,   Kermanshah, iran; 3Department  of Biostatistics and epidemiology,   school of Public health, Kermanshah  University of Medical sciences,   Kermanshah, iran correspondence: alireza abdi  Faculty of nursing and Midwifery, shahid  Beheshti University of Medical sciences,  niayesh cross Road, Valiasr avenue,  T ehran 1985717443, iran   T el +98 918 337 0389   email a_abdi61@yahoo.co mBackground:  Intuition as a way of learning in nursing is applied to decision making and  judgment in complicated clinical situations.",Non-OADS,/arxiv_data1/oa_pdf/e2/7f/prbm-9-031.PMC4790534.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/e2/7f/prbm-9-031.PMC4790534.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e2/7f/prbm-9-031.PMC4790534.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy Breast Cancer: Targets and Therapy 2016:8 29–37Dove press submit your manuscript | www.dovepress.co m Dove press  MeThodologyopen access to scientific and medical research open Access Full T ext Article 29 http: //dx.doi.org/10.2147/BCTT .S8843 4Identification and prioritization of candidate   genes for symptom variability in breast cancer  survivors based on disease characteristics   at the cellular level Theresa A Koleck1 yvette P Conley2 1School of Nursing, 2Department of  Human Genetics, School of Nursing  and Graduate School of Public Health,   University of Pittsburgh, Pittsburgh,   PA, USA Correspondence: Theresa A Koleck   Department of Health Promotion  and Development, School of Nursing,  University of Pittsburgh, 440 Victoria  Building, 3500 Victoria Street,   Pittsburgh, PA 15261, USA   Tel +1 412 383 7641   Fax +1 412 624 8521   email tat30@pitt.ed uAbstract:  Research is beginning to suggest that the presence and/or severity of symptoms  reported by breast cancer survivors may be associated with disease-related factors of cancer.",Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
"Breast Cancer: Targets and Therapy 2016:8Table  1 Prognostic multigene expression profiles Profile Provider Number of  cancer genes  evaluatedClinical utility Patient eligibility Website Reference 11-gene  expression  signatureBreast Cancer   IndexSM bioTheranostics,   Inc. (San Diego,   CA, USA)7 (5 gene molecular  grade index;   2 gene hoXB13:   IL17BR index, an  expression ratio  biomarker)Predicts late (5–10 year) and overall (0–10  year) recurrence risk as well as likelihood of  endocrine therapy benefit; stratifies patients  into high or low risk of distant recurrence   and high or low likelihood of benefit from  extended endocrine therapyPatients with eR ( +), lymph node   (-/+, 1-3 positive nodes), early  stage breast cancer who are distant  recurrence-freehttp://breastcancerindex.co m 20–22 14-gene  prognostic  expression  signature Not currently  supported14 Predicts distant metastasis; guides treatment  decisions related to adjuvant therapyPatients with eR ( +),   lymph node ( -), early stage   breast cancerNA 23 21-gene breast  cancer assayoncotype dX® genomic health®, Inc.  (Redwood City, CA,  USA) 16 (for invasive  breast cancer) 7 (for DCIS)Predicts 10-year risk of distant recurrence   and likelihood of chemotherapy benefit   for invasive breast cancer; gene expression  levels are aggregated and provided as a   scaled Recurrence Score® result (on a   0–100 scale); patients are stratified into   high, intermediate, or low risk groups;   also provides quantitative single gene scores   for ER, PR, and HER2; predicts 10-year   risk of distant recurrence (DCIS or invasive)  for DCISPre- or post-menopausal patients with   eR (+), lymph node ( -), HER2 ( -),   stage I, II or IIIa invasive breast cancer Post-menopausal patients with lymph  node (+, 1–3 positive nodes), HR ( +),  heR2 (-), stage I, II or IIIa invasive   breast cancer DCIS treated by lumpectomy,  not mastectomy,  regardless of Tamoxifen status ( +/-)http://breast-cancer.oncotypedx.co m 24,25 50-gene breast  cancer   prognostic gene  signature assayProsigna® NanoString®   Technologies, Inc. (Seattle, WA, USA)50 Predicts 10-year distant  recurrence-free survival using gene-algorithm  generated Prosigna® Score (0–100); stratifies  patients into high, intermediate, or low risk  groups.",Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
"Provides risk group classification to  facilitate interpretation of Prosigna®   score with clinical outcomesPost-menopausal patients with hR ( +),   lymph node ( -), stage I or II invasive  breast cancer to be treated with   adjuvant endocrine therapy alone Post-menopausal patients with hR ( +),  lymph node ( +, 1–3 positive nodes),   stage II invasive breast cancer treated  with adjuvant endocrine therapy alonehttp://www.prosigna.co m 26 70-gene breast  cancer   recurrence   assayMammaPrint®  Agendia® (Irvine, CA, USA)70 Predicts 5- and 10-year distant recurrence  and guides treatment decisions, including  potential chemotherapy benefit; stratifies  patients into low or high risk groupsPatients with eR ( +/-), lymph node (–),   stage I or II invasive breast cancer   tumor #5 cm in sizehttp://www.agendia.com/healthcare- professionals/breast-cancer/mammaprin t27 Notes:  Information regarding Prosigna® is provided courtesy of NanoString Technologies, Inc., www.Prosigna.co m. © 2014–15 NanoString Technologies, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
"Lists of genes  were obtained from the following locations in March 2014: the  eleven-gene expression profile (Jerevall et al),28 the 14-gene  prognostic expression signature (Tutt et al),23 the 21-gene  breast cancer assay ( http://breast-cancer.oncotypedx.co m),",OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
"Breast Cancer: Targets and Therapy 2016:8submit your manuscript | www.dovepress.co m Dove press Dove press 34Koleck and Conley the 50-gene breast cancer prognostic gene signature assay  (https://genome.unc.edu/pubsup/breastGEO /), and 70-gene  breast cancer recurrence assay (Tian et al).40 Genes utilized  in two or more profiles were prioritized for selection.",Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
The node shapes and relationship type  legend can be found at http://ingenuity.force.com/ipa/articles/Feature_Description/ legen d.,OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
"Available from: http://breast-cancer.oncotypedx.com/en-US/ Professional-Invasive/~/media/ODX-Breast/Images/Invasive/Invasive - SalesAid_11-2.pd f. Accessed November 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
Available from: http://breast-cancer.oncotypedx.com/en-US/Profes - sional-DCIS/~/media/ODX-Breast/Files/Downloads/DCIS_Sales_Aid.,Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
"Available from: http://prosigna.com/ docs/Prosigna_Packet_Insert_US.pd f. Accessed October 5, 2015.",OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
Available from: http://www.agendia.com/healthcare-professionals/ breast-cancer/mammaprint /.,Non-OADS,/arxiv_data1/oa_pdf/02/33/bctt-8-029.PMC4790538.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ff/f4/amep-7-145.PMC4790539.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/ff/f4/amep-7-145.PMC4790539.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Advances in Medical Education and Practice 2016:7 145–151Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  145OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S9358 2Perspectives of primary health care physicians on  diagnosing and referring patients with apparent  osteolytic lesions on plain X-ray films: a cross- sectional study Ali Alyami1,2 Yasser Alshomrani1,3 rayyan suqaty1 shaddy Futtiny1 Faisal Alnaqib1 Muath Albarakati1 Ahmad Alhazmi1,4 1King Abdullah international Medical  research center, Jeddah, 2Department  of Orthopaedic surgery, college of  Medicine, King saud Bin Abdul-Aziz  University for health science, Jeddah,   3Department of Orthopaedic surgery,   4Department of surgery, Faculty of  Medicine, Umm Alqura University,   Makkah, saudi Arabia correspondence: Yasser Alshomrani   Department of Orthopaedic surgery,  Faculty of Medicine, Umm Alqura  University, PO Box 71709, Jeddah 21597,  saudi Arabia   Email Yasser.shom@hotmail.co mBackground and objectives:  The identification and diagnosis of musculoskeletal symptoms  are major challenges for primary care physicians.",Non-OADS,/arxiv_data1/oa_pdf/ff/f4/amep-7-145.PMC4790539.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/ff/f4/amep-7-145.PMC4790539.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/f4/amep-7-145.PMC4790539.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/60/87/nss-8-073.PMC4790540.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Nature and Science of Sleep 2016:8 73–79submit your manuscript | www.dovepress.co m Dove press  73 http: //dx.doi.org/10.2147/NSS.S7151 3Progress in elucidating the pathophysiological  basis of nonrapid eye movement parasomnias: not  yet informing therapeutic strategies András Horváth1,2 Anikó Papp1 Anna Szűcs1 1Department of Neurology, National  institute of Clinical Neurosciences,   2János Szentágothai Doctoral School  of Neurosciences, Semmelweis  University School of PhD Studies,   Budapest, Hungary Correspondence: Anna Szűcs   Department of Neurology, National  institute of Clinical Neurosciences,    1144 Budapest, Amerikai út  57, Hungary   Tel +36 30 68 4262  email szucsan@gmail.co mAbstract:  Nonrapid eye movement (NREM) or arousal parasomnias are prevalent conditions  in children and young adults, apparently provoked by any medical, physical, mental, or  pharmacologic/toxic agent disturbing normal biorhythm and causing sleep fragmentation or  abundant amount of slow wave sleep.",Non-OADS,/arxiv_data1/oa_pdf/60/87/nss-8-073.PMC4790540.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/60/87/nss-8-073.PMC4790540.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/87/nss-8-073.PMC4790540.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/61/dkv416.PMC4790616.pdf
"Data analysis and software All data analysis was performed in the software NONMEM (version 7.3; Icon Development Solutions, http:/ /www.iconplc.com/technology/ products/nonmem) using the ﬁrst-order conditional estimation method with interaction (FOCE INTER).25R (version 3.2; R Foundation for Statistical Computing, http://www.R-project.org) was used for data man- agement and Xpose (version 4.5.0; Department of Pharmaceutical Biosciences, Uppsala University, http://xpose.sourceforge.net) was used for graphical assessment of results.26PsN (version 4.4.5; Department of Pharmaceutical Biosciences, Uppsala U niversity, http://psn.sourceforge.",OADS,/arxiv_data1/oa_pdf/0b/61/dkv416.PMC4790616.pdf
"net) was used for running models,26generating visual predictive checks (VPCs)26and prediction-corrected visual predictive checks (pcVPCs).27 Numerical model comparison and a run record were utilized and main-tained with the software Pirana (version 2.9.2; Pirana Software & Consulting, http://www.pirana-software.com).",OADS,/arxiv_data1/oa_pdf/0b/61/dkv416.PMC4790616.pdf
"London :European Medicinal Agency, 2010. http://www.ema.",Non-OADS,/arxiv_data1/oa_pdf/0b/61/dkv416.PMC4790616.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/bf/dkv430.PMC4790618.pdf
http://www.sante.,Non-OADS,/arxiv_data1/oa_pdf/69/bf/dkv430.PMC4790618.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/99/dkv441.PMC4790620.pdf
"ESBL- and carbapenemase-encoding genes were characterized by PCR and sequencing (BaseClear, Leiden, The Netherlands).8–11Sequenceswere analysed with Bionumerics software (version 6.6; Applied Maths, Sint-Martens-Latem, Belgium) and compared with sequences in the NCBI (http://www.ncbi.nlm.nih.gov/BLAST) and Lahey database (http:// www.lahey.org/studies/).",OADS,/arxiv_data1/oa_pdf/dd/99/dkv441.PMC4790620.pdf
Molecular typing E. coli strains were typed by MLST (http://mlst.warwick.ac.uk/mlst/mlst/ dbs/Ecoli).,OADS,/arxiv_data1/oa_pdf/dd/99/dkv441.PMC4790620.pdf
http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/ Pages/database.aspx.,Non-OADS,/arxiv_data1/oa_pdf/dd/99/dkv441.PMC4790620.pdf
2012. http://www.nvmm.nl/richtlijnen/hrmo-laboratory- detection-highly-resistant-microorganisms.,Non-OADS,/arxiv_data1/oa_pdf/dd/99/dkv441.PMC4790620.pdf
http://www.eucast.org/clinical_breakpoints/.,Non-OADS,/arxiv_data1/oa_pdf/dd/99/dkv441.PMC4790620.pdf
http://esa.un.org/unpd/wpp/General/Files/Deﬁnition_of_Regions.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/99/dkv441.PMC4790620.pdf
http://www.wageningenur.,Non-OADS,/arxiv_data1/oa_pdf/dd/99/dkv441.PMC4790620.pdf
"The extent of ICAM-1 immunostaining  in the heart  tissue was expressed  as a percentage  of the area of 10 random,   non-overlapping  fields per slide at x400 magnification  using  ImageJ software (http://rsb.info.nih.gov /ij).",OADS,/arxiv_data1/oa_pdf/0a/f1/ijmm-37-04-1023.PMC4790655.pdf
The Geneprint PowerPlex 16 System user  manual is available  at http://www.cstl.nist.gov/strbase/images/power - plex16.pdf.,OADS,/arxiv_data1/oa_pdf/8c/e4/ijmm-37-04-0879.PMC4790663.pdf
The predicted miRNA  binding sites were downloaded from TargetScan 6.2 Mouse  (http://www.targetscan.org/mmu_61/).,OADS,/arxiv_data1/oa_pdf/a7/29/ijmm-37-04-0967.PMC4790696.pdf
The microarray data are available at http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/fb/e2/ijmm-37-04-0867.PMC4790710.pdf
The captured images  were analyzed and their fluorescen ce intensity was analyzed by  densitometry with ImageJ software (http://imagej.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/fb/e2/ijmm-37-04-0867.PMC4790710.pdf
Annotations  for biological processes are from the Gene Ontology Consortium (http://geneontology.org/).,OADS,/arxiv_data1/oa_pdf/fb/e2/ijmm-37-04-0867.PMC4790710.pdf
GenBank and gene names can be  searched at http://www.ncbi.nlm.nih.gov/gene/.,OADS,/arxiv_data1/oa_pdf/fb/e2/ijmm-37-04-0867.PMC4790710.pdf
GenBank and gene names can be found at http://www.ncbi.nlm.nih.gov/gene/.,OADS,/arxiv_data1/oa_pdf/fb/e2/ijmm-37-04-0867.PMC4790710.pdf
Sequencing adaptors were removed using SEQPREP 0.4 (https://github.com/ jstjohn/SeqPrep).,OADS,/arxiv_data1/oa_pdf/03/43/MEC-25-943.PMC4790908.pdf
"2013) genes associated with stickleback ENSEMBL IDs, with annotation information from ftp://ftp.geneontology.org/pub/go/gene-associations/gene_association.z-ﬁn.gz.",OADS,/arxiv_data1/oa_pdf/03/43/MEC-25-943.PMC4790908.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org Ranz JM, Machado CA (2006) Uncovering evolutionary pat- terns of gene expression using microarrays.",Non-OADS,/arxiv_data1/oa_pdf/03/43/MEC-25-943.PMC4790908.pdf
": PRJEB8677, URL: http://www.ebi.ac.uk/ena/data/ view/PRJEB8677).",OADS,/arxiv_data1/oa_pdf/03/43/MEC-25-943.PMC4790908.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3f/f2/1002.PMC4791122.pdf
Computer code Software created for data analysis and simulation is accessible at  http://stmc.health.unm.edu/tools-and-data/index.html.The null hypothesis is not rejected if the p value is larger than a  specified level of significance.,Non-OADS,/arxiv_data1/oa_pdf/3f/f2/1002.PMC4791122.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a4/af/1015.PMC4791123.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/32/ce/1040.PMC4791125.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/de/a6/873.PMC4791126.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/18/46/875.PMC4791127.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f7/e5/877.PMC4791128.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1c/44/878.PMC4791129.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e5/5d/880.PMC4791130.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1f/06/881.PMC4791131.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e9/ca/882.PMC4791132.pdf
"Tools: Sequencing of the 0.9 Gb genomes of one inbred line and one natural population was recently  completed [4]; multiple transcriptomes are available from different tissues, stages and populations   (http://4dx.embl.de/platy/) [5].",OADS,/arxiv_data1/oa_pdf/e9/ca/882.PMC4791132.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/56/d2/888.PMC4791133.pdf
"MATERIALS AND METHODS Fly strains Detailed information for the fly strains used is given at FlyBase  (http://flybase.bio.indiana.edu/), except where noted.",Non-OADS,/arxiv_data1/oa_pdf/56/d2/888.PMC4791133.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/66/a6/897.PMC4791134.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/de/e5/907.PMC4791135.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5b/91/919.PMC4791136.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/930.PMC4791137.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0b/01/954.PMC4791139.pdf
Proteins were identified using  MS-Fit software (http://prospector.ucsf.edu/prospector/mshome   .htm).,OADS,/arxiv_data1/oa_pdf/0b/01/954.PMC4791139.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8b/65/967.PMC4791140.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a1/b6/979.PMC4791141.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3e/13/990.PMC4791142.pdf
The overall survival analysis inlung cancer patients was conducted using the Kaplan –Meier Plotter webtool (http://www.kmplot.com/lung) and mRNA data from an aggregate mega-database associated with kmplot.,OADS,/arxiv_data1/oa_pdf/cf/cf/onc2015328a.PMC4791215.pdf
Kaplan –Meier survival analysis associated with LZTFL1 mRNA expression value and copy number variation segment mean from TCGA level 3 data were performed by comparing the survival distribution of two groups with logrank test using the X-tile software (http://medicine.yale.,OADS,/arxiv_data1/oa_pdf/cf/cf/onc2015328a.PMC4791215.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)LZTFL1 in lung cancer Q Wei et al 2663 © 2016 Macmillan Publishers Limited Oncogene (2016) 2655 –2663",Non-OADS,/arxiv_data1/oa_pdf/cf/cf/onc2015328a.PMC4791215.pdf
http://www.mhlw.go.jp/bunya/koyoukintou/josei-jitsujo/11.html.,Non-OADS,/arxiv_data1/oa_pdf/5f/32/indhealth-54-005.PMC4791288.pdf
"http://en.wikipedia.org/ wiki/Shahrud,_Iran.",Non-OADS,/arxiv_data1/oa_pdf/36/7d/indhealth-54-014.PMC4791289.pdf
http://www.who.int/social_determinants/thecommission/finalreport/en/.,Non-OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
3) International Labour Office (2012) Global employment trends for youth 2012. http://www.ilo.org/global/research/global-reports/global-employment-trends/youth/2012/ WCMS_180976/lang–en/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
Annual Report on the Labour Force Survey 2012. http://www.stat.go.jp/english/data/roudou/ report/2012/.,OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
http://dx.doi.org/  10.1787/factbook-2014-en.,Non-OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
"16) Japan Ministry of Health, Labour and Welfare (2013) State  of Workers’ Accident Compensation for Brain and Heart  Disease and Mental Disorders 2013. http://www.mhlw.",Non-OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
http://www.ilo.,Non-OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
http://www.who.int/whr/2001/en/.,OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
28) Japan Cabinet Office White paper on suicide prevention in Japan (2012) http://www8.cao.go.jp/jisatsutaisaku/ whitepaper/en/w-2012/summary.html.,Non-OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
"[Medline]   [CrossRef]  43) Japan Ministry of Health, Labour and Welfare (2012) Year book of labour statistics 2012. http://www.mhlw.go.jp/english/database/db-yl/index2012.html.",Non-OADS,/arxiv_data1/oa_pdf/6d/e6/indhealth-54-020.PMC4791290.pdf
Available in PDF-format: https://osha.europa.eu/en/ publications/e-facts/efact38.,Non-OADS,/arxiv_data1/oa_pdf/1c/4c/indhealth-54-058.PMC4791294.pdf
9) Framework agreement on harassment and violence at work  Brussels: The European Trade Union Confederation; 2007.  http://www.etuc.org/framework-agreement-harassment- and-violence-work.,Non-OADS,/arxiv_data1/oa_pdf/a4/b1/indhealth-54-068.PMC4791295.pdf
[Medline]   [CrossRef]  25) Cambridge Neuropsychological Test Automated Battery  (CANTAB): http://www.cambridgecognition.com/ clinicaltrials/cantabsolutions/tests.,Non-OADS,/arxiv_data1/oa_pdf/40/13/indhealth-54-079.PMC4791297.pdf
http://collegiumramazzini.org/download/3_ThirdCRS   tatement(1993).pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://collegiumramazzini.org/download/6_SixthCRS   tatement(1999).pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://collegiumramazzini.org/ download/11_EleventhCRStatement(2004).pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://collegiumramazzini.org/download/15_ FifteenthCRStatement(2010).pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://minerals.usgs.gov/ minerals/pubs/commodity/asbestos/myb1-2013-asbes.pdf.,OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://www.who.int/ipcs/assessment/public_health/ chrysotile_asbestos_summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://monographs.iarc.fr/ENG/Monographs/ vol100C/mono100C.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://www.who.int/healthinfo/global_burden_ disease/GlobalHealthRisks_report_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://www.ibasecretariat.org/chron_ban_list.php.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
http://www.icohweb.org/ site_new/multimedia/news/pdf/ICOH%20Statement%20on%20global%20asbestos%20ban.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/indhealth-54-087.PMC4791298.pdf
"See Table 1 and Supplementary Table 2, http://links.lww.com/INNOV/A72, for reference.",Non-OADS,/arxiv_data1/oa_pdf/a0/30/itt-11-07.PMC4791312.pdf
Available at: http://www.asahq.org/resources/standards-and- guidelines.,Non-OADS,/arxiv_data1/oa_pdf/75/69/ane-122-1070.PMC4791313.pdf
Available at: http://www.gastro.org/practice/resour - celibrary/guidelines/Capnography_for_Moderate_Sedation.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/69/ane-122-1070.PMC4791313.pdf
"More detail  regarding statistical modeling issues and decisions made in  these analyses is provided as Supplemental Digital Content, Response to Statistical Editor Review (http://links.lww.com/AA/B357).",Non-OADS,/arxiv_data1/oa_pdf/75/69/ane-122-1070.PMC4791313.pdf
April 2016 • Volume 122 • Number 4  www.anesthesia-analgesia.org   1075  http://links.lww.com/AA/B357) shows comparison of  medication administration excluding patients who were transferred to other procedural or care areas early after  study participation).,Non-OADS,/arxiv_data1/oa_pdf/75/69/ane-122-1070.PMC4791313.pdf
"Database variable deﬁnitions used for the study are available at http://www.ucl.ac.uk/nicor/ audits/Adultcardiacsurgery/datasets, and variables generatedwithin this study predominately follow the deﬁnitions as given by the EuroSCORE model.",OADS,/arxiv_data1/oa_pdf/ef/6f/itt-11-15.PMC4791314.pdf
"The distributions of logistic EuroSCORE in the MIAVR and CAVR cohorts have remained comparable throughout the study (SupplementaryDigital Content, http://links.lww.com/INNOV/A71).",OADS,/arxiv_data1/oa_pdf/ef/6f/itt-11-15.PMC4791314.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/ef/6f/itt-11-15.PMC4791314.pdf
"E-mail: shohng@snu.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.12.235Received 16 November 2015Keywords: Argonaute, miRNA, siRNA, Single-molecule FRET Abbreviations:  miRNA, microRNA; siRNA, small interfering RNA;  RISC, RNA-induced silencing complex; FRET , fluorescence reso-nance energy transfer Perspective to:  Myung Hyun Jo et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/4f/BMB-48-643.PMC4791318.pdf
"(2015), Human Argonaute 2  Has Diverse Reaction Pathways on Target RNAs, Molecular Cell, Volume 59, Issue 1, p117-124, 2 July 2015, http://dx.doi.org /  10.1016/j.molcel.2015.04.027 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Single-molecule fluorescence  measurements reveal the  reaction mechanisms of the core-RISC, composed of human Argonaute 2 and a guide RNA Myung Hyun Jo1,2,3, Ji-Joon Song5 & Sungchul Hohng1,2,3,4,* 1Department of Physics and Astronomy, 2Institute of Applied Physics, 3National Center of Creative Research Initiatives, and 4Department of  Biophysics and Chemical Biology, Seoul National University, Seoul 08826, 5Department of Biological Sciences, KAIST, Daejeon 34141, Korea In eukaryotes, small RNAs play important roles in both gene  regulation and resistance to viral infection.",Non-OADS,/arxiv_data1/oa_pdf/ab/4f/BMB-48-643.PMC4791318.pdf
644 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/ab/4f/BMB-48-643.PMC4791318.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.12.227Received 2 November 2015Keywords: Bone marrow microenvironment, Hematopoietic stem  cell, Neuropeptide Y , Regeneration, Sympathetic nervous system Abbreviations:  NPY , Neuropeptide Y; SNS, Sympathetic nervous  system; HSCs, Hematopoietic stem cells; BM, Bone marrow; MSCs, Mesenchymal stem cells; ECs, Endothelial cells; TGF- Transform - ing growth factor-beta; CM, conditioned medium Perspective to:  Min Hee Park et al.",Non-OADS,/arxiv_data1/oa_pdf/bf/60/BMB-48-645.PMC4791319.pdf
646 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/bf/60/BMB-48-645.PMC4791319.pdf
"Tel: +82-31-961-5224; Fax: +82-31-961-  5206; E-mail: kohw@dongguk.edu http://dx.doi.org/10.5483/BMBRep.2015.48.12.229Received 4 November 2015Keywords: Ciliogenesis, Ciliopathy, Insulin, Leptin, Obesity, Primary  cilia ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Primary cilia in energy balance signaling and metabolic  disorder  Hankyu Lee, Jieun Song, Joo Hyun Jung & Hyuk Wan Ko * College of Pharmacy, Dongguk University, Goyang 10326, Korea Energy homeostasis in our body system is maintained by bal- ancing the intake and expenditure of energy.",Non-OADS,/arxiv_data1/oa_pdf/46/85/BMB-48-647.PMC4791320.pdf
648 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/46/85/BMB-48-647.PMC4791320.pdf
"649 http://bmbreports.org BMB ReportsGene Murine mutation Murine phenotype Human phenotypeCiliary  localization ALMS1 Alms1fozRetinal dysfunction, hearing loss, obesity,  hyperinsulinemia, male-specific hyperglycemia, hypogonadismShort stature, wide feet, retinal degeneration,  hearing loss, mental retardation, hypothyroidism, truncal obesity, t2dm, insulin resistance, hepatic  dysfunction, hyperlipidemia, hypogonadismTransition zone BBS1 Bbs1 tm1VcsPolydactyly, abnormal olfactory sensation,  hydrocephalus, obesity, polycystic kidneyPolydactyly, retinopathy, hypogenitalism, mental  retardation, congenital heart disease, obesity,  diabetes mellitus, hypertension, renal  malformationAxoneme, Basal  body BBS2 Bbs2tm1VcsAbnormal social interaction, polydactyly,  abnormal brain neuroanatomy, mislocalization of  rhodopsin, obesity, absent sperm flagellarDevelopmental delay, polydactyly, retinitis  pigmentosa, obesity, renal gonadal malformationAxoneme, Basal  body BBS3 Arl6tm1VcsPolydactyly, retinal degeneration, hydrocephalus,  obesity, absent sperm flagellarObesity, renal anormalies, reproductive  dysfunctionAxoneme BBS4 Bbs4tm1VcsEmbryonic lethality, retinal degeneration,  impaired olfaction, obesity, polyphagia, renal  abnormalities, male infertilityPolydactyly, retinal dystrophy, chronic nasal  congestion, genitourinary malformations,  learning disabilities, obesity, renal anormaliesBasal body,  pericentriolar BBS5 Bbs5tm1b(EUCOMM)WtsiSkeleton dysplasia, retina dysplasia, obesity,  thrombocytopeniaPolydactyly, retinal dystrophy, learning  difficulties, congenital heart disease, obesity,  renal anormaliesAxoneme, Basal  body, Membrane BBS6 Mkkstm1VcsDecreased aggression, hypoactivity, retinal  degeneration, impaired olfaction, hypertension,  obesity, hyperphagia, absence of flagellaPolydactyly, congenital heart disease,  hydrometrocolposCentrosome, Basal  body, Cytoplasm BBS7 Bbs7tm1VcsRetinal degeneration, ventriculomegaly, obesity,  polycystic kidney, lack of spermatozoa flagellaPolydactyly, retinal dystrophy, hypogenitalism,  learning difficulties, obesity, renal abnormalitiesBasal body,  Cytoplasm,  Nucleus BBS8 Ttc8tm1ReedRetinal degeneration, impaired olfation, obesity,  renal tubule dilationCognitive impairment, polydactyly, retinitis  pigmentosa, situs inversus, obesityBasal body,  Cytoplasm, Focal  adhesion BBS9 None None Polydactyly, retinal dystrophy, mental retardation,  obesity, renal dysfunctionBasal body BBS10 Bbs10−/−Retinal degeneration, obesity, hyperphagia,  hyperleptinemia, renal abnormalitiesPolydactyly, retinal dystrophy, intellectual  disability, obesity, renal dysfunction, hypogonadismBasal body BBS12 Bbs12tm1.1VmarObesity, increased insulin sensitivity, increased  glucose usage, decreased inflammatory responseMyopia, astigmatism, night blindness, retinitis  pigmentosa, hypodontia, obesityBasal body,  Cytoplasm BBS17 (LZTFL1)None None Polydactyly, retinal degeneration, polyuria,  polydypsia, obesity, polycystic kidney,  hypogonadismCytoplasm BBS18 (BBIP10)Bbip10tm1.1GnePostnatal lethality, retinal degeneration, obesity,  hyperphagia, male infertilityBehavioral dysfunction, brachydactyly, visual  impairment, learning difficulties, obesityAxoneme BBS19 (IFT27)Ift27null1Polydactyly, abnormal flexure of the wrists,  micrognathia, hypotelorism, omphaloceles,  cyanosis, cardiac malformation, lung isomerismsAtopy, polydactyly, retinitis pigmentosa,  hypogenitalism, congenital heart disease,  obesity, fatty liver, renal hypoplasiaAxoneme Arl13b Arl13bhnnLeft-right randomization, defects of neural  patterningRetinal anomalies, molar tooth sign, superior  vermian dysgenesis, elongated cerebellar  peduncles, obesityMembrane Cep19 Cep19tm2.1JmgiObesity, hyperphagia, glucose intolerant, insulin  resistantIntellectual disability, coronary artery disease,  myocardial infarctions, congestive heart failure,  obesity, t2dm, decreased sperm counts.Distal appendage IFT88 Tg737loxP; CAGG-CreERObesity, hyperphagia, hyperglycemia,  hyperinsulnemia, hyperleptinemia, cystic kidneyNone Axoneme INPP5E Inpp5etm1SschBilateral anophthalmos, bifid sternum, cleft palate,  hexadactyly, anencephaly or exencephaly, cystic kidneysRetinal dystrophy, molar tooth sign, mental  retardation, truncal obesity, micropenis syndromeMembrane Kif3A Kif3a loxP; CAGG-CreER  or POMC-CreObesity, hyperphagia, hyperglycemia,  hyperinsulnemia, hyperleptinemia, cystic kidneyNone Axoneme Rab23 Rab23opbEmbryonic lethal, polydactyly, open brain Craniosynostosis, polydactyly, obesity Axoneme RPGRIP1L Rpgrip1ltm1a(EUCOMM)WisiObesity, hyperphagia None Transition zone Tubby TubtubRetinal degeneration, hearing loss, obesity,  hyperinsulinemiaNight blindness, decreased visual acuity, obesity Axoneme(?",Non-OADS,/arxiv_data1/oa_pdf/46/85/BMB-48-647.PMC4791320.pdf
"650 BMB Reports http://bmbreports.orgshare common clinical features, indicating dedicated bio- logical roles for the each set of ciliary structural modules (15).",OADS,/arxiv_data1/oa_pdf/46/85/BMB-48-647.PMC4791320.pdf
651 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/46/85/BMB-48-647.PMC4791320.pdf
"652 BMB Reports http://bmbreports.org(Ptch1) to release its inhibition of the GPCR-like protein,  Smoothened (Smo), leading to ciliary localization.",Non-OADS,/arxiv_data1/oa_pdf/46/85/BMB-48-647.PMC4791320.pdf
"653 http://bmbreports.org BMB ReportsACKNOWLEDGEMENTS This research was supported by Korea Mouse Phenotyping  Project (NRF-2014M3A9D5A01073969) of the Ministry of  Science, ICT and Future Planning through the National Research Foundation to H.W.K.",Non-OADS,/arxiv_data1/oa_pdf/46/85/BMB-48-647.PMC4791320.pdf
"654 BMB Reports http://bmbreports.orgmice, and obesity.",Non-OADS,/arxiv_data1/oa_pdf/46/85/BMB-48-647.PMC4791320.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.12.249Received 1 December 2015Keywords: Adult stem cells, Advanced imaging, Intravital imaging,  Lineage tracing, Tissue clearing ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
656 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
657 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
"658 BMB Reports http://bmbreports.orgStandard Fluorescence  MicroscopeLaser scanning Confocal  Microscope2-photon Confocal  MicroscopeLight Sheet Microscope Imaging depth All (Out of focus because  of lacking focal plane  selection)Up to 500 m Up to 1 mm Up to 500 m Image plane selection No Yes Yes Yes Photo bleaching Medium – High (LED light  for reduced bleaching)Medium Low Very Low (Due to  increased imaging speed  and selected illumination) Cell Viability Low – High  (LED light for increased  cell viability)High High Very High (Due to  increased imaging speed  and selected illumination) Excitation All Entire specimen in  objective focal axisLimited to objective focal  volumeEntire specimen in focal  plane Laser light scattering N/A High Low Very highEmission light scattering N/A Dependent on specimen  and image depthDependent on specimen  and image depthDependent on specimen,  mounting, and image  depth Price Low - High High Very High (Laser) Low - Very High Main Limitations Imaging Depth,  Z-resolutionImaging time,  photo-damageImaging time, heat, price Imaging depth (Steric  hindrance), price, specimen mounting is  crucial, implementation  of most recent optimizations ongoing Main advantages Accessibility, very good  for 2D of thin sections, additional deconvolutionAccessibility, 3D imaging Imaging depth, low  photodamageImaging speed, very low  photodamage, specimen sizeTable 1.",Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
"659 http://bmbreports.org BMB ReportsBABB (Becker et al,  2008; Dent et al, 1989;  Dodt et al, 2007;  Spalteholz, 1914)Scale (Hama et al, 2011)Tetrahydrofuran (THF)  (Ertürk et al, 2012b)3DISCO (Becker et al,  2012; Ertürk et al,  2012a)CLARITY (Chung et al,  2013; Lee et al , 2014;  Tomer et al, 2014)PACT (passive CLARITY  technique ) / PARS  (perfusion-assisted agent  release in situ) (Yang et  al, 2014) Fixation method and  other tissue preparationPFA perfusion PFA perfusion PFA perfusion PFA perfusion PFA, acrylamide,  bis-acrylamide,  VA044 perfusionPFA perfusion and  subsequent hydrogel /  initiator perfusion Dehydration Yes No Yes Yes No No Clearing solution Benzylalcohol,  benzylbenzoateScaleA2:  Urea,  glycerol, Triton X-100THF, dichloromethane  (DCM),  benzylalcohol,  benzylbenzoateTHF, DCM, dibenzyl  ether (DBE)Active transport  organ-electrophoresis  approach  -electrophoretic tissue clearing (ETC) in  sodium borate buffer  containing 4% SDSUp to 2 weeks 8%SDS  in PBS, pH 7.5 at  37 o-42oC followed by  extensive PBS  perfusion washing  over 2-3 days Time of protocol Up to  3 days or more 3 days - several weeks  (- months)∼1 day ∼1 day ∼7-21 days 2-3 days for most  organs, 1-2 weeks for  whole brain Tissue clearing principle  (RI matching)Dehydration Increased RI of  aqueous phaseDehydration and lipid  removal (THF)Dehydration and lipid  removal (DCM)Ionic lipid extraction  (Passive or  electrophoretic)Ionic lipid extraction Fluorescence quenching High (Dehydration) Minimal High (Dehydration) Continuous quenching  in final clearing solutionNo No Main Disadvantages Not compatible with  tissues containing a high degree of lipids, fluorescence  quenching,  autofluorescence, benzylbenzoate and  benzylalcohol are  toxic and dissolve  plasticLong clearing process,  fragility of cleared  samples, sample expansion Impaired ultrastructure,  loss of cellular and molecular information due to lipid removal,  benzylbenzoate and  benzylalcohol are toxic and dissolve  plasticQuenching in final  clearing solution  requires immediate imaging, loss of  cellular and  molecular information due to lipid removalPassive: Long clearing  Electrophoretic:  Additional equipment  needed (platinum  electrodes), possible  epitope loss, heatingRelatively slow for  large organs like whole brain (compared to BABB,  Scale, THF or  3DISCO), perfusion chamber required Main Advantages Accessibility to  reagentsSignal preservation of  fluorescent proteins, adjustable formula for  various organs, low  toxicity of chemicalsReduced fluorescence  quenching, antibody use possible, but long  incubation times  requiredRelatively low  fluorescence quenching, lipid  removal, antibody use  possible, but long incubation times  requiredPreservation of  biological information  by providing physical  framework, no  quenching due to ionic extraction  technique, deep  antibody penetration with long incubation  timesSuperior to CLARITY  due to lack of  electrophoresis and  reduction of tissue  degradation, more cost effective than  CLARITY, reduced  tissue swelling, fast simultaneous clearing  of multiple tissuesTable 2.",Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
660 BMB Reports http://bmbreports.orgtissue (58).,OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
661 http://bmbreports.org BMB Reportsdetailed analysis of the stem cell compartment by discarding  potentially misleading clone information caused by the high proliferative turnover of the transit amplifying cell population.,Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
662 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
663 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
664 BMB Reports http://bmbreports.orgof 5-Bromodeoxyuridine on Deoxyribonucleic Acid-Thy- mine Synthesis and Cell Metabolism of Lymphatic Tissues and Tumors Effect of 5-Bromodeoxyuridine on Deoxyri- bonucleic Acid- Thymine Synthesis and Cell Metabolism  of Lymphatic Tissues and Tumors.,Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
665 http://bmbreports.org BMB Reportshigh spatiotemporal resolution.,Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
666 BMB Reports http://bmbreports.orgby clonal analysis.,OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
667 http://bmbreports.org BMB Reports109.,Non-OADS,/arxiv_data1/oa_pdf/38/54/BMB-48-655.PMC4791321.pdf
"Tel: +1-323-442-3308; Fax: +1-323-442-  4040; E-mail: qying@med.usc.edu http://dx.doi.org/10.5483/BMBRep.2015.48.12.215Received 20 October 2015Keywords: Adult stem cells, Embryonic stem cell self-renewal,  Neural stem cells, Stem cells, Wnt/ -catenin pathway ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Stem cell maintenance by manipulating signaling pathways:  past, current and future Xi Chen1, Shoudong Ye2 & Qi-Long Ying1,* 1Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Department of Stem Cell Biology and  Regenerative Medicine, Keck School of Medicine, Universi ty of Southern California, Los Angeles, CA 90033, USA, 2Center for Stem Cell  and Translational Medicine, School of Life Sciences, Anhui University, Hefei 230601, P.R.",Non-OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
"669 http://bmbreports.org BMB ReportsStem cell lines Source of origin Key components Key signaling pathways Species tested Ref Pluripotent     ESC ICM LIF + serum/BMP4 JAK/STAT3, SMAD Mouse 3 ICM CHIR + PD03 Wnt/ -catenin, MAPK Mouse, rat 4,5,6     EG cells PGC LIF + FGF2 + SCF JAK/STAT3, FGF Mouse 27-30 PGC LIF + FGF2 + Forskolin JAK/STAT3, FGF Human 25,26 PGC LIF + CHIR + PD03 JAK/STAT3, Wnt/ -catenin,  MAPKMouse, rat 31     EpiSC Epiblast Activin + FGF2 TGF- /SMAD, FGF Mouse, human 7,8 Epiblast CHIR + IWR-1 Wnt/ -catenin Mouse, human 22     SSC Testis GDNF + FGF2 + LIF PI3K/AKT, MAPK Mouse, rat 33Extraembryonic      TS Trophectoderm FGF4 + heparin + Activin/Nodal FGF/ERK Mouse 23     XEN Primitive endoderm FGF FGF/ERK Mouse 24Adult tissue     NSC Primitive neural  ectodermLIF + CHIR JAK/STAT, Wnt/ -catenin Mouse, rat, human 35-37 Late embryonic or  adult brainFGF2 + EGF MAPK, PI3K Mouse, human 38,39     Intestinal stem cells Intestine EGF + Noggin + R-spondin Wnt Mouse, human 34     Liver stem cells Liver EGF + Noggin + R-spondin +  Wnt-3A + FGF10 + HGF +  NicotinamideWnt Mouse, human 44Table 1.",Non-OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
"670 BMB Reports http://bmbreports.orggermline transmission test (1, 2, 5, 6).",OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
671 http://bmbreports.org BMB Reportsids undergo symmetric cell division to produce more stem  cells.,Non-OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
672 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
673 http://bmbreports.org BMB Reportsvealed that mouse ESCs cultured in 2i are similar to cells in  the E2.5-3.5 embryo while mouse ESCs maintained in LIF re-semble epiblast cells in the E4.5 late blastocyst.,Non-OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
674 BMB Reports http://bmbreports.orgof LIF or CHIR alone.,OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
"675 http://bmbreports.org BMB ReportsCell 13, 663-675 19.",Non-OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
676 BMB Reports http://bmbreports.orgMeloche S and Smith A (2007) FGF stimulation of the  Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage com-mitment.,OADS,/arxiv_data1/oa_pdf/06/85/BMB-48-668.PMC4791322.pdf
"Yael Yaniv, Tel: 972-4-8294124; Fax: 972-  4-8294599; E-mail: yaely@bm.technion.ac.il, Edward G. Lakatta,  Tel: 1-410-558-8202; Fax: 1-410-558-8150; E-mail: lakattae@  grc.nia.nih.gov http://dx.doi.org/10.5483/BMBRep.2015.48.12.061Received 1 April 2015, Revised 20 April 2015,  Accepted 11 May 2015 Keywords: Cardiac denervation, Coupled-clock pacemaker system,  Fractal-like behavior, Heart rate variability, Ultradian rhythm of the heart rate ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The end effector of circadian hear t rate variation: the sinoatrial  node pacemaker cell Yael Yaniv1,* & Edward G. Lakatta2,* 1Biomedical Engineering Faculty, Technion-IIT, Haifa, Israel, 2Laboratory of Cardiovascular Science, Biomedical Research Center,  Intramural Research  Program, National Institute on Aging, NIH, Baltimore, Maryland, USA Cardiovascular function is regulated by the rhythmicity of  circadian, infradian and ultradian clocks.",Non-OADS,/arxiv_data1/oa_pdf/a2/21/BMB-48-677.PMC4791323.pdf
Pacemaker cell and circadian variation Yael Yaniv and Edward G. Lakatta 678 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/a2/21/BMB-48-677.PMC4791323.pdf
Pacemaker cell and circadian variation Yael Yaniv and Edward G. Lakatta 679 http://bmbreports.org BMB ReportsMini summary * Circadian genes are expressed in the heart.,Non-OADS,/arxiv_data1/oa_pdf/a2/21/BMB-48-677.PMC4791323.pdf
Pacemaker cell and circadian variation Yael Yaniv and Edward G. Lakatta 680 BMB Reports http://bmbreports.orgcal diastolic Ca2+ releases that activate an inward Na+-Ca2+  exchanger current (23).,OADS,/arxiv_data1/oa_pdf/a2/21/BMB-48-677.PMC4791323.pdf
Pacemaker cell and circadian variation Yael Yaniv and Edward G. Lakatta 681 http://bmbreports.org BMB Reportsmitochondrial ATP production can maintain circadian rhythms  of pacemaker cell activity.,OADS,/arxiv_data1/oa_pdf/a2/21/BMB-48-677.PMC4791323.pdf
Pacemaker cell and circadian variation Yael Yaniv and Edward G. Lakatta 682 BMB Reports http://bmbreports.orgResearch Fund (Y.Y).,OADS,/arxiv_data1/oa_pdf/a2/21/BMB-48-677.PMC4791323.pdf
Pacemaker cell and circadian variation Yael Yaniv and Edward G. Lakatta 683 http://bmbreports.org BMB Reports31.,OADS,/arxiv_data1/oa_pdf/a2/21/BMB-48-677.PMC4791323.pdf
Pacemaker cell and circadian variation Yael Yaniv and Edward G. Lakatta 684 BMB Reports http://bmbreports.orgcompensated chronic heart failure.,Non-OADS,/arxiv_data1/oa_pdf/a2/21/BMB-48-677.PMC4791323.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.12.063 Received 6 April 2015, Revised 4 May 2015, Accepted 8 June 2015Keywords: Asf1, Epigenetic Regulation, Histone acetylation, Histone  chaperone, Histone H3 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Identification of small molecules that inhibit the histone  chaperone Asf1 and its chromatin function Ja-Hwan Seol1,†,#, Tae-Yang Song1,#, Se Eun Oh2, Chanhee Jo1, Ahreum Choi1, Byungho Kim1, Jinyoung Park1, Suji Hong1,  Ilrang Song1, Kwan Young Jung1, Jae-Hyun Yang1,‡, Hwangseo Park3, Jin-Hyun Ahn2, Jeung-Whan Han1 & Eun-Jung Cho1,* 1School of Pharmacy, Sungkyunkwan University, Suwon 16419, 2Department of Molecular Cell Biology, Sungkyunkwan University School  of Medicine, Suwon 16419, 3Department of Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea The eukaryotic genome is packed into chromatin, which is  important for the genomic integrity and gene regulation.",Non-OADS,/arxiv_data1/oa_pdf/df/1e/BMB-48-685.PMC4791324.pdf
686 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/1e/BMB-48-685.PMC4791324.pdf
687 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/1e/BMB-48-685.PMC4791324.pdf
688 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/1e/BMB-48-685.PMC4791324.pdf
"689 http://bmbreports.org BMB ReportsMATERIALS AND METHODS Preparation of GST-Asf1a Escherichia coli  harboring pGEX-hAsf1a or pGEX-hAsf1b were  induced by IPTG (Duchefa) and cells were harvested and re-suspended in ice-cold PBS containing 1% Triton X-100, 0.5 M  NaCl, and protease/phosphatase inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/df/1e/BMB-48-685.PMC4791324.pdf
"The docking library for Asf1, comprising  approximately 260,000 synthetic and natural compounds, was  constructed from the latest version of the chemical database distributed by InterBioScreen Ltd. (http://www.ibscreen.com).",OADS,/arxiv_data1/oa_pdf/df/1e/BMB-48-685.PMC4791324.pdf
"690 BMB Reports http://bmbreports.org(2013R1A2A2A01014702) and the Basic Science Research  Program (2010-0028646) through the National Research Foundation of Korea grant funded by the Ministry of Education,  Science and Technology to E.-J.C. REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/df/1e/BMB-48-685.PMC4791324.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.12.100Received 21 May 2015, Revised 8 June 2015, Accepted 15 June 2015Keywords: K562, Megakaryocyte, Phytosphingosine, Platelet, (R)-  TEMOSPho ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Phytosphingosine promotes megakaryocytic differentiation of  myeloid leukemia cells Sang Hee Han1,#, Jusong Kim1,#, Yerim Her1, Ikjoo Seong1, Sera Park2, Deepak Bhattarai3, Guanghai Jin3, Kyeong Lee3,  Gukhoon Chung4, Sungkee Hwang4, Yun Soo Bae1,* & Jaesang Kim1,* Departments of 1Life Science, 2Bio-informatics Science, Ewha Womans University, Seoul 03760, 3BK21 Plus R-FIND Team, College of  Pharmacy, Dongguk University, Goyang 10326, 4Doosan Corporation, Suwon 16229, Korea We report that phytosphingosine, a sphingolipid found in  many organisms and implicated in cellular signaling, promotes megakaryocytic differentiation of myeloid leukemia cells.",Non-OADS,/arxiv_data1/oa_pdf/df/9c/BMB-48-691.PMC4791325.pdf
692 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/9c/BMB-48-691.PMC4791325.pdf
693 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/9c/BMB-48-691.PMC4791325.pdf
"694 BMB Reports http://bmbreports.orgthat even in TPO or c-MPL knockout mice, low level mega- karyocytes and platelets are found which implies that TPO-c- MPL independent signaling pathway or pathways exist perhaps  as back-up systems (3).",Non-OADS,/arxiv_data1/oa_pdf/df/9c/BMB-48-691.PMC4791325.pdf
695 http://bmbreports.org BMB Reports6.,Non-OADS,/arxiv_data1/oa_pdf/df/9c/BMB-48-691.PMC4791325.pdf
"Tel: +82-2-2228-1821; Fax: +82-2-392-7088;  E-mail: inhong@yuhs.ac http://dx.doi.org/10.5483/BMBRep.2015.48.12.106Received 1 June 2015, Revised 11 June 2015, Accepted 15 June 2015Keywords: Astrocyte, Interferon, Isoform, Negative regulation,  TLR3 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.An inhibitory alternative splice isoform of Toll-like receptor 3  is induced by type I interferon s in human astrocyte cell lines Jin-Won Seo1, Eun-Jeong Yang1, Se Hoon Kim2 & In-Hong Choi1,* 1Department of Microbiology, Institute for Immunology and Immunological Diseases, and Brain Korea 21 PLUS Project for Medical Sc ience,  2Department of Pathology, Yonsei University College of Medicine, Seoul 03722, Korea Toll-like receptor 3 (TLR3) recognizes viral double-stranded  RNA.",Non-OADS,/arxiv_data1/oa_pdf/a8/dd/BMB-48-696.PMC4791326.pdf
697 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/dd/BMB-48-696.PMC4791326.pdf
698 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/dd/BMB-48-696.PMC4791326.pdf
699 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/dd/BMB-48-696.PMC4791326.pdf
"700 BMB Reports http://bmbreports.org(Takara, Tokyo, Japan).",OADS,/arxiv_data1/oa_pdf/a8/dd/BMB-48-696.PMC4791326.pdf
701 http://bmbreports.org BMB Reportsand pathology.,Non-OADS,/arxiv_data1/oa_pdf/a8/dd/BMB-48-696.PMC4791326.pdf
"Tel: +82-2-880-1268; Fax: +82-2-886-1268;  E-mail: jeycho@snu.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.12.158Received 23 July 2015, Revised 13 August 2015,  Accepted 25 September 2015 Keywords: Mesenchymal stem cells, Oxidative stress, Stanniocalcin-  2, Stem cell-based therapy ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Stanniocalcin 2 enhances mesenchymal stem cell survival by  suppressing oxidative stress Pyung-Hwan Kim1,2, Sang-Su Na2, Bomnaerin Lee2, Joo-Hyun Kim2 & Je-Yoel Cho2,* 1Department of Biomedical Laboratory Science, College of Medical Science, Konyang University, Daejeon 35365, Korea, 2Department of  Biochemistry, BK21 PLUS Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National Univer sity,  Seoul 08826, Korea To overcome the disadvantages of stem cell-based cell therapy  like low cell survival at the disease site, we used stanniocalcin 2 (STC2), a family of secreted glycoprotein hormones that  function to inhibit apoptosis and oxidative damage and to  induce proliferation.",Non-OADS,/arxiv_data1/oa_pdf/d9/31/BMB-48-702.PMC4791327.pdf
703 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/31/BMB-48-702.PMC4791327.pdf
704 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/31/BMB-48-702.PMC4791327.pdf
705 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/31/BMB-48-702.PMC4791327.pdf
706 BMB Reports http://bmbreports.orgindicate greater survival advantages in hazardous circum- stance.,Non-OADS,/arxiv_data1/oa_pdf/d9/31/BMB-48-702.PMC4791327.pdf
707 http://bmbreports.org BMB Reportsvivo delivery.,Non-OADS,/arxiv_data1/oa_pdf/d9/31/BMB-48-702.PMC4791327.pdf
"http://e-jbm.org/   1Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:1-7 http://dx.doi.org/10.11005/jbm.2016.23.1.1 pISSN 2287-6375 eISSN 2287-7029 The Association between Urine Albumin to  Creatinine Ratio and Osteoporosis in  Postmenopausal Women with Type 2 Diabetes Ye Yeon Lee1, Han Byul Kim1, Jong Won Lee1, Gyu Min Lee1, Sang Yoon Kim2, Ji An Hur3, Ho Chan Cho1 1Department of Internal Medicine, Keimyung University School of Medicine, Daegu;   2Department of Internal Medicine, Andong Medical Group Hospital, Andong;   3Department of Internal Medicine, School of Medicine, Yeungnam University, Daegu, Korea Background:  Osteoporosis is a progressive bone disease that is characterized by a de - crease in bone mass density and destruction of microstructure, which can lead to an in - creased risk of fracture.",Non-OADS,/arxiv_data1/oa_pdf/bc/56/jbm-23-1.PMC4791432.pdf
2  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.1menopausal women may be one of the major risk factors  for accelerated bone loss.,Non-OADS,/arxiv_data1/oa_pdf/bc/56/jbm-23-1.PMC4791432.pdf
The Association between UACR and Osteoporosis http://dx.doi.org/10.11005/jbm.2016.23.1.1  http://e-jbm.org/   3mg/g Cr.,Non-OADS,/arxiv_data1/oa_pdf/bc/56/jbm-23-1.PMC4791432.pdf
4  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.1mal consisted of patients with osteopenia and osteoporo - sis based on the result of BMD.,Non-OADS,/arxiv_data1/oa_pdf/bc/56/jbm-23-1.PMC4791432.pdf
"The Association between UACR and Osteoporosis http://dx.doi.org/10.11005/jbm.2016.23.1.1  http://e-jbm.org/   5with normoalbuminuria (UACR <30 mg/g Cr, P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/bc/56/jbm-23-1.PMC4791432.pdf
6  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.1not a statistically significant result.,OADS,/arxiv_data1/oa_pdf/bc/56/jbm-23-1.PMC4791432.pdf
Available from: http://stat.mohw.go.kr/front/statData/pub - licationView.jsp?menuId =47&bbsSeq =13&nttSeq =2119 3&searchKey =&searchWord =&nPage =1 8.,OADS,/arxiv_data1/oa_pdf/bc/56/jbm-23-1.PMC4791432.pdf
The Association between UACR and Osteoporosis http://dx.doi.org/10.11005/jbm.2016.23.1.1  http://e-jbm.org/   7Aging Clin Exp Res 2011;23:84-90.,Non-OADS,/arxiv_data1/oa_pdf/bc/56/jbm-23-1.PMC4791432.pdf
"16  http://e-jbm.org/Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:16-22 http://dx.doi.org/10.11005/jbm.2016.23.1.16 pISSN 2287-6375 eISSN 2287-7029 Serum Sclerostin Levels in Patients with Human  Immunodeficiency Virus Infection and Their  Association with Bone Turnover Markers and Bone  Mineral Densitometry Abdulrahman Y .",Non-OADS,/arxiv_data1/oa_pdf/bb/83/jbm-23-16.PMC4791433.pdf
Sclerostin Status in HIV Treatment-naive Patients http://dx.doi.org/10.11005/jbm.2016.23.1.16  http://e-jbm.org/   17tion and treatment strategies.,Non-OADS,/arxiv_data1/oa_pdf/bb/83/jbm-23-16.PMC4791433.pdf
"18  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.16counts were measured by flow cytometry (FACS Calibur;  Becton Dickinson, San Jose, CA).",OADS,/arxiv_data1/oa_pdf/bb/83/jbm-23-16.PMC4791433.pdf
Sclerostin Status in HIV Treatment-naive Patients http://dx.doi.org/10.11005/jbm.2016.23.1.16  http://e-jbm.org/   19are shown in Table 1 and Table 2.,Non-OADS,/arxiv_data1/oa_pdf/bb/83/jbm-23-16.PMC4791433.pdf
20  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.16DISCUSSION In the present study we examined the relationship be - tween serum sclerostin levels and bone health in HIV-treat - ment naive patients.,Non-OADS,/arxiv_data1/oa_pdf/bb/83/jbm-23-16.PMC4791433.pdf
Sclerostin Status in HIV Treatment-naive Patients http://dx.doi.org/10.11005/jbm.2016.23.1.16  http://e-jbm.org/   21itation in this study is the relatively small sample size.,Non-OADS,/arxiv_data1/oa_pdf/bb/83/jbm-23-16.PMC4791433.pdf
22  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.16of the human immunodeficiency virus in Saudi Arabia; 18- year surveillance results and prevention from an Islamic  perspective.,Non-OADS,/arxiv_data1/oa_pdf/bb/83/jbm-23-16.PMC4791433.pdf
"http://e-jbm.org/   23Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:23-26 http://dx.doi.org/10.11005/jbm.2016.23.1.23 pISSN 2287-6375 eISSN 2287-7029 Prevalence of Sarcopenia in the Korean Woman  Based on the Korean National Health and  Nutritional Examination Surveys Hyoung-Joon Kwon1, Yong-Chan Ha2, Hyoung-Moo Park1 1Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul;   2Department of Orthopedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea Background:  The criteria for defining sarcopenia vary among studies and confusion has  arisen when defining the cutoff value.",Non-OADS,/arxiv_data1/oa_pdf/d7/ec/jbm-23-23.PMC4791434.pdf
24  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.23and experts.,Non-OADS,/arxiv_data1/oa_pdf/d7/ec/jbm-23-23.PMC4791434.pdf
Prevalence of Sarcopenia in the Korean Woman http://dx.doi.org/10.11005/jbm.2016.23.1.23  http://e-jbm.org/   25DISCUSSION The definition of sarcopenia varies.,Non-OADS,/arxiv_data1/oa_pdf/d7/ec/jbm-23-23.PMC4791434.pdf
26  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.23people.,Non-OADS,/arxiv_data1/oa_pdf/d7/ec/jbm-23-23.PMC4791434.pdf
"http://e-jbm.org/   27Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:27-33 http://dx.doi.org/10.11005/jbm.2016.23.1.27 pISSN 2287-6375 eISSN 2287-7029 Relationship between Serum Inflammatory Marker  and Bone Mineral Density in Healthy Adults Hee-Sook Lim1,2, Yoon-Hyung Park1, Soon-Kyung Kim3 1Department of Preventive Medicine, Soonchunhyang University College of Medicine, Cheonan;   2Department of Clinical Nutrition, Soonchunhyang University Bucheon Hospital, Bucheon;   3Department of Food Sciences & Nutrition, Soonchunhyang University, Asan, Korea Background:  Inflammatory markers have been shown to play an important role in bone  remodeling.",Non-OADS,/arxiv_data1/oa_pdf/4b/b2/jbm-23-27.PMC4791435.pdf
"28  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.27Moreover, in order to elucidate the mechanism of correla - tion of bone mineral density (BMD) with obesity, body fat  mass,[4] diabetes,[5] and metabolic diseases,[6] studies are  investigating inflammatory markers.",Non-OADS,/arxiv_data1/oa_pdf/4b/b2/jbm-23-27.PMC4791435.pdf
"Inflammatory Marker and BMD in Adults http://dx.doi.org/10.11005/jbm.2016.23.1.27  http://e-jbm.org/   29was presented a)(P<0.05), b)(P<0.01), or c)(P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/4b/b2/jbm-23-27.PMC4791435.pdf
"30  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.27BMD group, respectively.",OADS,/arxiv_data1/oa_pdf/4b/b2/jbm-23-27.PMC4791435.pdf
"Inflammatory Marker and BMD in Adults http://dx.doi.org/10.11005/jbm.2016.23.1.27  http://e-jbm.org/   31reported that the concentrations of IL-1, IL-6, and TNF-α in  mononuclear cell culture supernatant positively correlated  with bone resorptive activity in menopausal women.",Non-OADS,/arxiv_data1/oa_pdf/4b/b2/jbm-23-27.PMC4791435.pdf
32  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.27Table 4.,Non-OADS,/arxiv_data1/oa_pdf/4b/b2/jbm-23-27.PMC4791435.pdf
Available from: http://www.ksbmr.org/ image/journal/ 골다공증 %20지침서 2015_final_1002.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/4b/b2/jbm-23-27.PMC4791435.pdf
Inflammatory Marker and BMD in Adults http://dx.doi.org/10.11005/jbm.2016.23.1.27  http://e-jbm.org/   33puted tomography assessment of spinal trabecular bone.,Non-OADS,/arxiv_data1/oa_pdf/4b/b2/jbm-23-27.PMC4791435.pdf
"34  http://e-jbm.org/Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:34-39 http://dx.doi.org/10.11005/jbm.2016.23.1.34 pISSN 2287-6375 eISSN 2287-7029 Osteoporotic Fracture Risk Assessment Using Bone  Mineral Density in Korean: A Community-based  Cohort Study Eun Jin Jang1, Young-Kyun Lee2, Hyung Jin Choi3, Yong-Chan Ha4, Sunmee Jang5, Chan Soo Shin6, Nam Han Cho7 1Department of Information Statistics, Andong National University, Andong;   2Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam;   3Department of Anatomy, Seoul National University College of Medicine, Seoul;   4Department of Orthopaedic Surgery, School of Medicine, Chung-Ang University College of Medicine, Seoul;   5College of Pharmacy, Gachon University, Incheon;   6Department of Internal Medicine, Seoul National University College of Medicine, Seoul;   7Department of Preventive Medicine, Ajou University School of Medicine, Suwon, Korea Background:  Fracture-risk assessment tool (FRAX) using just clinical risk factors of os - teoporosis has been developed to estimate individual risk of osteoporotic fractures.",Non-OADS,/arxiv_data1/oa_pdf/d0/0e/jbm-23-34.PMC4791436.pdf
"Fracture Risk Assessment Using BMD in Korean  http://dx.doi.org/10.11005/jbm.2016.23.1.34  http://e-jbm.org/   35risk,[6] and dual energy X-ray absorptiometry (DXA; Lunar  Prodigy, GE Medical Systems, Madison, WI, USA) is the most  widely accepted method to diagnose osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/d0/0e/jbm-23-34.PMC4791436.pdf
"36  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.34model in the modeling set, because the date of fracture  could not be exactly identified.",OADS,/arxiv_data1/oa_pdf/d0/0e/jbm-23-34.PMC4791436.pdf
"Fracture Risk Assessment Using BMD in Korean  http://dx.doi.org/10.11005/jbm.2016.23.1.34  http://e-jbm.org/   3715.34) + 0.4201 ×(alcohol -0.1873) f(x) without BMD =-2.3166 + 0.0476 ×(age- 61.30) -0.0952  ×(BMI - 23.57) + 0.5681 ×(history of osteoporotic fracture -   0.0275) + 0.00695 ×(daily smoking - 15.34) + 0.4201 ×(alco - hol - 0.1873) Model including BMD and model without BMD showed  same c-statistics of 0.739 in men, indicating that the discri- minatory power is high.",Non-OADS,/arxiv_data1/oa_pdf/d0/0e/jbm-23-34.PMC4791436.pdf
38  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.34fracture.,Non-OADS,/arxiv_data1/oa_pdf/d0/0e/jbm-23-34.PMC4791436.pdf
Fracture Risk Assessment Using BMD in Korean  http://dx.doi.org/10.11005/jbm.2016.23.1.34  http://e-jbm.org/   39and fracture risk in women of different ethnic groups.,Non-OADS,/arxiv_data1/oa_pdf/d0/0e/jbm-23-34.PMC4791436.pdf
Avail - able from: http://www.kosis.kr 14.,Non-OADS,/arxiv_data1/oa_pdf/d0/0e/jbm-23-34.PMC4791436.pdf
"40  http://e-jbm.org/Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:40-44 http://dx.doi.org/10.11005/jbm.2016.23.1.40 pISSN 2287-6375 eISSN 2287-7029 Multiple Fractures in Patient with Graves’ Disease  Accompanied by Isolated Hypogonadotropic  Hypogonadism Hyon-Seung Yi1,2, Ji Min Kim1,2, Sang Hyeon Ju1, Younghak Lee1, Hyun Jin Kim1,2, Koon Soon Kim1,2 1Department of Internal Medicine, 2Research Center for Endocrine and Metabolic Diseases, Chungnam National University School of  Medicine, Daejeon, Korea Isolated hypogonadotropic hypogonadism (IHH) is known to decrease bone mineral  density due to deficiency of sex steroid hormone.",Non-OADS,/arxiv_data1/oa_pdf/76/54/jbm-23-40.PMC4791437.pdf
"Graves’ Disease in Hypogonadotropic Hypogonadism http://dx.doi.org/10.11005/jbm.2016.23.1.40  http://e-jbm.org/   41Maintenance of proper BMD requires not only sex ste - roid hormones but also thyroid hormones and vitamin D.  Moreover, abnormal status of thyroid hormone or lower  levels of vitamin D can promote pathologic or non-trauma  induced fractures.",Non-OADS,/arxiv_data1/oa_pdf/76/54/jbm-23-40.PMC4791437.pdf
42  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.40lished by suggestive clinical findings with primary amen - orrhea and absence of growth and development of sec - ondary sexual characteristics and laboratory findings at 16  years.,Non-OADS,/arxiv_data1/oa_pdf/76/54/jbm-23-40.PMC4791437.pdf
Graves’ Disease in Hypogonadotropic Hypogonadism http://dx.doi.org/10.11005/jbm.2016.23.1.40  http://e-jbm.org/   43Table 4.,Non-OADS,/arxiv_data1/oa_pdf/76/54/jbm-23-40.PMC4791437.pdf
"44  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.40possible for hyperthyroidism secondary to toxic thyroid  nodule, to occur with hypopituitarism.",Non-OADS,/arxiv_data1/oa_pdf/76/54/jbm-23-40.PMC4791437.pdf
"http://e-jbm.org/   45Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:45-48 http://dx.doi.org/10.11005/jbm.2016.23.1.45 pISSN 2287-6375    eISSN 2287-7029 Calcaneal Insufficiency Fracture after Ipsilateral  Total Knee Arthroplasty Min Jeong, Jin Woo Jin, Sung Jin Shin, Byoung Youl Kang Department of Orthopaedic Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea Insufficiency fracture of the calcaneus is a rare entity.",Non-OADS,/arxiv_data1/oa_pdf/96/61/jbm-23-45.PMC4791438.pdf
46  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.45 Fig.,Non-OADS,/arxiv_data1/oa_pdf/96/61/jbm-23-45.PMC4791438.pdf
Calcaneal Insufficiency Fracture after Ipsilateral TKA http://dx.doi.org/10.11005/jbm.2016.23.1.45  http://e-jbm.org/   47DISCUSSION Stress fracture is a term that is referred to as a fatigue one  or an insufficiency one.,Non-OADS,/arxiv_data1/oa_pdf/96/61/jbm-23-45.PMC4791438.pdf
48  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.45should consider the possibility of insufficiency fracture of  the calcaneus and then make a differential diagnosis from  other diseases.,Non-OADS,/arxiv_data1/oa_pdf/96/61/jbm-23-45.PMC4791438.pdf
"http://e-jbm.org/   49Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:49 http://dx.doi.org/10.11005/jbm.2016.23.1.49 pISSN 2287-6375    eISSN 2287-7029 Erratum to: Vitamin D Deficiency Is Highly  Concomitant but Not Strong Risk Factor for  Mortality in Patients Aged 50 Year and Older with  Hip Fracture Kyung-Hag Lee1, Jung-Won Lim2, Yong-Gum Park3, Yong-Chan Ha2 1Department of Orthopaedic Surgery, National Medical Center, Seoul;   2Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul;   3Department of Surgery, Chung-Ang University College of Medicine, Seoul, Korea J Bone Metab 2015;22(4):205-209 In this article, on page 205, the author’s name has been  spelled incorrectly in this article: “Gyeong-Hak Lee” should  have appeared as “Kyung-Hag Lee” .",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/jbm-23-49.PMC4791439.pdf
"8  http://e-jbm.org/ Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2016;23:8-15 http://dx.doi.org/10.11005/jbm.2016.23.1.8 pISSN 2287-6375 eISSN 2287-7029 Deficiency of Lipocalin-2 Promotes Proliferation and  Differentiation of Osteoclast Precursors via  Regulation of c-Fms Expression and Nuclear Factor- kappa B Activation Hyun-Ju Kim1,2, Boram Ohk1, Woo Youl Kang1, Sook Jin Seong1, Kyoungho Suk3, Mi-Sun Lim4, Shin-Yoon Kim2,   Young-Ran Yoon1 1Department of Biomedical Science, Cell and Matrix Research Institute, BK21 Plus KNU Biomedical Convergence Program, Clinical Trial     Center, School of Medicine, Kyungpook National University and Hospital, Daegu;   2Skeletal Diseases Genome Research Center, School of Medicine, Kyungpook National University, Daegu;   3Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu;   4College of Pharmacy, Yeungnam University, Gyeongsan, Korea Background:  Lipocalin-2 (LCN2), a small glycoprotein, has a pivotal role in diverse bio - logical processes such as cellular proliferation and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/93/e5/jbm-23-8.PMC4791440.pdf
"Effect of LCN2 Deficiency on Osteoclast Formation http://dx.doi.org/10.11005/jbm.2016.23.1.8  http://e-jbm.org/   9sion, and differentiation of hematopoietic precursors of the  monocyte/macrophage lineage.",Non-OADS,/arxiv_data1/oa_pdf/93/e5/jbm-23-8.PMC4791440.pdf
"10  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.8Proliferation assay was performed using a cell-proliferation  Biotrak ELISA system (GE Healthcare/Amersham, Freiburg,  Germany).",OADS,/arxiv_data1/oa_pdf/93/e5/jbm-23-8.PMC4791440.pdf
Effect of LCN2 Deficiency on Osteoclast Formation http://dx.doi.org/10.11005/jbm.2016.23.1.8  http://e-jbm.org/   11role of LCN2 in osteoclast development.,Non-OADS,/arxiv_data1/oa_pdf/93/e5/jbm-23-8.PMC4791440.pdf
12  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.8WT cells.,OADS,/arxiv_data1/oa_pdf/93/e5/jbm-23-8.PMC4791440.pdf
"Effect of LCN2 Deficiency on Osteoclast Formation http://dx.doi.org/10.11005/jbm.2016.23.1.8  http://e-jbm.org/   13WT and LCN2-/- mice were serum-starved and exposed to  RANKL, to then perform an immunoblotting assay.",Non-OADS,/arxiv_data1/oa_pdf/93/e5/jbm-23-8.PMC4791440.pdf
"14  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2016.23.1.8Osteoclast number is determined by proliferation, differ - entiation, and apoptosis rates of osteoclast lineage cells.",OADS,/arxiv_data1/oa_pdf/93/e5/jbm-23-8.PMC4791440.pdf
Effect of LCN2 Deficiency on Osteoclast Formation http://dx.doi.org/10.11005/jbm.2016.23.1.8  http://e-jbm.org/   15with the macrophage response toward proliferation or  activation.,Non-OADS,/arxiv_data1/oa_pdf/93/e5/jbm-23-8.PMC4791440.pdf
"1 cSee Electronic Supplementary File 3 for further details of the elicitation panel dBased on mean of elective inpatient general surgery excess bed-day costs ePabrinex/C210IV, GBP1.96 per pair of ampoules fMultivitamin capsules, GBP1.50 per 28-capsule pack gNon-proprietary magnesium maximum dose 160 mmol IV over 5 days hhttp://www.dsmedical.co.uk/iv_giving_set iNon-proprietary 1 L saline jVenﬂon, www.vivomed.com210 E. C. F. Wilson et al.",Non-OADS,/arxiv_data1/oa_pdf/90/cc/40258_2015_Article_214.PMC4791451.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/90/cc/40258_2015_Article_214.PMC4791451.pdf
Available from: http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/90/cc/40258_2015_Article_214.PMC4791451.pdf
Available from: http://tonyohagan.co.uk/shelf .,Non-OADS,/arxiv_data1/oa_pdf/90/cc/40258_2015_Article_214.PMC4791451.pdf
http://www.ons.gov.uk/ons/rel/ lifetables/interim-life-tables/2010-2012/rft-england.xls .,Non-OADS,/arxiv_data1/oa_pdf/90/cc/40258_2015_Article_214.PMC4791451.pdf
https://www.gov.uk/government/uploads/ system/uploads/attachment_data /ﬁle/260405/2012-13_national_ schedule_of_reference_costs.xls .,OADS,/arxiv_data1/oa_pdf/90/cc/40258_2015_Article_214.PMC4791451.pdf
http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/90/cc/40258_2015_Article_214.PMC4791451.pdf
Available from: http://emc.medicines.org.uk/emc/assets/c/ html/DisplayDoc.asp?DocumentID=11913 .,OADS,/arxiv_data1/oa_pdf/90/cc/40258_2015_Article_214.PMC4791451.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/29/c3/40265_2015_Article_534.PMC4791452.pdf
Available at: https://clinicaltrials.gov/ct2/show/ NCT01261793 .,Non-OADS,/arxiv_data1/oa_pdf/29/c3/40265_2015_Article_534.PMC4791452.pdf
"The model critique was undertaken by M.J., with advice and quality assurance from J.C. N.H. reported the decision problem and the NICE recommendations.The guarantor for overall content is A.S. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/92/42/40258_2015_Article_202.PMC4791453.pdf
2015. https://www.nice.org.uk/ guidance/MTG25 .,Non-OADS,/arxiv_data1/oa_pdf/92/42/40258_2015_Article_202.PMC4791453.pdf
2014. http://www.hscic.gov.uk/catalogue/PUB13893/adul- crit-care-data-eng-apr-12-mar-13-rep.pdf .,Non-OADS,/arxiv_data1/oa_pdf/92/42/40258_2015_Article_202.PMC4791453.pdf
2012. https://www.nice.org.uk/ guidance/cg139 .,Non-OADS,/arxiv_data1/oa_pdf/92/42/40258_2015_Article_202.PMC4791453.pdf
2011.http://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-medical-technologies/Medical-technologies- evaluation-programme-process-guide.pdf .,Non-OADS,/arxiv_data1/oa_pdf/92/42/40258_2015_Article_202.PMC4791453.pdf
http://www.supplychain.nhs.,Non-OADS,/arxiv_data1/oa_pdf/92/42/40258_2015_Article_202.PMC4791453.pdf
2015. https://www.nice.org.uk/guidance/gid-mt 238/documents/the-3m-tegaderm-chg-iv-securement-dressing-for-central-venous-and-arterial-catheter-insertion-sites-consultation- document2 .,Non-OADS,/arxiv_data1/oa_pdf/92/42/40258_2015_Article_202.PMC4791453.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7a/61/40258_2015_Article_200.PMC4791454.pdf
"John F. Kennedy School ofGovernment, Harvard University, Faculty Research Working Papers Series RWP02-046; 2002. http://ssrn.com/abstract_id= 372280 13.",Non-OADS,/arxiv_data1/oa_pdf/7a/61/40258_2015_Article_200.PMC4791454.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/00/19/40258_2016_Article_222.PMC4791455.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/58/37/40262_2015_Article_324.PMC4791456.pdf
https://www.pharmgkb.org/guideline/ PA166104996 .,Non-OADS,/arxiv_data1/oa_pdf/58/37/40262_2015_Article_324.PMC4791456.pdf
http://www.genome.gov/gwastudies .,OADS,/arxiv_data1/oa_pdf/58/37/40262_2015_Article_324.PMC4791456.pdf
2014. http://www.crediblemeds.,OADS,/arxiv_data1/oa_pdf/58/37/40262_2015_Article_324.PMC4791456.pdf
http://www.nature.com/ng/journal/v42/n2/ suppinfo/ng.511_S1.html .,OADS,/arxiv_data1/oa_pdf/58/37/40262_2015_Article_324.PMC4791456.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncom- mercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,provide a link to the Creative Commons license, and indicate ifchanges were made.",Non-OADS,/arxiv_data1/oa_pdf/76/41/198_2015_Article_3426.PMC4791462.pdf
Methods We performed a comprehensive PubMed ( http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/59/35/198_2015_Article_3440.PMC4791473.pdf
"5 1 4 –18 years: 3 14 –18 years: 2.5 4 –8 years: 92 14 –18 years: 97 14 –18 years: 99 19–30 years: 3 19 –30 years: 2.5 19 –30 years: 93 19 –30 years: 94 aBased on the 2010 Dietary Guidelines f or Americans, which may be accessed via http://www.health.gov/di etaryguidelines/dga2010/ dietaryguidelines2010.pdf (modified from: http://www.choosemyplate.gov ) bRecommended servings of dairy are determined by age cRecommended servings of fruits and vegetables are determined by age, sex, and level of physical activityOsteoporos Int (2016) 27:1281 –1386 1371",Non-OADS,/arxiv_data1/oa_pdf/59/35/198_2015_Article_3440.PMC4791473.pdf
These re ports may be accessed via www.nap.edu (modified from: http://www.iom.,OADS,/arxiv_data1/oa_pdf/59/35/198_2015_Article_3440.PMC4791473.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/59/35/198_2015_Article_3440.PMC4791473.pdf
"The external control  cohort comprises subjects enrolled in the National Heart, Lung,  and Blood Institute Grand Opportunity Exome Sequencing  Project ( n = 6,503, http://evs.gs.washington.edu/EVS/).",Non-OADS,/arxiv_data1/oa_pdf/6d/f7/gim2014191a.PMC4791490.pdf
Polymerase chain reaction duplicates were removed  using picard-tools-1.59 (http://picard.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/6d/f7/gim2014191a.PMC4791490.pdf
"SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS We appreciate all the patients, their parents, the clinical research coordinators, and the referring physicians for participating in this study.",Non-OADS,/arxiv_data1/oa_pdf/6d/f7/gim2014191a.PMC4791490.pdf
Additional con-trol samples were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through accession number phs000473.,Non-OADS,/arxiv_data1/oa_pdf/6d/f7/gim2014191a.PMC4791490.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ GeNeTICs in MeDICINe  |   Volume 17  |  Number 10  |  October 2015",Non-OADS,/arxiv_data1/oa_pdf/6d/f7/gim2014191a.PMC4791490.pdf
http://www.bgs.org.uk/index.,Non-OADS,/arxiv_data1/oa_pdf/bf/ab/198_2015_Article_3413.PMC4791513.pdf
http://www.osteoporosis.ca/fracture- liaison%20service/?utm_source=Home+Page&utm_medium=Menu+Button&utm_campaign=FLS .,Non-OADS,/arxiv_data1/oa_pdf/bf/ab/198_2015_Article_3413.PMC4791513.pdf
http://www.aacn.nche.edu/education-resources/ APRNReport.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ab/198_2015_Article_3413.PMC4791513.pdf
http://cna-aiic.ca/~/media/cna/ page-content/pdf-en/anp_national_framework_e.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ab/198_2015_Article_3413.PMC4791513.pdf
E-mail: ibrahim.eldaghayes@vetmed.edu.l yOriginal Article   DOI: http://dx.doi.org/10.4314/ovj.v6i1.6 Submitted: 05/10/2015 Accepted: 25/01/2016 Published: 02/03/2016 Isolation and molecular identification of Vibrio  spp.,Non-OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
http://www.openveterinaryjournal.com S.M.,Non-OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
http://www.openveterinaryjournal.com S.M.,Non-OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
"Sequences were  assembled and edited using SeqMan module within  Lasergene package, (DNAStar Inc., Madison, WI, USA)  The obtained consensus sequences were subjected to  BLAST search both at NCBI (http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
http://www.openveterinaryjournal.com S.M.,Non-OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
http://www.openveterinaryjournal.com S.M.,Non-OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
http://www.openveterinaryjournal.com S.M.,Non-OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
http://www.openveterinaryjournal.com S.M.,Non-OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
http://www.openveterinaryjournal.com S.M.,Non-OADS,/arxiv_data1/oa_pdf/9f/69/OpenVetJ-6-36.PMC4791562.pdf
"The  authors reported that only 29 of 64 patients (45.3%) were Letter to the editor: Comment on “Simultaneous  treatment of anterior vaginal wall prolapse and stress urinary incontinence by using transobturator four arms polypropylene mesh” Salvatore Giovanni Vitale1, Antonio Simone Laganà1, Agnese Maria Chiara Rapisarda2 1Department of Human Pathology in Adulthood and Childhood ""G. Barresi"", University of Messina, Messina, 2Department of General Surgery and Medical Surgical  Specialties, University of Catania, Catania, Italy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Letter Received: 18 January, 2016  •  Accepted: 21 February, 2016 Corresponding Author: Salvatore Giovanni Vitale Department of Human Pathology in Adulthood and Childhood ""G. Barresi"" , University of Messina, Via Consolare Valeria 1, 98125 Messina (ME), ItalyTEL: +39-3479354575, FAX: +39-0902937083, E-mail: vitalesalvatore@hotmail.com ⓒ The Korean Urological Association, 2016 sexually active at baseline; of  these women, 20 reported  improvement in sexual activity and 7 had no change  in sexual function.",Non-OADS,/arxiv_data1/oa_pdf/e4/c2/icu-57-150.PMC4791663.pdf
"In particular, the FSFI consists of  six domains—desire (2 items), arousal (4 items), lubrication  (4r items), orgasm (3 items), satisfaction (3 items), and pain  www.icurology.orgICUrology 2016;57:150-151. http://dx.doi.org/10.4111/icu.2016.57.2.150pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/e4/c2/icu-57-150.PMC4791663.pdf
"Keywords: Nephrectomy; Prostatectomy; Robotics This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Innovative Surgical Techniques Received: 11 February, 2016  •  Accepted: 2 March, 2016 Corresponding Author: Koon Ho Rha Department of Urology and Urological Science Institute, Severance Hospital, Yonsei University College of Medicine,  50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTEL: +82-2-2228-2310, FAX: +82-2-312-2538, E-mail: khrha@yuhs.ac ⓒ The Korean Urological Association, 2016 morbidity.",Non-OADS,/arxiv_data1/oa_pdf/80/25/icu-57-146.PMC4791664.pdf
The prostatic biopsy revealed adenocarcinoma  www.icurology.orgICUrology 2016;57:146-149.http://dx.doi.org/10.4111/icu.2016.57.2.146pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/80/25/icu-57-146.PMC4791664.pdf
"Scan this QR code to see the accompanying video, or visit  www.icurology.org or https://youtu.be/TJ3ZVPtRdCU.Umbilicus Symyphysis pubisXiphoid process1 2 34 567 8",Non-OADS,/arxiv_data1/oa_pdf/80/25/icu-57-146.PMC4791664.pdf
148 www.icurology.orgRaheem et al http://dx.doi.org/10.4111/icu.2016.57.2.146 of the bladder neck.,Non-OADS,/arxiv_data1/oa_pdf/80/25/icu-57-146.PMC4791664.pdf
"SUPPLEMENTARY MATERIAL An accompanying video can be found in the ‘urology in  motion’ section of the journal homepage (www.icurology.org)  or, be available on YouTube (https://youtu.be/TJ3ZVPtRdCU).",Non-OADS,/arxiv_data1/oa_pdf/80/25/icu-57-146.PMC4791664.pdf
Available from: http://urology.jhu.edu/prostate/partintables.,Non-OADS,/arxiv_data1/oa_pdf/80/25/icu-57-146.PMC4791664.pdf
"Keywords: Compliance; Medication adherence; Mirabegron; Muscarinic antagonists; Overactive urinary bladder  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 13 February, 2016  •  Accepted: 4 March, 2016 Corresponding Author: Kyu-Sung Lee Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTEL: +82-2-3410-3554, FAX: +82-2-3410-3027, E-mail: ksleedr@skku.edu ⓒ The Korean Urological Association, 2016of men and 14.3% of women) [6].",Non-OADS,/arxiv_data1/oa_pdf/32/55/icu-57-84.PMC4791665.pdf
"OAB symptoms are associated with serious negative  effects on activities of daily living and emotional well-being,  www.icurology.orgICUrology 2016;57:84-93. http://dx.doi.org/10.4111/icu.2016.57.2.84pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/32/55/icu-57-84.PMC4791665.pdf
"86 www.icurology.orgKim and Lee http://dx.doi.org/10.4111/icu.2016.57.2.84 for the assumption that adherence is a superior term or  is preferred by patients, and there is also a concern that  adherence seems too sticky a concept [15,19].",Non-OADS,/arxiv_data1/oa_pdf/32/55/icu-57-84.PMC4791665.pdf
88 www.icurology.orgKim and Lee http://dx.doi.org/10.4111/icu.2016.57.2.84 for OAB at 3 months was 69% and fell to 48% by 6 months  [57] .,OADS,/arxiv_data1/oa_pdf/32/55/icu-57-84.PMC4791665.pdf
90 www.icurology.orgKim and Lee http://dx.doi.org/10.4111/icu.2016.57.2.84 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/32/55/icu-57-84.PMC4791665.pdf
92 www.icurology.orgKim and Lee http://dx.doi.org/10.4111/icu.2016.57.2.84 Changes in overactive bladder symptoms after discontinuation  of successful 3-month treatment with an antimuscarinic agent:  a prospective trial.,Non-OADS,/arxiv_data1/oa_pdf/32/55/icu-57-84.PMC4791665.pdf
http://dx.doi.org/10.1007/s11136-015-1216-z.,Non-OADS,/arxiv_data1/oa_pdf/32/55/icu-57-84.PMC4791665.pdf
http://dx.doi.org/10.1002/nau.22943.,Non-OADS,/arxiv_data1/oa_pdf/32/55/icu-57-84.PMC4791665.pdf
"Keywords: Goodness of Fit; Gumbel Max distribution; Intravaginal ejaculation latency time; Lognormal distribution; Premature  ejaculation This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Sexual Dysfunction/Infertility Received: 25 January, 2016  •  Accepted: 29 February, 2016                  See Editorial on page 126.",Non-OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
"Corresponding Author: Marcel D. Waldinger Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19103, USATEL: +31-20-640-44-66, E-mail: info@praktijkwaldinger.nl ⓒ The Korean Urological Association, 2016  www.icurology.orgICUrology 2016;57:119-128.http://dx.doi.org/10.4111/icu.2016.57.2.119pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
"120 www.icurology.orgJanssen and Waldinger http://dx.doi.org/10.4111/icu.2016.57.2.119 INTRODUCTION In 1994, Waldinger et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
"122 www.icurology.orgJanssen and Waldinger http://dx.doi.org/10.4111/icu.2016.57.2.119 distribution any number of IELTs, with reasonable accuracy.",Non-OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
124 www.icurology.orgJanssen and Waldinger http://dx.doi.org/10.4111/icu.2016.57.2.119 specific IELT value can be calculated in a cohort of men with  lif elong PE.,Non-OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
126 www.icurology.orgJanssen and Waldinger http://dx.doi.org/10.4111/icu.2016.57.2.119 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
Available from:  http://www.mathwave.com.,Non-OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
"Available from: http://statline.cbs.nl/Stat- Web/publication/?VW=T&DM=SLNL&PA=37296ned&D1=a &D2=0,10,20,30,40,50,60,(l-1),l&HD=130605-0924&HDR=G 1&STB=T.",OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
"128 www.icurology.orgJanssen and Waldinger http://dx.doi.org/10.4111/icu.2016.57.2.119 The serotonergic system in the brain is a complex,  extremely ramified system emerging in the raphé nuclei  in the midbrain and projecting to practically all areas of  the brain and spinal cord [3].",Non-OADS,/arxiv_data1/oa_pdf/5e/61/icu-57-119.PMC4791666.pdf
"Keywords: Antibiotic prophylaxis; Enterococcus; Microbial drug resistance; Urinary tract infection; Vancomycin-resistant enterococci This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Infection/Inflammation Received: 1 February, 2016  •  Accepted: 23 February, 2016 Corresponding Author: Nathan Lawrentschuk Urology Research Office, Austin Hospital, Level 8 Harold Stokes Building, 145 Studley Road, Heidelberg VIC 3084, AustraliaTEL: +61-3-9455-3363, FAX: +61-3-9496-5000, E-mail: Lawrentscuk@gmail.com ⓒ The Korean Urological Association, 2016 is of increasing clinical significance.",Non-OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
"In the United States, the Centers  www.icurology.orgICUrology 2016;57:129-134. http://dx.doi.org/10.4111/icu.2016.57.2.129pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
130 www.icurology.orgToner et al http://dx.doi.org/10.4111/icu.2016.57.2.129 for Disease Control and Prevention estimate approximately  30% of hospital enterococcal infections are VRE [5].,Non-OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
"132 www.icurology.orgToner et al http://dx.doi.org/10.4111/icu.2016.57.2.129 DISCUSSION To date, there have been relatively few large-scale studies  considering VRE antibiograms specific to urinary tract  infection and we believe our study represents the second  largest.",Non-OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
Available from: http://www.cdc.gov/ncidod/dhqp/ar_VRE_publicFAQ.html.,OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
134 www.icurology.orgToner et al http://dx.doi.org/10.4111/icu.2016.57.2.129 of Gram-negative and Gram-positive organisms: tigecycline  Evaluation and Surveillance Trial 2004 to 2007.,OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
http://dx.doi.org/10.1007/s00345-015-1718-x.,Non-OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
http://dx.doi.org/10.1093/qjmed/hcv202.,OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
Infect Ecol Epidemiol 2014 Oct 1;4.  http://dx.doi.org/10.3402/iee.v4.24555.,OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
Available from: http://www.tg.org.au/.,Non-OADS,/arxiv_data1/oa_pdf/c3/b8/icu-57-129.PMC4791667.pdf
"Keywords: Biopsy; Complications; Infection; Prostatic neoplasms; Sepsis This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Special Article Received: 1 February, 2016  •  Accepted: 26 February, 2016 Corresponding Author: Nathan Lawrentschuk Urology Research Office, Level 8 Harold Stokes Building, Austin Hospital, 145 Studley Road, Heidelberg VIC 3084, AustraliaTEL: +61-3-9455-3363, FAX: +61-3-9496-5000, E-mail: Lawrentscuk@gmail.com ⓒ The Korean Urological Association, 2016 Therefore, even a low rate of complications can cause harm  to significant numbers of patients.",Non-OADS,/arxiv_data1/oa_pdf/9e/b7/icu-57-94.PMC4791668.pdf
It appears that the number  www.icurology.orgICUrology 2016;57:94-99.http://dx.doi.org/10.4111/icu.2016.57.2.94pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/9e/b7/icu-57-94.PMC4791668.pdf
96 www.icurology.orgToner et al http://dx.doi.org/10.4111/icu.2016.57.2.94 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/b7/icu-57-94.PMC4791668.pdf
98 www.icurology.orgToner et al http://dx.doi.org/10.4111/icu.2016.57.2.94 analysis than swiping onto material such as paper [22].,Non-OADS,/arxiv_data1/oa_pdf/9e/b7/icu-57-94.PMC4791668.pdf
Available from: http://www.tg.org.au/.,Non-OADS,/arxiv_data1/oa_pdf/9e/b7/icu-57-94.PMC4791668.pdf
http://dx.doi.org/10.1007/s00345-015-1718-x.,Non-OADS,/arxiv_data1/oa_pdf/9e/b7/icu-57-94.PMC4791668.pdf
"Keywords: Biomarkers; DNA topoisomerase II alpha; Hematuria; Urinary bladder neoplasms; Urine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received: 25 January, 2016  •  Accepted: 20 February, 2016 Corresponding Author: Wun-Jae Kim Department of Urology, Institute for Tumor Research, Chungbuk National University College of Medicine, 1 Chungdae-ro, Seowon-gu, Cheongju 28644, KoreaTEL: +82-43-269-6371, FAX: +82-43-269-6144, E-mail: wjkim@chungbuk.ac.kr ⓒ The Korean Urological Association, 2016 (MIBCs) and metastatic disease.",Non-OADS,/arxiv_data1/oa_pdf/28/e5/icu-57-106.PMC4791669.pdf
"Despite the fact that  NMIBC has a better prognosis than MIBC or metastatic BC,  frequent recurrence (50%–80%) and a tendency to progress  www.icurology.orgICUrology 2016;57:106-112.http://dx.doi.org/10.4111/icu.2016.57.2.106pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/28/e5/icu-57-106.PMC4791669.pdf
"108 www.icurology.orgKim et al http://dx.doi.org/10.4111/icu.2016.57.2.106 centrifuged for an additional 1 minute at 13,000 rpm and  then placed into a clean 1.5-mL microcentrifuge tube.",Non-OADS,/arxiv_data1/oa_pdf/28/e5/icu-57-106.PMC4791669.pdf
110 www.icurology.orgKim et al http://dx.doi.org/10.4111/icu.2016.57.2.106 in NMIBC (26.0 [8.5–224.8]×103 copies/ng) (p=0.002) (Fig.,OADS,/arxiv_data1/oa_pdf/28/e5/icu-57-106.PMC4791669.pdf
"112 www.icurology.orgKim et al http://dx.doi.org/10.4111/icu.2016.57.2.106 government (MSIP) (2014R1A2A2A007036), and by the  Functional Districts of the Science Belt support program  funded by Ministry of Science, ICT and Future Planning.",Non-OADS,/arxiv_data1/oa_pdf/28/e5/icu-57-106.PMC4791669.pdf
"Keywords: Giant hydronephrosis; Pyelovesicostomy; Robot-assisted This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Innovative Surgical Techniques Received: 25 January, 2016  •  Accepted: 20 February, 2016 Corresponding Author: Santosh Kumar Advanced Urology Center, Department of Urology, Postgraduate Institute of Medical Education and Research.",Non-OADS,/arxiv_data1/oa_pdf/e4/0f/icu-57-141.PMC4791670.pdf
"Following  initial percutaneous nephrostomy (PCN) tube placement  and resolution of her fever with antibiotics, a computed  tomography (CT) nephrostogram with 3 ­dimensional  reconstruction revealed giant hydronephrosis on the right  side with ureteropelvic junction obstruction as evidenced  by significant contrast retention after 30 minutes of study  www.icurology.orgICUrology 2016;57:141-145.http://dx.doi.org/10.4111/icu.2016.57.2.141pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/e4/0f/icu-57-141.PMC4791670.pdf
142 www.icurology.orgKumar et al http://dx.doi.org/10.4111/icu.2016.57.2.141 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e4/0f/icu-57-141.PMC4791670.pdf
144 www.icurology.orgKumar et al http://dx.doi.org/10.4111/icu.2016.57.2.141 exposure to contrast in the setting of a solitary functioning  kidney.,Non-OADS,/arxiv_data1/oa_pdf/e4/0f/icu-57-141.PMC4791670.pdf
"Keywords: Classification; Diagnostic imaging; Renal cell carcinoma This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received: 17 November, 2015  •  Accepted: 20 January, 2016                  See Editorial on page 105.",Non-OADS,/arxiv_data1/oa_pdf/0f/85/icu-57-100.PMC4791671.pdf
The limited ability to predict malignancy in category  www.icurology.orgICUrology 2016;57:100-105. http://dx.doi.org/10.4111/icu.2016.57.2.100pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/0f/85/icu-57-100.PMC4791671.pdf
102 www.icurology.orgOh and Seo http://dx.doi.org/10.4111/icu.2016.57.2.100 Bosniak classification between ours and other previously  published studies (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/0f/85/icu-57-100.PMC4791671.pdf
104 www.icurology.orgOh and Seo http://dx.doi.org/10.4111/icu.2016.57.2.100 are not necessarily more likely to be malignant [14] .,Non-OADS,/arxiv_data1/oa_pdf/0f/85/icu-57-100.PMC4791671.pdf
"Keywords: Radiation; Urolithiasis; X-ray computed tomography This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Endourology/Urolithiasis Received: 24 November, 2015  •  Accepted: 20 January, 2016                  See Editorial on page 118.",Non-OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
"Even with modern  CT scanners, some believe that patients are being exposed to  www.icurology.orgICUrology 2016;57:113-118.http://dx.doi.org/10.4111/icu.2016.57.2.113pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
"114 www.icurology.orgO'Kane et al http://dx.doi.org/10.4111/icu.2016.57.2.113 unacceptably high doses of radiation, largely as a result of a  combination of “over scanning” and failing to appropriately  utilize alternative imaging modalities.",Non-OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
116 www.icurology.orgO'Kane et al http://dx.doi.org/10.4111/icu.2016.57.2.113 abdominal pain.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
Available from:  https://www.gov.uk/government/publications/ionising-radia- tion-dose-comparisons/ionising-radiation-dose-comparisons.,OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
Available from: http://www.ilo.org/wcmsp5/groups/pub- lic/@ed_protect/@protrav/@safework/documents/publication/ wcms_152685.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
Available from: http://www.nrc.gov/reading-rm/doc- collections/cfr/part020/full-text.html.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
Available  from: http://uroweb.org/wp-content/uploads/22-Urolithiasis_LR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
118 www.icurology.orgO'Kane et al http://dx.doi.org/10.4111/icu.2016.57.2.113 EDITORIAL COMMENT This article compared the amount and frequency of  radiation exposure of patients between the year 1990 and  2013 during diagnostic procedures due to the change in  imaging equipment.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/icu-57-113.PMC4791672.pdf
"Keywords: Cystectomy; Nephrectomy; Prostatectomy; Robotics This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 23 February, 2016  •  Accepted: 4 March, 2016 Corresponding Author: Wooju Jeong Vattikuti Urology Institute, Henry Ford Health System, 2799 West Grand Boulevard, K-9, Detroit, MI, 48202 USATEL: +1-313-916-2062, FAX: +1-313-916-4707, E-mail: wjeong1@hfhs.org ⓒ The Korean Urological Association, 2016informed his foresight in seeking to apply the surgical robot  to urologic surgery.",Non-OADS,/arxiv_data1/oa_pdf/01/35/icu-57-75.PMC4791673.pdf
www.icurology.orgICUrology 2016;57:75-83. http://dx.doi.org/10.4111/icu.2016.57.2.75pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/01/35/icu-57-75.PMC4791673.pdf
76 www.icurology.orgJeong et al http://dx.doi.org/10.4111/icu.2016.57.2.75 Demonstrating a benefit in terms of perioperative  outcomes reflected the initial experience with robotic  prostatectomy at the VUI.,OADS,/arxiv_data1/oa_pdf/01/35/icu-57-75.PMC4791673.pdf
"78 www.icurology.orgJeong et al http://dx.doi.org/10.4111/icu.2016.57.2.75 arm for renal hilar dissection, vascular control and during  renorrhaphy [51] .",Non-OADS,/arxiv_data1/oa_pdf/01/35/icu-57-75.PMC4791673.pdf
80 www.icurology.orgJeong et al http://dx.doi.org/10.4111/icu.2016.57.2.75 nique; report of 20 cases.,OADS,/arxiv_data1/oa_pdf/01/35/icu-57-75.PMC4791673.pdf
82 www.icurology.orgJeong et al http://dx.doi.org/10.4111/icu.2016.57.2.75 51.,OADS,/arxiv_data1/oa_pdf/01/35/icu-57-75.PMC4791673.pdf
"In a review article regarding the impact of  pelvic organ prolapse surgery on sexual function, Dietz and  Maher [5] concluded that sexual function is similar after  anterior polypropylene mesh and anterior colporrhaphy.The authors reply: Simultaneous treatment of  anterior vaginal wall prolapse and stress urinary incontinence by using transobturator four arms polypropylene mesh Farzaneh Sharifiaghdas1, Azar Daneshpajooh2 1Urology-Nephrology Research Center, Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, 2Department of Urology, Shahid Bahonar Hospital,  Kerman University of Medical Sciences, Kerman, Iran This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Letter Received: 20 February, 2016  •  Accepted: 23 February, 2016 Corresponding Author: Azar Daneshpajooh Department of Urology, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, IranTEL: +98-34-321156, FAX: +98-34-322391, E-mail: azdaneshpajooh@yahoo.com ⓒ The Korean Urological Association, 2016 In response to the comment, we accept that for  evaluating sexual function, high-quality questionnaires  and tools such as the Female Sexual Function Index (FSFI)  and Pelvic Organ Prolapse/Urinary Incontinence Sexual  Questionnaire (PISQ-12) are needed.",Non-OADS,/arxiv_data1/oa_pdf/59/d9/icu-57-152.PMC4791674.pdf
www.icurology.orgICUrology 2016;57:152-153. http://dx.doi.org/10.4111/icu.2016.57.2.152pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/59/d9/icu-57-152.PMC4791674.pdf
"Keywords: Mouth mucosa; Surgery; Urethral stricture This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Innovative Surgical Techniques Received: 3 December, 2015  •  Accepted: 3 February, 2016 Corresponding Author: Jonathan Warner Department of Surgery, City of Hope Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USATEL: +1-801-699-8975, E-mail: Jonathan.n.warner@gmail.com ⓒ The Korean Urological Association, 2016 strictures, particularly complex strictures associated with  failed urethroplasty, lichen sclerosis, and hypospadias.",Non-OADS,/arxiv_data1/oa_pdf/ec/45/icu-57-135.PMC4791675.pdf
[8] described a dorsal  www.icurology.orgICUrology 2016;57:135-140.http://dx.doi.org/10.4111/icu.2016.57.2.135pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/ec/45/icu-57-135.PMC4791675.pdf
136 www.icurology.orgWarner et al http://dx.doi.org/10.4111/icu.2016.57.2.135 inlay technique 1 year later.,Non-OADS,/arxiv_data1/oa_pdf/ec/45/icu-57-135.PMC4791675.pdf
138 www.icurology.orgWarner et al http://dx.doi.org/10.4111/icu.2016.57.2.135 was used to secure the penile skin where it was dissected  off the urethra ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/ec/45/icu-57-135.PMC4791675.pdf
140 www.icurology.orgWarner et al http://dx.doi.org/10.4111/icu.2016.57.2.135 at the site of previous repair given the adherent nature  of the penile skin to the underlying tubularized urethra.,Non-OADS,/arxiv_data1/oa_pdf/ec/45/icu-57-135.PMC4791675.pdf
www.icurology.orgICUrology 2016;57:73-74. http://dx.doi.org/10.4111/icu.2016.57.2.73pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/b8/92/icu-57-73.PMC4791676.pdf
74 www.icurology.orgHong http://dx.doi.org/10.4111/icu.2016.57.2.73 CONFLICTS OF INTEREST The authors have nothing to disclose.,Non-OADS,/arxiv_data1/oa_pdf/b8/92/icu-57-73.PMC4791676.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/ff/rjw031.PMC4791685.pdf
Microarray data have been de- posited in the NCBI Gene Expression Omnibus ( http://www.ncbi.nlm.ni- h.gov/geo/ ) under accession no.,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/ journal.pone.0086737 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Platelets kill intraerythrocytic malarial parasites and mediate survival to infection.Science 323:797– 800. http://dx.doi.org/10.1126/science.1166296 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/S0140-6736(14)60844-8 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain.Am J Pathol 155: 395– 410. http://dx.doi.org/10.1016/S0002 -9440(10)65136-X .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1086/ 505078 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Front Cell Infect Microbiol 4:104. http://dx.doi.org/10.3389/fcimb.2014.00104 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/j.ajpath.2011.01.016 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/journal.ppat.1000349 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/j.ejrad.2009.02.010 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/ nri1686 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
J Infect Dis 187: 461– 466. http://dx.doi.org/10.1086/367960 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/nm986 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1093/brain/awu001 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/ S0035-9203(96)90116-9 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1128/IAI.69.9.5849 -5856.2001 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/nature12216 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Nature 318:64 – 66. http://dx.doi.org/10.1038/318064a0 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/journal.pmed.0020204 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1093/infdis/jis371 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Am J Med 91:37– 44. http://dx.doi.org/10.1016/0002 -9343(91)90071-5 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1111/j.1365-2141.1994.tb04877.x .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/ nri2956 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/ 10.1172/JCI112426 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/nri3024 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.4049/jimmunol.1201028 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1126/ science.1092385 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/journal.pgen.1000360 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/ j.trsl.2014.05.002 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Malar J 12:317. http://dx.doi.org/10.1186/1475-2875-12-317 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1086/429297 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1128/IAI.06008-11 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/nature09247 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/j.cca.2013.03.011 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Malar J 5:101. http://dx.doi.org/10.1186/1475 -2875-5-101 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/ 10.1056/NEJMoa1303944 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
J ExpMed 160:618 – 623. http://dx.doi.org/10.1084/jem.160.2.618 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Front Cell Infect Microbiol 4:100. http://dx.doi.org/10.3389/fcimb.2014.00100 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Cell Host Microbe12:815– 823. http://dx.doi.org/10.1016/j.chom.2012.10.017 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Trans R Soc Trop Med Hyg86:598 – 601. http://dx.doi.org/10.1016/0035-9203(92)90143-Z .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1111/j.1365 -3083.1987.tb02198.x .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/journal.pone.0009871 .Feintuch et al.,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1097/00003246-200205001 -00003 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1159/ 000237464 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/ 10.1084/jem.20110845 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/S1383-5769(01)00063-0 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/journal.pntd.0001710 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Blood 112:4250 – 4258. http://dx.doi.org/10.1182/blood-2007 -12-128967 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/journal.ppat.1004528 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Malar J 10:271. http://dx.doi.org/10.1186/1475-2875-10-271 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/ 10.1111/bjh.12014 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/journal.ppat.1002579 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Microbes Infect 14:851– 862. http://dx.doi.org/10.1016/ j.micinf.2012.05.006 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Ann Trop MedParasitol 98:71– 83. http://dx.doi.org/10.1179/000349804225003055 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/j.gene.2013.01.011 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.4049/jimmunol.179.1.162 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1128/IAI.00408-06 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/ journal.pone.0014798 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/ sj.gene.6363962 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/sj.gene.6364417 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1004537 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003864 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.2217/fmb.11.3 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/ ng0506-500 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/ng1180 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1016/S0065 -2776(08)60791-9 .,OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.4049/jimmunol.1303339 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/ ajh.2007.14 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1126/science.1106830 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.2174/157016112798829760 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
http://dx.doi.org/10.1038/ ki.2015.159 .,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/mBio.01300-15.PMC4791846.pdf
Curr Opin Cell Biol 17: 409 – 414. http://dx.doi.org/10.1016/j.ceb.2005.06.010 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/ 10.1073/pnas.052545099 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1038/emboj.2011.286 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
Curr Opin Cell Biol 25: 403– 405. http://dx.doi.org/10.1016/j.ceb.2013.06.001 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/ 10.1101/cshperspect.a000422 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
Annu Rev Microbiol 64:391– 408. http://dx.doi.org/10.1146/ annurev.micro.112408.134211 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
Mol Micro-biol76:833– 847. http://dx.doi.org/10.1111/j.1365-2958.2010.07153.x .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1007/s11120-013 -9851-0 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1016/j.cell.2013.10.044 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1371/ journal.pone.0076127 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1126/science.1186090 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1111/j.1365-2958.2011.07874.x .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1002/jobm.200900408 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1111/j.1574-6976.2011.00315.x .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1128/ AEM.70.2.1040-1050.2004 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1002/pmic.200500887 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1093/dnares/dsi002 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1111/1462 -2920.12128 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1111/j.1365-2958.2011.07631.x .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
Mol Microbiol 85:684 – 699. http://dx.doi.org/ 10.1111/j.1365-2958.2012.08132.x .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1371/journal.pgen.1004811 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/ 10.1038/nature04382 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1371/journal.pone.0033562 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/ 10.1128/AEM.01537-10 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
Front Microbiol 5:9.http://dx.doi.org/10.3389/ fmicb.2014.00009 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1016/j.sbi.2007.03.002 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/ 10.1016/j.mib.2009.03.007 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1101/ cshperspect.a000307 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1126/science.1123231 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1111/j.1365-2958.2011.07815.x .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
J Biol Chem 288:4265– 4277. http://dx.doi.org/10.1074/jbc.M112.417030 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1128/JB.01292-09 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
JBacteriol 196:650 – 659. http://dx.doi.org/10.1128/JB.00804-13 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1371/journal.pone.0009151 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
Ann Math Stat 18:50 – 60. http://dx.doi.org/10.1214/aoms/1177730491 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1126/science.1223539 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2010.07202.x .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/ 10.1016/j.tibs.2012.09.001 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1073/ pnas.0913306107 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
"http://dx.doi.org/10.1038/nrm3151 .49.Shibata Y, Shemesh T, Prinz WA, Palazzo AF, Kozlov MM, Rapoport TA.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1016/j.cell.2010.11.007 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
BMC Biol 11:71.http://dx.doi.org/10.1186/ 1741-7007-11-71 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1146/ annurev.physchem.012809.103450 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
Mol Microbiol 76:480 – 488. http://dx.doi.org/10.1111/j.1365 -2958.2010.07117.x .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1111/j.1574 -6976.2012.00348.x .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
Nat Methods 9:671– 675. http://dx.doi.org/ 10.1038/nmeth.2089 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1006/jsbi.1996.0013 .,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1038/nprot.2006.432 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1017/ S1431927608080781 .,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
http://dx.doi.org/10.1016/ j.jsb.2006.06.005 .Dynamic Control of Organelle Size in Bacteria January/February 2016 Volume 7 Issue 1 e01898-15 ®mbio.asm.org 9,OADS,/arxiv_data1/oa_pdf/e4/5d/mBio.01898-15.PMC4791847.pdf
"(A) Predicted cytochrome b5-like heme-binding and transmembrane (TM) domains in DapA, DapB, and DapC, based on a SMART protein search ( http://smart.embl-heidelberg.de/ ).",OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
A. fumigatus strain Af1160 was obtained from FGSC ( http://www.fg- sc.net ).,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1126/ science.1258137 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1529/ biophysj.107.123224 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/ j.bbamem.2010.11.012 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/ mBio.00647-15 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/0006 -2952(87)90694-0 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/ j.bbagen.2006.07.017 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1074/jbc.M706770200 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/ JCM.39.7.2431-2438.2001 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/AAC.49.6.2536-2538.2005 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
"Expression, puriﬁcation, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B. An-timicrob Agents Chemother 54:4225– 4234. http://dx.doi.org/10.1128/ AAC.00316-10 .",Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1371/journal.ppat.0030024 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/ j.fgb.2015.06.001 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/ mBio.00536-15 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/ j.bmc.2004.03.034 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/ 10.1128/AAC.47.3.956-964.2003 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/EC.2.2.306-317.2003 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/MCB.25.5.1669 -1679.2005 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/ j.cmet.2006.12.009 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/ 10.1111/j.1432-1033.1996.0726u.x .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/S0163 -7258(02)00327-3 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/AAC.05027-11 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1093/ oxfordjournals.jbchem.a022666 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1097/01.cco.0000152975.65477.7c .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1086/323335 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/S1369-5274(98)80087-8 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/ 10.2165/11596540-000000000-00000 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/ 10.1046/j.1432-1327.2001.02116.x .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
Clin Microbiol Infect 20(Suppl 6):42– 48. http://dx.doi.org/ 10.1111/1469-0691.12513 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/ 10.2217/fmb.14.27 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1021/bi7013739 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
Int J Antimicrob Agents 28:450 – 453. http://dx.doi.org/10.1016/ j.ijantimicag.2006.08.017 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/AAC.47.2.577-581.2003 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/AAC.01092-06 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1093/jac/dkh507 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1371/journal.pgen.1002374 .45.,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/mBio.00966-14 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/mBio.00941-14 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/ 10.1016/j.fgb.2014.12.005 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1111/ mmi.12026 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1128/ EC.00201-14 .,Non-OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
http://dx.doi.org/10.1016/j.fgb.2013.11.003 .,OADS,/arxiv_data1/oa_pdf/47/87/mBio.01919-15.PMC4791848.pdf
J Virol 89:8082– 8087. http://dx.doi.org/ 10.1128/JVI.01046-15 .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
http://dx.doi.org/10.1016/j.virol.2014.10.018 .,OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
http://dx.doi.org/10.1016/ j.virol.2011.09.016 .,OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
http://dx.doi.org/10.1128/JVI.02203-14 .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
http://dx.doi.org/10.1371/journal.pone.0090714 .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
http://dx.doi.org/10.1128/ JVI.06677-11 .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
http://dx.doi.org/10.1099/0022-1317-7-2-129 .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
http://dx.doi.org/10.1371/ journal.pgen.1001342 .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
J Virol 89:844 – 856. http://dx.doi.org/10.1128/ JVI.02697-14 .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
http://dx.doi.org/10.1128/genomeA.00978-14 .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
https://www.gpo.gov/fdsys/pkg/USCODE-2013-title7/pdf/ USCODE-2013-title7-chap54.pdf .,Non-OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
https://www.aaalac.org/resources/Guide_2011.pdfWahl-Jensen et al.,OADS,/arxiv_data1/oa_pdf/32/36/mBio.02009-15.PMC4791849.pdf
Front Immunol 5:311. http://dx.doi.org/ 10.3389/ﬁmmu.2014.00311 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1128/CMR.00066-12 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1099/mic.0.058115-0 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
Curr Opin Microbiol 16:38 – 44. http://dx.doi.org/ 10.1016/j.mib.2012.11.006 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1128/IAI.73.6.3219-3227.2005 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1128/IAI.73.11.7161-7169.2005 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.4049/jimmunol.174.3.1675 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1038/ nri3532 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/ 10.1038/cdd.2009.40 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1016/ j.cub.2012.06.001 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1126/ science.1103966 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
Proc Natl Acad Sc iUSA 104:6031– 6036. http://dx.doi.org/ 10.1073/pnas.0700036104 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.4161/auto.2825 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1053/j.gastro.2013.08.035 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1016/ j.chom.2013.05.004 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
Trends Microbiol 21:451– 456. http://dx.doi.org/10.1016/ j.tim.2013.06.009 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1016/ j.mib.2014.11.020 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1016/ j.chom.2015.10.015 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1371/journal.ppat.1004159 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1126/science.1136880 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1073/ pnas.0704014104 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1073/ pnas.0911267106 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
Nat Immunol 4:471– 477. http://dx.doi.org/10.1038/ni910 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1073/ pnas.091096998 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1111/ j.1600-0854.2005.00360.x .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1099/mic.0.032896-0 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1371/journal.pone.0023135 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1073/ pnas.202476699 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.4049/ jimmunol.0903704 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1371/ journal.ppat.1001345 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1084/jem.20101664 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1074/jbc.273.5.2714 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1038/nature03464 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1074/jbc.M112.387803 .42.,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1038/ni1511 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/ 10.1084/jem.20110547 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1084/jem.166.5.1229 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
Cytokine Growth Factor Rev 26:311–327 http://dx.doi.org/10.1016/j.cytogfr.2014.11.009 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
CellHost Microbe 15:72– 83. http://dx.doi.org/10.1016/j.chom.2013.12.006 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1016/j.immuni.2006.08.007 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity.Front Immunol 5:431. http://dx.doi.org/10.3389/ﬁmmu.2014.00431 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1074/ jbc.M109.018283 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.4049/jimmunol.173.2.1266 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1084/ jem.20040976 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
J Exp Med 200: 437– 445. http://dx.doi.org/ 10.1084/jem.20040712 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1084/jem.20040769 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.4049/ jimmunol.0902065 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1016/j.immuni.2011.12.002 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1038/ni.2397 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1111/j.1462 -5822.2008.01144.x .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1093/infdis/jis187 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1371/ journal.pone.0041879 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1016/ j.cytogfr.2014.07.015 .,OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
Immunology 99:464 – 472. http://dx.doi.org/ 10.1046/j.1365-2567.2000.00955.x .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1128/ IAI.01066-08 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/ 10.4161/jkst.23820 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.4049/ jimmunol.178.9.5789 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1371/ journal.pone.0023123 .,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/mBio.02051-15.PMC4791850.pdf
http://dx.doi.org/10.1056/NEJMra064142 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1016/S1473 -3099(13)70263-9 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
Parasitol Today 12:448 – 450. http://dx.doi.org/ 10.1016/0169-4758(96)40006-0 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1016/S0140-6736(96)11094-1 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1371/ journal.pntd.0001210 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1111/ j.1708-8305.2012.00605.x .Speciﬁc Biomarker of Loa loa Microﬁlarial Infection January/February 2016 Volume 7 Issue 1 e02132-15 ®mbio.asm.org 7,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
Clin Infect Dis 29:680 – 682. http://dx.doi.org/10.1086/598654 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1046/j.1365 -2257.2000.00318.x .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1016/j.trstmh.2008.12.016 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1371/journal.pntd.0001299 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1126/scitranslmed.aaa3480 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1179/136485906X112194 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1051/parasite/1997044351 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1371/ journal.pone.0022282 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1371/journal.pntd.0000326 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1371/journal.pntd.0000410 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1038/ nrurol.2013.24 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1038/ng.2585 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
"http://dx.doi.org/10.1128/ JCM.00490-08 .24.Drame PM, Fink DL, Kamgno J, Herrick JA, Nutman TB .",OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1038/nbt1235 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1016/ j.jchromb.2008.04.018 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
Mol Oncol 8:840 – 858. http://dx.doi.org/ 10.1016/j.molonc.2014.03.006 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
J Parasitol76:829 – 833. http://dx.doi.org/10.2307/3282801 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
J Proteome Res10:637– 645. http://dx.doi.org/10.1021/pr100835s .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1016/j.aca.2012.11.041 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
BMC Biotechnol 5:22. http://dx.doi.org/10.1186/ 1472-6750-5-22 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
J Vis Exp32:1459. http://dx.doi.org/10.3791/1549 .,Non-OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1016/ j.trsl.2014.08.006 .,OADS,/arxiv_data1/oa_pdf/69/07/mBio.02132-15.PMC4791851.pdf
http://dx.doi.org/10.1371/ journal.ppat.1005221 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1371/journal.ppat.1002304 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1056/NEJMoa1404505 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1038/ nature07082 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
Curr OpinStruct Biol 19:408 – 417. http://dx.doi.org/10.1016/j.sbi.2009.05.004 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/ 10.1128/JVI.76.24.12463-12472.2002 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1128/JVI.01170-07 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
J Virol 80:4174 – 4178. http://dx.doi.org/10.1128/ JVI.80.8.4174-4178.2006 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1126/ science.1110656 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1038/ emboj.2012.53 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1016/ j.cell.2015.01.041 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1371/journal.ppat.1001110 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1128/JVI.03398-14 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1371/journal.ppat.1001121 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1128/JVI.01956-08 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1038/nature10348 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1038/nature10380 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.3390/v4112471 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1128/ mBio.00565-15 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1016/j.cell.2015.01.031 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1371/journal.pntd.0001395 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1128/JVI.02433-06 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
J Virol 79:4793– 4805. http://dx.doi.org/ 10.1128/JVI.79.8.4793-4805.2005 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1016/ j.virusres.2006.06.002 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1128/JVI.01598-12 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1074/jbc.M110.207084 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1016/ j.coviro.2012.02.015 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/ 10.1038/nsmb.2150 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
Virology 468 – 470: 637– 646. http://dx.doi.org/10.1016/j.virol.2014.08.019 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1038/ nature13777 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1038/ nature14594 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1056/NEJMoa1411099 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.3201/ eid1809.111536 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
Sci Data 1:140042. http://dx.doi.org/10.1038/ sdata.2014.42 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
J Appl Crystallogr 40: 658 – 674. http://dx.doi.org/10.1107/S0021889807021206 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1107/S0907444994003112 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
Acta Crystallogr D Biol Crystallogr 62:72– 82. http://dx.doi.org/10.1107/ S0907444905036693 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1107/ S0907444909052925 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
Acta Crystallogr D BiolCrystallogr 62:439 – 450. http://dx.doi.org/10.1107/S0907444906005270 .,OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
Nature 355:472– 475. http://dx.doi.org/ 10.1038/355472a0 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1107/ S0907444909042073 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1073/ pnas.181342398 .,Non-OADS,/arxiv_data1/oa_pdf/03/96/mBio.02154-15.PMC4791852.pdf
http://dx.doi.org/10.1128/mBio.00716-15 .,Non-OADS,/arxiv_data1/oa_pdf/4a/df/mBio.02228-15.PMC4791853.pdf
http://dx.doi.org/10.1097/ FJC.0b013e318232b1a4 .,Non-OADS,/arxiv_data1/oa_pdf/4a/df/mBio.02228-15.PMC4791853.pdf
http://dx.doi.org/10.1002/path.1711470308 .,Non-OADS,/arxiv_data1/oa_pdf/4a/df/mBio.02228-15.PMC4791853.pdf
IntHeart J 56:656 – 660. http://dx.doi.org/10.1536/ihj.15-200 .,OADS,/arxiv_data1/oa_pdf/4a/df/mBio.02228-15.PMC4791853.pdf
"(Accessed June 24, 2015, at https://www.aace.com/ ﬁ les/ aace_algorithm.pdf).",OADS,/arxiv_data1/oa_pdf/3d/d7/NAJMS-8-106.PMC4791897.pdf
"(Accessed June 24, 2015 at http://www.essensstudy.com/).",Non-OADS,/arxiv_data1/oa_pdf/3d/d7/NAJMS-8-106.PMC4791897.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/61/dew008.PMC4791917.pdf
"Bioinformatics The STRTprep pipeline version 2.0.0, available at https://github.com/shka/ STRTprep , was developed and used for processing the raw sequenced reads.",OADS,/arxiv_data1/oa_pdf/45/61/dew008.PMC4791917.pdf
"( B) Typical STRTprep protocol ( https://github.com/shka/STRTprep ), which is an open-source pre-processing and analysis package for STRT RNA-seq.",OADS,/arxiv_data1/oa_pdf/45/61/dew008.PMC4791917.pdf
Bioinformatics analysis We developed an open-source pipeline for pre-processing and differen- tial expression analysis of the STRT data ( https://github.com/shka/ STRTprep ).,OADS,/arxiv_data1/oa_pdf/45/61/dew008.PMC4791917.pdf
"Although the standard protocol consists of four steps (Fig.1B; see also https://github.com/shka/STRTprep/wiki andSupple- mentary Text SI ), for the present study we used only the ﬁrst round of analysis for classiﬁcation and QC of the cells and the second round forinvestigation of differential gene expression based on the classiﬁcation (Fig.",Non-OADS,/arxiv_data1/oa_pdf/45/61/dew008.PMC4791917.pdf
Available from: http://biology.unm.edu/MARC/what‑is‑biomedical‑research.html.,Non-OADS,/arxiv_data1/oa_pdf/49/45/PRev-10-39.PMC4791986.pdf
Available from: http://www.fitnesstipsforlife.,Non-OADS,/arxiv_data1/oa_pdf/49/45/PRev-10-39.PMC4791986.pdf
Available from: http://biq.iqm.,Non-OADS,/arxiv_data1/oa_pdf/33/ab/PRev-10-6.PMC4791989.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs369/en/.,Non-OADS,/arxiv_data1/oa_pdf/25/5c/PM-12-27.PMC4791995.pdf
Available from: http://www.who.int/mediacentre/factsheets/2003/fs134/en.,Non-OADS,/arxiv_data1/oa_pdf/2c/96/PM-12-71.PMC4792004.pdf
Available from: http://www.tropicos.,Non-OADS,/arxiv_data1/oa_pdf/88/a8/PM-12-96.PMC4792008.pdf
A vailable from: http://www.notrickszone.com/2016/01/02/ how‑the‑250‑billion‑us‑diabetes‑industry‑operates‑theres‑a‑lot‑of‑ money‑to‑be‑made‑keeping‑you‑sick/#sthash.,Non-OADS,/arxiv_data1/oa_pdf/5d/de/IJEM-20-151.PMC4792011.pdf
A vailable from: http://www.greenmedinfo.com/blog/ cracking‑cholesterol‑myth‑how‑statins‑harm‑body‑and‑mind.,Non-OADS,/arxiv_data1/oa_pdf/5d/de/IJEM-20-151.PMC4792011.pdf
Available from: http://www.health.gov/ dietaryguidelines/2015/guidelines/.,Non-OADS,/arxiv_data1/oa_pdf/5d/de/IJEM-20-151.PMC4792011.pdf
A vailable from: http://www.shape.com/healthy‑eating/diet‑tips/ usda‑dietary‑guidelines?utm_source=shapetw_& utm_ campaign=Editorial%20Content_20160107202147.,Non-OADS,/arxiv_data1/oa_pdf/5d/de/IJEM-20-151.PMC4792011.pdf
A vailable from: http://www.nypost.com/2016/01/07/ added‑sugars‑are‑the‑new‑cigarettes/.,Non-OADS,/arxiv_data1/oa_pdf/5d/de/IJEM-20-151.PMC4792011.pdf
A vailable from: http://www.forbes.com/sites/davidsturt/2015/01/13/ is‑sitting‑the‑new‑smoking/#2715e4857a0b6a4fe70239a3.,Non-OADS,/arxiv_data1/oa_pdf/5d/de/IJEM-20-151.PMC4792011.pdf
Available from: http://www.gkaonlineacademy.com/ blog/item/sglt2‑inhibitors‑in ‑diabetes‑more‑than‑glorified‑diuretics.,Non-OADS,/arxiv_data1/oa_pdf/77/51/IJEM-20-154.PMC4792012.pdf
Available from: http://www.cbhidghs.nic.in/writereaddata/ linkimages/10176695673813.pdf.,Non-OADS,/arxiv_data1/oa_pdf/01/7c/IJEM-20-171.PMC4792016.pdf
Available from: http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/5d/db/IJEM-20-219.PMC4792024.pdf
Available from: http://cms2.selesti.com/ media/NationalDiabetesGuidelinesUAE.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/db/IJEM-20-219.PMC4792024.pdf
Available from: http://www.who.int/childgrowth/ publications/physical_status/en/.,Non-OADS,/arxiv_data1/oa_pdf/3d/d4/IJEM-20-228.PMC4792025.pdf
Available from: http://www.en.sanofi.com/ Images/33756_20130912_lixisenatide_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/c8/IJEM-20-254.PMC4792029.pdf
Available from: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm415180.,Non-OADS,/arxiv_data1/oa_pdf/0b/c8/IJEM-20-254.PMC4792029.pdf
Available from: https://investor.lilly.com/releasedetail.,Non-OADS,/arxiv_data1/oa_pdf/0b/c8/IJEM-20-254.PMC4792029.pdf
Available from: http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm393289.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/c8/IJEM-20-254.PMC4792029.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/0b/c8/IJEM-20-254.PMC4792029.pdf
Available from: http://ec.europa.eu/ health/documents/community ‑register/2014/20141121130063/ anx_130063_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/c8/IJEM-20-254.PMC4792029.pdf
Available from: http://www.en.sanofi.,Non-OADS,/arxiv_data1/oa_pdf/0b/c8/IJEM-20-254.PMC4792029.pdf
Available  from: http://www.diabetes.org/newsroom/press‑releases/2013/ recommendations‑for.html.,Non-OADS,/arxiv_data1/oa_pdf/0b/c8/IJEM-20-254.PMC4792029.pdf
Available from:  http://www.cursoenarm.net/UPTODATE/contents/mobipreview.,Non-OADS,/arxiv_data1/oa_pdf/15/2f/IJEM-20-268.PMC4792030.pdf
Available at: https://www.kidney.org/sites/default/files/docs/ckd_evaluation_classification_ stratification.pdf [Accessed on 24/6/2015].,OADS,/arxiv_data1/oa_pdf/15/2f/IJEM-20-268.PMC4792030.pdf
"Available at: http://www2.kidney.org/professionals/ KDOQI/guideline_diabetes/guide1.htm#tab6 [Accessed on 23/6/2015]diabetics is projected to rise from 171 million in 2000–366  million in 2030, of  which up to 79.4 million may be from  India.",Non-OADS,/arxiv_data1/oa_pdf/15/2f/IJEM-20-268.PMC4792030.pdf
Available from:  http://www.apiindia.org/medicine_update_2013/chap130.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/2f/IJEM-20-268.PMC4792030.pdf
Available from: http://www.who.int/vmnis/ indicators/haemoglobin.pdf.,OADS,/arxiv_data1/oa_pdf/15/2f/IJEM-20-268.PMC4792030.pdf
Available from:  https://www.kidney.org/sites/default/files/docs/anemiainckd.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/2f/IJEM-20-268.PMC4792030.pdf
Available from: http://www.ndt.,Non-OADS,/arxiv_data1/oa_pdf/15/2f/IJEM-20-268.PMC4792030.pdf
Available from: http://www.cursoenarm.,Non-OADS,/arxiv_data1/oa_pdf/15/2f/IJEM-20-268.PMC4792030.pdf
(Cell Mol Gastro- enterol Hepatol 2016;2:210 –221; http://dx.doi.org/10.1016/ j.jcmgh.2015.12.003 )Keywords: Biomarkers; Sialyl-Lewis A; Antibody Arrays; Lectins.,OADS,/arxiv_data1/oa_pdf/cf/d4/main.PMC4792034.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/d4/main.PMC4792034.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.12.003,OADS,/arxiv_data1/oa_pdf/cf/d4/main.PMC4792034.pdf
Available from: http://www.who.int/emergencies/zika-virus/en/.,Non-OADS,/arxiv_data1/oa_pdf/18/6c/CCD-7-1.PMC4792037.pdf
Available from: http://www.wpro.who.int/mediacentre/factsheets/ fs_05182015_zika/en/.,Non-OADS,/arxiv_data1/oa_pdf/18/6c/CCD-7-1.PMC4792037.pdf
Available from: http://www.ci.nii.ac.jp/ naid/110002985143.,Non-OADS,/arxiv_data1/oa_pdf/50/fe/CCD-7-107.PMC4792039.pdf
Available from: http://www.censusindia.,OADS,/arxiv_data1/oa_pdf/b1/a0/CCD-7-11.PMC4792040.pdf
Available from: http://www.oralhealthgroup.com/features/ paediatrics‑a‑review‑of‑the‑antibacterial‑effect‑of‑fluoride/.,Non-OADS,/arxiv_data1/oa_pdf/81/a3/CCD-7-45.PMC4792055.pdf
The supplemental material PDF has been corrected and is available at http://jcb.rupress.org/content/209/4/507/suppl/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ae/33/JCB_20141203502192016c.PMC4792070.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/e0/ijn-11-941.PMC4792178.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 941–953International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  941OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9979 1A bio-artificial poly([ d,l]-lactide-co-glycolide)  drug-eluting nanofibrous periosteum for segmental  long bone open fractures with significant  periosteal stripping injuries correspondence: shih-Jung liu Biomaterials lab, Department of  Mechanical engineering, chang gung  University, 259, Wen-Hwa 1st Road,  Kwei-Shan, Taoyuan 333, Taiwan Tel +886 3 211 8166 Fax +886 3 211 8558 email shihjung@mail.cgu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chou et al Running head recto: PLGA drug-eluting nanofibrous periosteum DOI: http://dx.doi.org/10.2147/IJN.S99791 Ying-chao chou1,2 Yi-shiun cheng1 Yung-heng hsu1,2 Yi-hsun Yu1,2 shih-Jung liu1,2 1Biomaterials lab, Department  of Mechanical engineering, chang  Gung University, 2Department of  Orthopedic Surgery, Chang Gung  Memorial Hospital, Taoyuan, TaiwanAbstract:  Biodegradable poly([ d,l]-lactide-co-glycolide) (PLGA) nanofibrous membrane  embedded with two drug-to-polymer weight ratios, namely 1:3 and 1:6, which comprised  PLGA 180 mg, lidocaine 20 mg, vancomycin 20 mg, and ceftazidime 20 mg, and PLGA  360 mg, lidocaine 20 mg, vancomycin 20 mg, and ceftazidime 20 mg, respectively, was  produced as an artificial periosteum in the treatment of segmental femoral fractures.",Non-OADS,/arxiv_data1/oa_pdf/b1/e0/ijn-11-941.PMC4792178.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b1/e0/ijn-11-941.PMC4792178.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e0/ijn-11-941.PMC4792178.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bc/b4/ijn-11-955.PMC4792179.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 955–975International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  955OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9612 3Targeting melanoma with immunoliposomes  coupled to anti-Mage a1 Tcr-like single-chain  antibody Mesha saeed1 Mandy van Brakel2 sara Zalba1 erik schooten2 Joost aP rens1 gerben a Koning1,† reno Debets2 Timo lM ten hagen1 1laboratory of experimental  surgical Oncology, section surgical  Oncology, Department of surgery,   erasmus M c, rotterdam, the  Netherlands; 2laboratory of Tumor  Immunology, Department of Medical  Oncology, erasmus M c cancer  Institute, rotterdam, the Netherlands †Dr gerben a Koning passed away on  December 29, 2015Abstract:  Therapy of melanoma using T-cells with genetically introduced T-cell receptors  (TCRs) directed against a tumor-selective cancer testis antigen (CTA) NY-ESO1 demonstrated  clear antitumor responses in patients without side effects.",Non-OADS,/arxiv_data1/oa_pdf/bc/b4/ijn-11-955.PMC4792179.pdf
"This method of TCR introduction results in T-cells which can  be forced to target specific antigens expressed only by cancer cells.5–8 To mimic the correspondence: Timo lM ten hagen laboratory of experimental surgical  Oncology, Department of surgery,  erasmus Mc, room ee-104a,  Post Bus 2040, 3000 ca, rotterdam,  the Netherlands Tel +31 10 704 3682 Fax +31 10 704 4746 email t.l.m.tenhagen@erasmusmc.n l Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Saeed et al Running head recto: Targeting melanoma with scFv-immunoliposomes DOI: http://dx.doi.org/10.2147/IJN.S96123",Non-OADS,/arxiv_data1/oa_pdf/bc/b4/ijn-11-955.PMC4792179.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bc/b4/ijn-11-955.PMC4792179.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/b4/ijn-11-955.PMC4792179.pdf
Available at: http://www.oticonme- dical.com/ /C24asset/cache.ashx?id=12639&type=14&format=web.,OADS,/arxiv_data1/oa_pdf/2d/69/mao-37-374.PMC4792196.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/ppa-10-291.PMC4792212.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 291–296Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  291OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9096 7impact of overweight and obesity on the  musculoskeletal system using lumbosacral angles ndubuisi Oc Onyemaechi1,2 godson e Anyanwu3 emmanuel n Obikili3 Okechukwu Onwuasoigwe1,2 Okechukwu e nwankwo1,2 1Department of surgery, college of  Medicine, University of nigeria enugu  campus, enugu, nigeria; 2University  of nigeria T eaching hospital, enugu,   nigeria; 3Department of Anatomy,   college of Medicine, University of  nigeria, enugu, nigeriaBackground:  Overweight and obesity have been identified as independent risk factors for  musculoskeletal disorders.",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/ppa-10-291.PMC4792212.pdf
"A systematic review of the relationship  between obesity and LBP revealed inconsistent results.8correspondence: ndubuisi Oc  Onyemaechi Department of surgery, college of  Medicine, University of nigeria enugu  campus, PMB 01129, enugu, nigeria Tel +234 80 3550 4767 email bisionyemaechi@yahoo.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Onyemaechi et al Running head recto: Impact of obesity and being overweight on the musculoskeletal system DOI: http://dx.doi.org/10.2147/PPA.S90967",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/ppa-10-291.PMC4792212.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/ppa-10-291.PMC4792212.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/87/7a/ott-9-1361.PMC4792213.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1361–1370OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1361Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9987 4impact of the care provided by gynecologic  oncologists on outcomes of cervical cancer  patients treated with radical hysterectomy Miao-fang Wu1,* Jing li1,2,* huai-wu lu1 li-juan Wang1 Bing-zhong Zhang1 Zhong-qiu lin1 1Department of gynecologic  Oncology, sun Yat-sen Memorial  hospital, 2Team-based learning  group of clinical study, sun Yat- sen University, guangzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  For many malignant diseases, specialized care has been reported to be associated  with better outcomes.",Non-OADS,/arxiv_data1/oa_pdf/87/7a/ott-9-1361.PMC4792213.pdf
"Keywords:  gynecologic oncologist, cervical cancer, radical hysterectomy, prognosis, surgical  outcome Introduction Cervical cancer is a leading cause of cancer death in women in developing countries;1 in  People’s Republic of China, it represents a great disease burden, with a high incidence  of 7.5/100,000 and mortality of 3.4/100,000.2 For patients with Federation International  of Gynecology and Obstetrics stage IB1–IIA2 cervical cancer, treatment of choice  consists of radical hysterectomy (RH) with pelvic lymphadenectomy or concurrent  chemoradiotherapy.1,3 Compared with concurrent chemoradiotherapy, RH can provide  more accurate staging information, remove the primary tumor, thereby obviating the correspondence: Bing-zhong Zhang;   Zhong-qiu lin Department of gynecologic Oncology,  sun Yat-sen Memorial hospital, sun  Yat-sen University, 102 Western Yanjiang  road, guangzhou 510120, People’s  republic of china Tel +86 20 34071153; +86 20 34071260 Fax +86 20 34071260; +86 20 81330211 email mdzhangbz@163.co m;   zhongqiu_lin@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wu et al Running head recto: Specialized surgery for cervical cancer DOI: http://dx.doi.org/10.2147/OTT.S99874",Non-OADS,/arxiv_data1/oa_pdf/87/7a/ott-9-1361.PMC4792213.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/87/7a/ott-9-1361.PMC4792213.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/7a/ott-9-1361.PMC4792213.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/62/opth-10-419.PMC4792214.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2016:10 419–429Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  419Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8956 1An evaluation of the safety and efficacy of  bimatoprost for eyelash growth in pediatric  subjects Mark Borchert1 suzanne Bruce2 David Wirta3 steven g Y oelin4 sungwook lee5 Cheri Mao5 amanda VanDenburgh5 1Children’s hospital los angeles,    los angeles, C a, Usa; 2suzanne Bruce  and associates, P a, houston, TX, Usa;   3David Wirta and associates, newport  Beach, C a, Usa; 4Medical associates  inc., newport Beach, C a, Usa;   5allergan plc, irvine, C a, UsaPurpose:  Evaluate the safety and effectiveness of bimatoprost 0.03% for treatment of eyelash  hypotrichosis in a pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/9b/62/opth-10-419.PMC4792214.pdf
"Correspondence: Mark Borchert Children’s hospital los angeles,  4650 sunset Boulevard, los angeles,  Ca 90027, Usa Tel +1 323 361 2347 Fax +1 323 361 3524 email mborchert@chla.usc.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Borchert et al Running head recto: Bimatoprost in pediatric subjects DOI: http://dx.doi.org/10.2147/OPTH.S89561",Non-OADS,/arxiv_data1/oa_pdf/9b/62/opth-10-419.PMC4792214.pdf
Available from: http://www.aao.org/newsroom/news-releases/detail/ american-academy-of-ophthalmology-warnsconsumers -.,Non-OADS,/arxiv_data1/oa_pdf/9b/62/opth-10-419.PMC4792214.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9b/62/opth-10-419.PMC4792214.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/62/opth-10-419.PMC4792214.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/ae/ott-9-1381.PMC4792215.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 1381–1387OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1381Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9273 6Quantitative assessment of caveolin-1 g14713a  polymorphism and cancer susceptibility in the  asian population Jianjun Tang1,* gang Wang2,* Qiang li1 rongfeng song1 1Department of gastroenterology,   cancer hospital of Jiangxi  Province, nanchang, Jiangxi, 2state  Key laboratory of Oncology in  south china, sun Yat- sen University  cancer center, guangzhou,   People’s  republic of china *These authors contributed equally  to this workPurpose:  The relationship between caveolin-1  (CAV1 ) G14713A polymorphism and cancer  susceptibility remains inconclusive.",Non-OADS,/arxiv_data1/oa_pdf/27/ae/ott-9-1381.PMC4792215.pdf
"Among these polymorphisms, the associa - tions of CAV1  G14713A polymorphism and cancer susceptibility have been widely  investigated; however, results are conflicting.8–19 For instance, Liu et al reported correspondence: rongfeng song Department of gastroenterology, cancer  hospital of Jiangxi Province, 519 Beijing  road, nanchang, Jiangxi Province 330029,  People’s republic of china email rongfengsong1975@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Tang et al Running head recto: Caveolin-1 G14713A polymorphism and cancer susceptibility DOI: http://dx.doi.org/10.2147/OTT.S92736",Non-OADS,/arxiv_data1/oa_pdf/27/ae/ott-9-1381.PMC4792215.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/27/ae/ott-9-1381.PMC4792215.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/ae/ott-9-1381.PMC4792215.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/1d/ott-9-1351.PMC4792216.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1351–1360OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1351Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9871 3p53 inhibits the expression of p125 and the  methylation of POLD1  gene promoter by  downregulating the sp1-induced DnMT1  activities in breast cancer liang Zhang1 Weiping Yang2 Xiao Zhu1 changyuan Wei1 1Department of Breast surgery,   2Department of Ultrasound, affiliated  T umor hospital of guangxi Medical  University, nanning, guangxi, People’s  republic of chinaAbstract:  p125 is one of four subunits of human DNA polymerases – DNA Pol δ as well as  one of p53 target protein encoded by POLD1 .",Non-OADS,/arxiv_data1/oa_pdf/df/1d/ott-9-1351.PMC4792216.pdf
"Keywords:  breast cancer, apoptosis, DNMT1, MCF-7, methylation, p125 Introduction The American Cancer Society has estimated that 231,840 new cases of invasive breast  cancer will be diagnosed and that 40,290 of these women will die from breast cancer  in 2015 in the USA.1 Breast cancer is now the most common cancer in women in  developed countries, and in the USA, up to 12% women will develop invasive breast  cancer over the course of their lifetime.2 It is now known that “atypical” changes in the  breast duct and lobular epithelium may be the basis for the development of carcinoma  in situ and that it is a risk factor for invasive breast carcinoma, mainly adenocarcinoma  of either ductal or lobular type.3correspondence: changyuan Wei Department of Breast Surgery, Affiliated  Tumor hospital of guangxi Medical  University, 71 hedi road, nanning,  guangxi 530021, People’s republic  of china email weicy63@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: p53 inhibits p125 expression DOI: http://dx.doi.org/10.2147/OTT.S98713",Non-OADS,/arxiv_data1/oa_pdf/df/1d/ott-9-1351.PMC4792216.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/df/1d/ott-9-1351.PMC4792216.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/1d/ott-9-1351.PMC4792216.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/72/bd/jbm-7-013.PMC4792217.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/72/bd/jbm-7-013.PMC4792217.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Blood Medicine 2016:7 13–18Journal of Blood Medicine Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/72/bd/jbm-7-013.PMC4792217.pdf
"Or use: http://youtu.be/yTVU7-0nUQ 4Dove press submit your manuscript | www.dovepress.co m Dove press  13 Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S9583 9Kozhikode criteria for diagnosing systemic lupus  erythematosus as a hematological disorder n arathi1 PK sasidharan1,2 P geetha1 1Department of Medicine,   2Department of haematology,   government Medical college,   Kozhikode, Kerala, india correspondence: PK sasidharan   Department of Medicine, PVs hospital,  Parijatham, Pipeline road, Patteri,  Kozhikode 673016, Kerala, india   T el +91 98 4700 5177   email sasidharanpk@gmail.co mAbstract:  Systemic lupus erythematosus (SLE) is an autoimmune disease in which cells and  tissues undergo damage mediated by tissue-binding autoantibodies.",Non-OADS,/arxiv_data1/oa_pdf/72/bd/jbm-7-013.PMC4792217.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal­of­blood­medicine­journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/72/bd/jbm-7-013.PMC4792217.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/bd/jbm-7-013.PMC4792217.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/42/TOBEJ-10-1.PMC4792218.pdf
"[http://dx.doi.org/10.1007/s10165-013-0836-9] [PMID: 24261772] [2] Upfold LI, Sullivan JS, Prendergast JK, Geczy AF.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1038/nrrheum.2010.79] [PMID: 20517295] [5] Ramos-Remus C, Russell AS.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1038/ng.513] [PMID: 20062062] [7] Brown MA, Pile KD, Kennedy LG, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1002/1529-0131 (199804) 41:4<588: :AID-ART5>3.3.CO;2-S] [PMID: 9550467] [8] Lin Z, Bei JX, Shen M, et al.",Non-OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1038/ng.1005] [PMID: 22138694] [9] Wei JC, Hsu YW, Hung KS, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1371/journal.pone.0052801] [PMID: 23308121] [10] Cortes A, Hadler J, Pointon JP, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1038/ng.2667] [PMID: 23749187] [11] Davidson SI, Liu Y, Danoy PA, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1136/ard.2010.133322] [PMID: 21068102] [12] Sánchez  A,  Szczypiorska  M,  Juanola  X,  et  al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.3899/jrheum.100211] [PMID: 20810504] [13] Pimentel-Santos FM, Ligeiro D, Matos M, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1007/s00296-010-1712-y] [PMID: 21229357] [15] Davidson SI, Wu X, Liu Y, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1002/art.24933] [PMID: 19877036] [16] Bang SY, Kim TH, Lee B, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.3899/jrheum.100652] [PMID: 21041274] [17] Wang CM, Ho HH, Chang SW, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1186/ar3855] [PMID: 22632381] [18] Erali M, Palais R, Wittwer C. SNP genotyping by unlabeled probe melting analysis.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1007/978-1-60327-040-3_14] [PMID: 18695968] [19] Choi CB, Kim TH, Jun JB, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1136/ard.2008.105296] [PMID: 19414429] [20] Aguirre-Lamban  J,  Riveiro-Alvarez  R,  Garcia-Hoyos  M,  et  al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1167/iovs.09-4518] [PMID: 19959634] [21] Tsui FW, Haroon N, Reveille JD, et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1136/ard.2008.103804] [PMID: 19433412] [22] Maksymowych WP, Inman RD, Gladman DD, Reeve JP, Pope A, Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis.",Non-OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1002/art.24467] [PMID: 19404951] [23] Goto Y, Tanji H, Hattori A, Tsujimoto M. Glutamine-181 is crucial in the enzymatic activity and substrate specificity of human endoplasmic- reticulum aminopeptidase-1.",Non-OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"[http://dx.doi.org/10.1042/BJ20080965] [PMID: 18593381] Received: July 16, 2015 Revised: November 18, 2015 Accepted: November 26, 2015 © Wang et al.",OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/26/TORJ-10-1.PMC4792219.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/66/64/ceo-2016-9-1-70.PMC4792235.pdf
"1: 70- 74, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.70 Original Article INTRODUCTION Narrow band imaging (NBI) is an innovative optical technology  that can increase contrast showing precise morphological chang - es in the mucosal surface.",Non-OADS,/arxiv_data1/oa_pdf/66/64/ceo-2016-9-1-70.PMC4792235.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/ca/c0/ceo-2016-9-1-62.PMC4792236.pdf
"1: 62- 69, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.62 Original Article INTRODUCTION The incidence of thyroid cancer is increasing rapidly worldwide  [1].",Non-OADS,/arxiv_data1/oa_pdf/ca/c0/ceo-2016-9-1-62.PMC4792236.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/bd/2d/ceo-2016-9-1-1.PMC4792237.pdf
"1: 1- 7, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.1 Review  INTRODUCTION Obstructive sleep apnea (OSA) is a common disease worldwide,  affecting over 4% of men and 2% of women [1].",Non-OADS,/arxiv_data1/oa_pdf/bd/2d/ceo-2016-9-1-1.PMC4792237.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/ac/13/ceo-2016-9-1-80.PMC4792238.pdf
"1: 80- 84, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.80 Original Article INTRODUCTION Malignant mucosal melanoma is a rare tumor.",Non-OADS,/arxiv_data1/oa_pdf/ac/13/ceo-2016-9-1-80.PMC4792238.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/9d/cc/ceo-2016-9-1-33.PMC4792239.pdf
"1: 33- 38, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.33 Original Article INTRODUCTION Otitis media with effusion (OME) is an inflammatory disorder of the middle ear that is characterised by the presence of endo - tympanic fluid without any sign or symptom of acute ear infec - tion [1], which may lead to hearing loss (HL) or long-term se - quelae and have a negative impact on speech development and  behaviour [1-3].",Non-OADS,/arxiv_data1/oa_pdf/9d/cc/ceo-2016-9-1-33.PMC4792239.pdf
Available from: http://www.asha.org/poli - cy/GL2005-00014.htm.,Non-OADS,/arxiv_data1/oa_pdf/9d/cc/ceo-2016-9-1-33.PMC4792239.pdf
Available  from: http://www.ncbi.nlm.nih.gov/books/NBK143306/.,Non-OADS,/arxiv_data1/oa_pdf/9d/cc/ceo-2016-9-1-33.PMC4792239.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/27/23/ceo-2016-9-1-8.PMC4792240.pdf
"1: 8- 13, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.8 Review  INTRODUCTION Granulomatosis with polyangiitis (GPA), previously known as  Wegener granulomatosis, is an idiopathic vasculitis of medium  and small arteries, characterized by necrotizing granulomatous  inflammation of the respiratory tract with coexisting glomerulo - nephritis.",Non-OADS,/arxiv_data1/oa_pdf/27/23/ceo-2016-9-1-8.PMC4792240.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/58/35/ceo-2016-9-1-39.PMC4792241.pdf
"1: 39- 43, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.39 Original Article INTRODUCTION Approximately 15% of the normal population have lateralized  olfaction, and this percentage rises to 26%–32% in individuals  with chronic rhinosinusitis or a sinonasal tumor [1].",Non-OADS,/arxiv_data1/oa_pdf/58/35/ceo-2016-9-1-39.PMC4792241.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/34/09/ceo-2016-9-1-56.PMC4792242.pdf
"1: 56- 61, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.56 Original Article INTRODUCTION The extracellular matrix (ECM) of the vocal fold lamina propria  (LP) consists of a number of important molecules that contrib - ute to tissue characteristics during oscillation [1,2].",Non-OADS,/arxiv_data1/oa_pdf/34/09/ceo-2016-9-1-56.PMC4792242.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/1d/0b/ceo-2016-9-1-21.PMC4792243.pdf
"1: 21- 26, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.21 Original Article INTRODUCTION Bone-anchored hearing devices of percutaneous type have been  successfully used to treat conductive hearing loss (HL) patients  that cannot be corrected by surgery and single side deaf pa - tients.",Non-OADS,/arxiv_data1/oa_pdf/1d/0b/ceo-2016-9-1-21.PMC4792243.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/08/b8/ceo-2016-9-1-44.PMC4792244.pdf
"1: 44- 50, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.44 Original Article INTRODUCTION Functional endoscopic sinus surgery, in which the surgeon can  reach the paranasal sinuses directly under endoscopic vision, is  a surgical method that is used quite often in the ENT (ear, nose,  and throat) practice.",Non-OADS,/arxiv_data1/oa_pdf/08/b8/ceo-2016-9-1-44.PMC4792244.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/0b/5a/ceo-2016-9-1-75.PMC4792245.pdf
"1: 75- 79, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.75 Original Article INTRODUCTION Lymph node metastasis (LNM) is a significant factor associated  with disease recurrence in patients with papillary thyroid carci -noma (PTC) [1-3].",Non-OADS,/arxiv_data1/oa_pdf/0b/5a/ceo-2016-9-1-75.PMC4792245.pdf
"9.1.3 (SAS Insti - tute Inc., Cary, NC, USA) and R 2.13.2 (R Foundation for Statis - tical Computing, Vienna, Austria; http://www.R-project.org).",Non-OADS,/arxiv_data1/oa_pdf/0b/5a/ceo-2016-9-1-75.PMC4792245.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/69/96/ceo-2016-9-1-14.PMC4792246.pdf
"1: 14- 20, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.14 Original Article INTRODUCTION Cisplatin is a commonly used antineoplastic agent that treats  many neoplastic diseases, including ovarian, testicular, lung, and  head and neck cancer.",Non-OADS,/arxiv_data1/oa_pdf/69/96/ceo-2016-9-1-14.PMC4792246.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/3c/ac/ceo-2016-9-1-27.PMC4792247.pdf
"1: 27- 32, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.27 Original Article INTRODUCTION The mastoid air cell system (MACS) is a highly cellular, posterior  extension of the middle ear.",Non-OADS,/arxiv_data1/oa_pdf/3c/ac/ceo-2016-9-1-27.PMC4792247.pdf
Available from:  http://www.python.org/.,OADS,/arxiv_data1/oa_pdf/3c/ac/ceo-2016-9-1-27.PMC4792247.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/cb/e3/ceo-2016-9-1-51.PMC4792248.pdf
"1: 51- 55, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.51 Original Article INTRODUCTION Nasal septal deviation is the most common nasal pathology, and surgical correction of the nasal deformity results in alterations in  the upper and the lower airways.",Non-OADS,/arxiv_data1/oa_pdf/cb/e3/ceo-2016-9-1-51.PMC4792248.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/41/c0/ceo-2016-9-1-85.PMC4792249.pdf
"1: 85- 88, March 2016 http://dx.doi.org/10.21053/ceo.2016.9.1.85 Case Report INTRODUCTION Mandibular osteoradionecrosis (ORN) is a potentially debilitat - ing complication from ionizing radiotherapy, whose incidence is  reported to range between 5% and 15%.",Non-OADS,/arxiv_data1/oa_pdf/41/c0/ceo-2016-9-1-85.PMC4792249.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/3b/main.PMC4792280.pdf
http://dx.doi.org/10.1016/j.btre.2015.07.0012215-017X/ ã 2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/50/3b/main.PMC4792280.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  7  (2015)  157–165 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/50/3b/main.PMC4792280.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/37/main.PMC4792283.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.05.003 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/f6/37/main.PMC4792283.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2, 261e267",Non-OADS,/arxiv_data1/oa_pdf/f6/37/main.PMC4792283.pdf
"1: 109-112, February 2016  http://dx.doi.org/ 10.3347/kjp.2016.54.1.109 ▣BRIEF COMMUNICATION  • Received 18 November 2015, revised 27 December 2015,   accepted 16 January 2016.",Non-OADS,/arxiv_data1/oa_pdf/24/12/kjp-54-1-109.PMC4792311.pdf
"*Corresponding author (cjy@snu.ac.kr) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Molecular Description of Macroorchis spinulosus   (Digenea: Nanophyetidae) Based on ITS1 Sequences Eun Jeong Won1, Deok-Gyu Kim2, Jaeeun Cho2, Bong-Kwang Jung2, Min-Jae Kim2, Yong Woon Yun3,   Jong-Yil Chai2,*, Dong Wook Ryang1 1Departments of Laboratory Medicine, Chonnam National University Hospital, Gwangju 61469, Korea; 2Department of Parasitology and Tropical  Medicine, Seoul National University College of Medicine, Seoul 03080, Korea; 3Department of Preventive Medicine, Chonnam National University  Medical School and Regional Cardiocerebrovascular Center, Gwangju 61469, Korea Abstract:  We performed a molecular genetic study on the sequences of 18S ribosomal RNA (ITS1 region) gene in 4-day- old adult worms of Macroorchis spinulosus  recovered in mice experimentally infected with metacercariae from crayfish in  Jeollanam-do Province, Korea.",Non-OADS,/arxiv_data1/oa_pdf/24/12/kjp-54-1-109.PMC4792311.pdf
"1: 31-38, February 2016  http://dx.doi.org/ 10.3347/kjp.2016.54.1.31 ▣ORIGINAL ARTICLE  • Received 16 September 2015, revised 3 November 2015,   accepted 7 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/e1/6d/kjp-54-1-31.PMC4792312.pdf
"*Corresponding author (howoo@catholic.ac.kr) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Afatinib Reduces STAT6 Signaling of Host ARPE-19 Cells  Infected with Toxoplasma gondii   Zhaoshou Yang1, Hye-Jin Ahn1, Young-Hoon Park2, Ho-Woo Nam1,* 1Department of Parasitology and 2Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea,    Seoul 06591, Republic of Korea Abstract:  Specific gene expressions of host cells by spontaneous STAT6 phosphorylation are major strategy for the sur - vival of intracellular Toxoplasma gondii  against parasiticidal events through STAT1 phosphorylation by infection provoked  IFN- γ.",Non-OADS,/arxiv_data1/oa_pdf/e1/6d/kjp-54-1-31.PMC4792312.pdf
"1: 61-66, February 2016  http://dx.doi.org/ 10.3347/kjp.2016.54.1.61 ▣ORIGINAL ARTICLE •Received 6 March 2015, revised 30 September 2015, accepted 1 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/02/kjp-54-1-61.PMC4792313.pdf
"*Corresponding author (guraishi@yahoo.com) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.In Vitro Scolicidal Effects of Salvadora persica  Root  Extract against Protoscolices of Echinococcus granulosus   Abdel-Azeem S. Abdel-Baki1,2, Esam Almalki1,3, Lamjed Mansour1,4, Saleh Al-Quarishy1,* 1Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia; 2Zoology Department, Faculty of Science, Beni-Suef  University, Beni-Suef, Egypt; 3Department of Medical Laboratory, College of Applied Medical Sciences, Majmaah University, Saudi Arabia;   4Unité de Recherche de Biologie intégrative et Ecologie évolutive et Fonctionnelle des Milieux Aquatiques, Département de Biologie,   Faculté des Sciences de Tunis, Université De Tunis El Manar, Tunis, Tunisia Abstract:  It has been known that Arak, Salvadora persica , has a number of medicinal properties.",Non-OADS,/arxiv_data1/oa_pdf/4e/02/kjp-54-1-61.PMC4792313.pdf
"1: 71-74, February 2016  http://dx.doi.org/ 10.3347/kjp.2016.54.1.71 ▣BRIEF COMMUNICATION  • Received 18 November 2015, revised 30 December 2015,   accepted 7 January 2016.",Non-OADS,/arxiv_data1/oa_pdf/f4/7f/kjp-54-1-71.PMC4792314.pdf
"*Corresponding author (hyagape@cu.ac.kr) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Influence of 120 kDa Pyruvate:Ferredoxin Oxidoreductase  on Pathogenicity of Trichomonas vaginalis   Hyun-Ouk Song * Department of Parasitology, School of Medicine, Catholic University of Daegu, Daegu 42472, Korea Abstract:  Trichomonas vaginalis  is a flagellate protozoan parasite and commonly infected the lower genital tract in wom - en and men.",Non-OADS,/arxiv_data1/oa_pdf/f4/7f/kjp-54-1-71.PMC4792314.pdf
"1: 81-85, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.81 ▣BRIEF COMMUNICATION •Received 25 August 2015, revised 3 November 2015, accepted 4 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/kjp-54-1-81.PMC4792315.pdf
"© 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Molecular Characterization of Enterocytozoon bieneusi  in  Domestic Rabbits ( Oryctolagus cuniculus ) in Northeastern  China  Xiao-Xuan Zhang1,†, Jing Jiang2,†, Ya-Nan Cai1, Chun-Feng Wang1, Peng Xu3, Gui-Lian Yang1,*, Quan Zhao1,* 1College of Animal Science and Technology, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Agricultural University,  Changchun, Jilin Province 130118, PR China; 2College of Animal Science and Technology, Changchun University of Science and Technology,  Shuangyang, Jilin Province 130600, PR China; 3College of Animal Husbandry and Veterinary Medicine, Liaoning Medical University, Jinzhou,  Liaoning Province 121001, PR China Abstract:  A study of 426 rabbits from 3 cities in Jilin province (Changchun City and Jilin City) and Liaoning province  (Shenyang City) was conducted between May and June 2015.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/kjp-54-1-81.PMC4792315.pdf
"1: 113-118, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.113 ▣BRIEF COMMUNICATION •Received 21 March 2015, revised 6 December 2015, accepted 11 January 2016.",Non-OADS,/arxiv_data1/oa_pdf/be/8a/kjp-54-1-113.PMC4792316.pdf
"*Corresponding author (myriam.mrad@gnet.tn) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Environmental Contamination by Echinococcus  granulosus  sensu lato Eggs in Relation to  Slaughterhouses in Urban and Rural Areas in Tunisia Raja Chaâbane-Banaoues1, Myriam Oudni-M’rad1,*, Selim M’rad1, Habib Mezhoud1, Hamouda Babba1,2 1LP3M: Laboratoire de Parasitologie-Mycologie Médicale et Moléculaire, LR12ES08, Département de Biologie Clinique B, Faculté de Pharmacie,  Université de Monastir, 1 Rue Avicenne, 5000 Monastir, Tunisie; 2Laboratoire de Parasitologie, E.P .S.",Non-OADS,/arxiv_data1/oa_pdf/be/8a/kjp-54-1-113.PMC4792316.pdf
http://www.au-ibar.org/events/au-ibar/237-the-9th-conference- of-ministers-responsible-for-livestock-in-africa?showall=&start=1.,Non-OADS,/arxiv_data1/oa_pdf/be/8a/kjp-54-1-113.PMC4792316.pdf
"1: 47-53, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.47 ▣ORIGINAL ARTICLE  •Received 7 October 2015, revised 15 November 2015, accepted 26 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/02/c1/kjp-54-1-47.PMC4792317.pdf
"*Corresponding author (bthida@kku.ac.th) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Animal Models for Echinostoma malayanum  Infection:  Worm Recovery and Some Pathology Jiraporn  Songsri1,2,3, Ratchadawan Aukkanimart1,2,3,4, Thidarut Boonmars1,2,3,*, Panaratana Ratanasuwan4,   Porntip Laummaunwai1,2, Pranee Sriraj1,2,3,4, Panupan Sripan1,3 1Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 2Neglected Zoonosis and Vector-Borne  Disease Group,  Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 3Liver Fluke and Cholangiocarcinoma Research Center,  Khon Kaen University, Khon Kaen 40002, Thailand; 4Rajamangala University of  Technology Isan Sakonnakhon Campus, Sakonnakhon 47160,  Thailand; 5Department of Anesthesiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  Echinostomes are intestinal trematodes that infect a wide range of vertebrate hosts, including humans, in their  adult stage and also parasitize numerous invertebrate and cold-blooded vertebrate hosts in their larval stages.",Non-OADS,/arxiv_data1/oa_pdf/02/c1/kjp-54-1-47.PMC4792317.pdf
"1: 75-80, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.75 ▣BRIEF COMMUNICATION •Received 21 October 2015, revised 4 December 2015, accepted 26 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/c8/92/kjp-54-1-75.PMC4792318.pdf
"*Corresponding author (ychong@knu.ac.kr) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Prevalence of Trichomonas vaginalis  in Women Visiting 2  Obstetrics and Gynecology Clinics in Daegu, South Korea Youn-Kyoung Goo1, Won-Sik Shin2, Hye-Won Yang1, So-Young Joo1, Su-Min Song1, Jae-Sook Ryu3,   Won-Myung Lee4, Hyun-Hee Kong5, Won-Ki Lee6, Sang-Eun Lee7, Won-Ja Lee7, Dong-Il Chung1, Yeonchul Hong1,* 1Department of Parasitology and Tropical Medicine, Kyungpook National University School of Medicine, Daegu 41944, Korea; 2Department of  Obstetrics and Gynecology, Shinsegae Women’s Hospital, Daegu 41535, Korea; 3Department of Environmental Biology & Medical Parasitology,  Hanyang University College of Medicine, Seoul 04763, Korea; 4Department of Obstetrics and Gynecology, Rosemary Hospital, Daegu 41422,  Korea; 5Department of Parasitology, Dong-A University College of Medicine, Busan 49201, Korea; 6Center of Biostatistics, Kyungpook National  University School of Medicine, Daegu 41944, Korea; 7Division of Malaria and Parasitic Diseases, Korea National Institute of Health, Korea Centers  for Diseases Control and Prevention, Osong 28159, Korea Abstract:  This study explored epidemiological trends in trichomoniasis in Daegu, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/c8/92/kjp-54-1-75.PMC4792318.pdf
"1: 103-107, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.103 ▣BRIEF COMMUNICATION  •Received 17 December 2015, revised 8 January 2016, accepted 11 January 2016.",Non-OADS,/arxiv_data1/oa_pdf/2e/a2/kjp-54-1-103.PMC4792319.pdf
"*Corresponding author (sungshik@jnu.ac.kr) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Effects of Disinfectants on Larval Development of Ascaris  suum  Eggs Ki-Seok Oh1, Geon-Tae Kim2, Kyu-Sung Ahn2, Sung-Shik Shin2,* 1Department of Obstetrics and 2Department of Parasitology, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Korea Abstract:  The objective of this study was to evaluate the effects of several different commercial disinfectants on the em - bryogenic development of Ascaris suum  eggs.",Non-OADS,/arxiv_data1/oa_pdf/2e/a2/kjp-54-1-103.PMC4792319.pdf
"1: 93-96, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.93 ▣BRIEF COMMUNICATION •Received 15 October 2015, revised 16 November 2015, accepted 26 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/11/4f/kjp-54-1-93.PMC4792320.pdf
"*Corresponding author (smartsci2013@163.com) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Seroprevalence of Toxoplasma gondii  Infection among  HIV/AIDS Patients in Eastern China Guoqiang Shen *, Xiaoming Wang, Hui Sun, Yaying Gao Department of Laboratory Medicine, Wuxi No.",Non-OADS,/arxiv_data1/oa_pdf/11/4f/kjp-54-1-93.PMC4792320.pdf
"1: 67-70, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.67 ▣CASE REPORT •Received 15 October 2015, revised 5 December 2015, accepted 3 January 2016.",Non-OADS,/arxiv_data1/oa_pdf/96/0a/kjp-54-1-67.PMC4792321.pdf
"*Corresponding authors (sdhywangli@163.com; caixp@vip.163.com) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Infection of Taenia asiatica  in a Bai Person in Dali, China Li Wang1,2,*, Xuenong Luo2, Junling Hou2, Aijiang Guo2, Shaohua Zhang2, Hailong Li3, Xuepeng Cai1,2,* 1College of Veterinary Medicine, Jilin University, Changchun, Jilin, P .",Non-OADS,/arxiv_data1/oa_pdf/96/0a/kjp-54-1-67.PMC4792321.pdf
"1: 39-46, February 2016  http://dx.doi.org/ 10.3347/kjp.2016.54.1.39 ▣ORIGINAL ARTICLE  •Received 4 February 2015, revised 17 October 2015, accepted 1 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/23/ba/kjp-54-1-39.PMC4792322.pdf
"*Corresponding author (guanguiquan@caas.cn; luojianxun@caas.cn) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Validation of Reference Genes for Quantitative Real-Time  PCR in Bovine PBMCs Transformed and Non-transformed  by Theileria annulata Hongxi Zhao1,3, Junlong Liu1, Youquan Li1, Congshan Yang1, Shuaiyang Zhao1, Juan Liu1, Aihong Liu1,   Guangyuan Liu1, Hong Yin1,2, Guiquan Guan1,*, Jianxun Luo1,* 1State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research  Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, People’s Republic of China; 2Jiangsu Co-innovation Center for Prevention  and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, People’s Republic of China; 3Agricultural College of Ningxia  University, Yinchuan 750021, People’s Republic of China Abstract:  Theileria annulata  is a tick-borne intracellular protozoan parasite that causes tropical theileriosis, a fatal bovine  lymphoproliferative disease.",Non-OADS,/arxiv_data1/oa_pdf/23/ba/kjp-54-1-39.PMC4792322.pdf
"1: 97-101, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.97 ▣BRIEF COMMUNICATION • Received 11 September 2015, revised 29 December 2015,   accepted 30 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/cc/88/kjp-54-1-97.PMC4792323.pdf
"*Corresponding author (dmkwak@knu.ac.kr) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Serological Detection of Borrelia burgdorferi  among  Horses in Korea Seung-Hun Lee1, Sun-Hee Yun2, Eunsang Choi3, Yong-Soo Park4, Sang-Eun Lee5, Gil-Jae Cho1, Oh-Deog Kwon1,  Dongmi Kwak1,6,* 1College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea; 2Division of Veterinary Service Lab, Institute of Public Health &  Environment, Incheon 22320, Korea; 3Smile Equine Clinic, Busan 46745, Korea; 4Korea National College of Agriculture and Fisheries, Jeonju 54874,  Korea; 5Division of Malaria and Parasitic Diseases, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju  28159, Korea; 6Cardiovascular Research Institute, Kyungpook National University, Daegu 41566, Korea Abstract:  Lyme disease is a tick-borne zoonotic infectious disease caused by Borrelia burgdorferi .",Non-OADS,/arxiv_data1/oa_pdf/cc/88/kjp-54-1-97.PMC4792323.pdf
"1: 21-29, February 2016  http://dx.doi.org/ 10.3347/kjp.2016.54.1.21 ▣ORIGINAL ARTICLE  • Received 3 November 2015, revised 21 December 2015,   accepted 29 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/91/e8/kjp-54-1-21.PMC4792324.pdf
"*Corresponding authors (sluo815@gmail.com; haowa@126.com) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.A Novel Polyclonal Antiserum against Toxoplasma gondii   Sodium Hydrogen Exchanger 1 Bin Xiao, Zhenzhan Kuang, Yanli Zhan, Daxiang Chen, Yang Gao, Ming Li, Shuhong Luo *, Wenbo Hao *  State Key Laboratory of Organ Failure, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Biotechnology, Southern  Medical University, Guangzhou 510515, People’s Republic of China Abstract:  The sodium hydrogen exchanger 1 (NHE1), which functions in maintaining the ratio of Na+ and H+ ions, is wide - ly distributed in cell plasma membranes.",Non-OADS,/arxiv_data1/oa_pdf/91/e8/kjp-54-1-21.PMC4792324.pdf
AAR85890.1) contains 12 possible  transmembrane helices predicted by TMHMM Server v.2.0  (http://www.cbs.dtu.dk/services/TMHMM-2.0/).,OADS,/arxiv_data1/oa_pdf/91/e8/kjp-54-1-21.PMC4792324.pdf
"1: 55-60, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.55 ▣ORIGINAL ARTICLE  •Received 1 January 2015, revised 16 November 2015, accepted 26 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/aa/c7/kjp-54-1-55.PMC4792325.pdf
"*Corresponding author (Bmeshgi@ut.ac.ir) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Genotype and Phenotype of Echinococcus granulosus   Derived from Wild Sheep ( Ovis orientalis ) in Iran Ali Eslami1, Behnam Meshgi1,*, Fatemeh Jalousian1, Shima Rahmani2, Mohammad Ali Salari2 1Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran (Center of Excellent of Ecosystem and Ultrastructural  Changes of Helminthes); 2Under Graduate Student, School of Specialized Sciences of Veterinary Medicine, Unit of Sciences and Research, Islamic  Azad University, Tehran, Iran Abstract:  The aim of the present study is to determine the characteristics of genotype and phenotype of Echinococcus  granulosus  derived from wild sheep and to compare them with the strains of E. granulosus sensu stricto (sheep-dog) and  E. granulosus  camel strain (camel-dog) in Iran.",Non-OADS,/arxiv_data1/oa_pdf/aa/c7/kjp-54-1-55.PMC4792325.pdf
"1: 15-20, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.15 ▣ORIGINAL ARTICLE  •Received 3 October 2015, revised 30 November 2015, accepted 9 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/a5/dd/kjp-54-1-15.PMC4792326.pdf
"*Corresponding author (razmi@um.ac.ir) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Isolation and Genotyping of Toxoplasma gondii  Strains in  Ovine Aborted Fetuses in Khorasan Razavi Province, Iran Leila Danehchin1, Gholamreza Razmi1,2,*, Abolghasem Naghibi1 1Department of Pathobiology and 2Center of Excellence in Ruminant Abortion and Neonatal Mortality, Faculty of Veterinary Medicine, Ferdowsi  University of Mashhad, Mashhad, Iran Abstract:  Toxoplasmosis is an important zoonotic disease that can cause abortion in humans and animals.",Non-OADS,/arxiv_data1/oa_pdf/a5/dd/kjp-54-1-15.PMC4792326.pdf
"1: 9-14, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.9 ▣ORIGINAL ARTICLE •Received 31 March 2015, revised 15 August 2015, accepted 31 August 2015.",Non-OADS,/arxiv_data1/oa_pdf/2f/44/kjp-54-1-9.PMC4792327.pdf
"*Corresponding author (adoroudgar@gmail.com) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Tamoxifen Induces Apoptosis of Leishmania major   Promastigotes in Vitro Masoud Doroodgar1, Mahdi Delavari2, Moein Doroodgar1, Ali Abbasi2, Ali Akbar Taherian3, Abbas Doroodgar2,* 1School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR.",Non-OADS,/arxiv_data1/oa_pdf/2f/44/kjp-54-1-9.PMC4792327.pdf
"1: 1-8, February 2016  http://dx.doi.org/ 10.3347/kjp.2016.54.1.1 ▣ORIGINAL ARTICLE •Received 21 August 2015, revised 18 October 2015, accepted 4 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/8a/27/kjp-54-1-1.PMC4792328.pdf
"*Corresponding author (yousryhawash@gmail.com) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.An Improved PCR-RFLP Assay for Detection and  Genotyping of Asymptomatic Giardia lamblia Infection   in a Resource-Poor Setting Yoursry Hawash1,2,*, M. M. Ghonaim1,3, S. S. Al-Shehri1 1Department of Medical Laboratory Science, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia; 2Department of Medical  Parasitology, National Liver Institute, Menoufia University, Shebin El-Koom, Menoufia 23513, Egypt; 3Medical Microbiology and Immunology  Department, Faculty of Medicine, Menoufia University, Shebin El-Koom, Menoufia 23513, Egypt Abstract:  Laboratory workers, in resource-poor countries, still consider PCR detection of Giardia lamblia  more costly and  more time-consuming than the classical parasitological techniques.",Non-OADS,/arxiv_data1/oa_pdf/8a/27/kjp-54-1-1.PMC4792328.pdf
"1: 87-91, February 2016   http://dx.doi.org/ 10.3347/kjp.2016.54.1.87 ▣BRIEF COMMUNICATION  •Received 12 September 2015, revised 23 October 2015, accepted 26 November 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/b7/kjp-54-1-87.PMC4792329.pdf
"*Corresponding author (jschae@snu.ac.kr) © 2016, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Prevalence of Anaplasma  and Bartonella  spp.",Non-OADS,/arxiv_data1/oa_pdf/c2/b7/kjp-54-1-87.PMC4792329.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/3c/sfv100.PMC4792610.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/15/sfv132.PMC4792611.pdf
USG was measured using reagent strips at the JGH Diagnostic Medicine la-boratory ( http://jgh.ca/en/DiagnosticMedicine ).,OADS,/arxiv_data1/oa_pdf/3d/15/sfv132.PMC4792611.pdf
All blood for serum creatinine measure- ments was processed at the JGH Diagnostic Medicine laboratory(http://jgh.ca/en/DiagnosticMedicine ).,OADS,/arxiv_data1/oa_pdf/3d/15/sfv132.PMC4792611.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/d6/sfv133.PMC4792612.pdf
Supplementary data Supplementary data are available online at http://ckj.oxfordjour-nals.org.,OADS,/arxiv_data1/oa_pdf/b6/d6/sfv133.PMC4792612.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/79/sfv138.PMC4792613.pdf
Interactive simulation-based physi- ology teaching is available at http://www.learnphysiology.org/ sim1 .,Non-OADS,/arxiv_data1/oa_pdf/d5/79/sfv138.PMC4792613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/f2/sfv139.PMC4792614.pdf
"2006. http://www.vidal.fr (12 September 2012, date last accessed) 30.",Non-OADS,/arxiv_data1/oa_pdf/5a/f2/sfv139.PMC4792614.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/ac/sfv140.PMC4792615.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/cf/sfv141.PMC4792616.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/0d/a5/sfv142.PMC4792617.pdf
"Am J Kidney Dis 2013; 62: 860 –873 9.http://www.nice.org.uk/guidance/ng8 (9 December 2015, date last accessed) 10.http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_ and_events/news/2013/06/news_detail_001833.jsp&mid=WC0b01ac058004d5c1 (26 January 2015, date last accessed) 11.",Non-OADS,/arxiv_data1/oa_pdf/0d/a5/sfv142.PMC4792617.pdf
"Am J Nephrol 2014; 39: 130 –141 19.https://www.clinicaltrialsregister.eu/ctr-search/trial/2013- 002267-25/GB#F (15 April 2015, date last accessed) 20.",Non-OADS,/arxiv_data1/oa_pdf/0d/a5/sfv142.PMC4792617.pdf
"64.http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_ and_events/news/2013/06/news_detail_001833.jsp&mid=WC0b01ac058004d5c1 (26 January 2015, date last accessed) 65.",Non-OADS,/arxiv_data1/oa_pdf/0d/a5/sfv142.PMC4792617.pdf
"Am J Hematol 2010; 85: 650 –65476.http://www.fda.gov/Drugs/DrugSafety/ucm440138.htm (15 April 2015, date last accessed) 77.",Non-OADS,/arxiv_data1/oa_pdf/0d/a5/sfv142.PMC4792617.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/c5/61/sfv143.PMC4792618.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/dd/sfv144.PMC4792619.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/b7/sfv145.PMC4792620.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/56/sfv146.PMC4792621.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/5f/4f/sfv147.PMC4792622.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/d9/sfv148.PMC4792623.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/ac/sfv149.PMC4792624.pdf
"https://clinicaltrials.gov/ct2/show/ NCT01907802?term=dabrafenib&rank=9 (20 April 2015, date last accessed) 14.",Non-OADS,/arxiv_data1/oa_pdf/bb/ac/sfv149.PMC4792624.pdf
"https://clinicaltrials.gov/ct2/ results?term=vemurafenib&recr=Open&pg=3 (20 April 2015, date last accessed) 15.",Non-OADS,/arxiv_data1/oa_pdf/bb/ac/sfv149.PMC4792624.pdf
http://www.accessdata.fda.gov/ drugsatfda_docs/label/2011/202429s000lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bb/ac/sfv149.PMC4792624.pdf
http://www.accessdata.fda.gov/ drugsatfda_docs/label/2013/202806s000lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bb/ac/sfv149.PMC4792624.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/83/sfv150.PMC4792625.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/a2/sfv152.PMC4792626.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/50/sfv153.PMC4792627.pdf
"Classi ﬁcation pharmacothérapeutique / Cardiologie - Angéio- logie / Antihypertenseurs .https://www.vidal.fr/classi ﬁcations/ vidal/ (20 November 2015, date last accessed) 12.",Non-OADS,/arxiv_data1/oa_pdf/90/50/sfv153.PMC4792627.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/f8/sfv157.PMC4792628.pdf
http://www.cms.hhs.gov/apps/ media/press/release.asp?Counter=1818 18.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/sfv157.PMC4792628.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/32/sfv158.PMC4792629.pdf
"http://www.esrdncc.org (10 December 2015, date last accessed) 31.",Non-OADS,/arxiv_data1/oa_pdf/04/32/sfv158.PMC4792629.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/56/sfw001.PMC4792630.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/60/sfw003.PMC4792631.pdf
"MAGIC: Shared Decision Making — Health Foundation , 2014. http://www.health.org.uk/areas-of- work/programmes/shared-decision-making/ (27 May 2014, date last accessed) 12.",Non-OADS,/arxiv_data1/oa_pdf/be/60/sfw003.PMC4792631.pdf
"About Shared Decision Making —AQuA , 2012. http://www.advancingqualityn w.nhs.uk/sandbox/SDM3/AQuA- Shared-Decision-Making-introduction.html (27 May 2014, date last accessed) 13.",Non-OADS,/arxiv_data1/oa_pdf/be/60/sfw003.PMC4792631.pdf
"A report from the Creating a Receptive Culture for Shared Decision MakingProject, Right Care NHS 2011 –13, 2013. https://www.aquanw.",Non-OADS,/arxiv_data1/oa_pdf/be/60/sfw003.PMC4792631.pdf
http://www.nhsiq.,Non-OADS,/arxiv_data1/oa_pdf/be/60/sfw003.PMC4792631.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/b3/sfw004.PMC4792632.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/aa/sfw006.PMC4792633.pdf
[PubMed: 21068410]  74. https://www.clinicaltrials.gov/ct2/show/NCT02423083 75.,Non-OADS,/arxiv_data1/oa_pdf/fc/09/nihms765612.PMC4792730.pdf
"Available http://www.abstractsonli-ne.com/Plan/ViewAbstract.aspx?sKey=c37b776c-fbc2-484c-bf42-8f2f5a175d3e&cKey=60864c3a-891f-418f-86d6-b70a28d01abb&mKey=%7b54C85D94-6D69-4B09-AFAA-502C0E680CA7%7d Boyden, E.S., Zhang, F., Bamberg, E., Nagel, G. & Deisseroth, K. (2005) Millisecond-timescale, genetically targeted optical control of neural activ- ity.Nat.",OADS,/arxiv_data1/oa_pdf/de/bc/EJN-43-1298.PMC4792792.pdf
L ’evolution etait marquee par le deces precoce chez 2 patients (hematome cerebral inter- hemispherique complique de coma et de New Microbe and New Infect 2016; 11:28–31 © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseaseshttp://dx.doi.org/10.1016/j.nmni.2016.02.009 DOI of original article: http://dx.doi.org/10.1016/j.nmni.2014.12.002,Non-OADS,/arxiv_data1/oa_pdf/b0/0a/main.PMC4792813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.03.001,OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.org/10.1101/ gad.1787609.,Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.org/10.1016/S1046-2023(02)00072-5 [PMID 12095278.].,OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.org/10.1016/S1097-2765(03)00479-9 [ISSN 1097 – 2765].,OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5214-12.2013 .,Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.org/10.1093/ carcin/bgt124.,Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-11-0046 [Epub 2011 Apr 28].,Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
"Pathol Oncol Res 18(3), 713 –720.http://dx.doi.org/10.1007/s12253-012- 9499-7 [Epub 2012 Jan 20].",Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
"J Neurochem 126(1), 4 –18.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.org/10.1186/1471-2121-9-66 .,Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
http://dx.doi.org/10.1158/2159-8290.,Non-OADS,/arxiv_data1/oa_pdf/36/42/main.PMC4792814.pdf
"Peer review under responsibility of Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China.Genomics Proteomics Bioinformatics 14(2016) 42–54 HOSTED BY Genomics Proteomics Bioinformatics www.elsevier.com/locate/gpb www.sciencedirect.com http://dx.doi.org/10.1016/j.gpb.2015.09.006 1672-0229 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b3/89/main.PMC4792843.pdf
"Production and hosting by Elsevier B.V. on behalf of Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b3/89/main.PMC4792843.pdf
"Databases with RNA-seq and other primary datasets ENCODE Produced many RNA-seq and complementary datasets for a certain set of human cell lineshttps://genome.ucsc.edu/ENCODE/ [28] FANTOM Produced many RNA-seq and complementary datasets from mice http://fantom.gsc.riken.jp/ [114] TCGA Contains lncRNAs from primary patient tumors http://cancergenome.nih.gov/ [115] Curated lists of lncRNAs lncRNome A curated list of >17,000 annotated lncRNAs with information on chromosomal locations, biological functions, diseases associations, and the types of the lncRNAs.",OADS,/arxiv_data1/oa_pdf/b3/89/main.PMC4792843.pdf
"Datasets on protein–lncRNA interactionsand genomic variations in lncRNA loci are also accessible from thisdatabasehttp://genome.igib.res.in/lncRNome/ [116] LNCipedia An integrated database with a curated list of 111,685 annotated lncRNAs obtained from diﬀerent sources.",OADS,/arxiv_data1/oa_pdf/b3/89/main.PMC4792843.pdf
"This database providestranscript and structure information on the lncRNAs as well asstatistics for secondary structure information, protein coding potential, and microRNA binding siteshttp://www.lncipedia.org/ [119] LncRNADisease A curated list of >1000 lncRNA–disease associated data from /C24500 publications, as well as predictions of novel lncRNA–diseaseassociations of 1564 human lncRNAshttp://www.cuilab.cn/lncrnadisease [117] Annotators LncRNAtor Co-expression between mRNAs and lncRNAs in various tissues http://lncrnator.ewha.ac.kr/index.htm [118]Fang Y and Fullwood MJ / Long Non-coding RNAs in Cancer 49",OADS,/arxiv_data1/oa_pdf/b3/89/main.PMC4792843.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: InterleukinCytokinePolymorphismMeta-analysisAlzheimer's disease 1.,Non-OADS,/arxiv_data1/oa_pdf/64/8a/main.PMC4792847.pdf
http://dx.doi.org/10.1016/j.mgene.2016.01.001 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/64/8a/main.PMC4792847.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/8a/main.PMC4792847.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.01.008,Non-OADS,/arxiv_data1/oa_pdf/56/dd/main.PMC4792849.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 2 –33 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/56/dd/main.PMC4792849.pdf
"Translational bioinformatics Deﬁning translational bioinformatics According to the American Medical Informatics Association (AMIA), translational bioinformatics (hereafter ‘‘TBI ”)i s ‘‘the development of storage, analytic, and interpretive meth-ods to optimize the transformation of increasingly voluminous biomedical data, and genomic data, into proactive, predictive, preventive, and participatory health ”(http://www.amia.org/*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"Peer review under responsibility of Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China.Genomics Proteomics Bioinformatics 14(2016) 31–41 HOSTED BY Genomics Proteomics Bioinformatics www.elsevier.com/locate/gpb www.sciencedirect.com http://dx.doi.org/10.1016/j.gpb.2016.01.003 1672-0229 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"Production and hosting by Elsevier B.V. on behalf of Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"In his 2014 presentation he provided the fol-lowing deﬁnition for TBI: ‘‘informatics methods that link bio- logical entities (genes, proteins, and small molecules) to clinical entities (diseases, symptoms, and drugs)—or vice versa ” (https://dl.dropboxusercontent.com/u/273 4365/amia-tbi-14-ﬁnal.",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"In the year 2000, the initial drafts of the human genome were released, arguablynecessitating this new ﬁeld of study ( http://web.ornl.gov/sci/techresources/Human_Genome/project/clinton1.shtml ).",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"Initially intended to be a tra- ditional print textbook, this resource was published using an open source model, making it freely available on the Internet(http://collections.plos.org/translational-bioinformatics ).",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"Data derived from clinical care can thus inform clinical guide-lines and future practice.Table 1 Large-scale research initiatives integrating human specimens with clinical annotation Name Link Description Million Veteran Program http://www.research.va.gov/mvp/ veterans.cfmUS Veterans Aﬀairs (VA)-sponsored research program to partner with veterans to study how genes aﬀect health Personal Genome Project http://www.personalgenomes.org/ Based at Harvard University with an emphasis on open access sharing of genomic, environmental, and human trait data MURDOCK Study http://www.murdock-study.com A community-based registry and biorepository aimed at reclassifying disease based on molecular biomarkers UK Biobank http://www.ukbiobank.ac.uk UK-based national health resource aimed at improving the prevention, diagnosis, and treatment of disease Genomics England http://www.genomicsengland.co.uk/ Company formed to sequence samples in the UK-based 100,000 Genomes Project, focused on rare diseases, cancer,and infectious disease Framingham Heart Study https://www.framinghamheartstudy.org/ A long-term, ongoing study started in 1948, based in Framingham, Massachusetts.",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"The study is now on its third generation of participants China Kadoorie Biobank http://www.ckbiobank.org/site/ Focused on genetic and environmental causes of common chronic diseases in the Chinese population Kaiser Permanente/UC San Francisco Research Program onGenes, Environment, and Healthhttps://www.dor.kaiser.org/external/ DORExternal/rpgeh/index.aspxA collaborative resource that will link electronic medical records, behavioral and environmental data, and biospecimensto examine the genetic and environmental factors thatinﬂuence common diseases Google Baseline http://www.wsj.com/articles/google-to- collect-data-to-deﬁne-healthy-human-1406246214 *Designed to collect numerous diﬀerent types of clinical andmolecular data to help deﬁne what a ‘‘healthy ”individual looks like US Precision Medicine Cohort http://www.nih.gov/precision-medicine- initiative-cohort-programA United States population-based research cohort that aims to engage a million or more volunteers over many years toimprove health outcomes, fuel new disease treatments, andcatalyze precision medicine The eMERGE Consortium https://emerge.mc.vanderbilt.edu An NIH-funded national research network that combines DNA biorepositories with EHRs for large-scale, high-throughput genetic research to enable genomic medicine National Biobank of Korea http://www.nih.go.kr/NIH/eng/contents/ NihEngContentView.jsp?cid=17881A collection of well-annotated, high quality human biospecimens for distribution to Korean scientists, and to facilitate international cooperation toward personalizedmedicine Estonian Biobank http://www.geenivaramu.ee/en/access- biobankAn Estonian population-based cohort recruited at random by physicians.",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"There are a number of groups focusing on this problem: the Electronic Medical Records and Genomics (eMERGE)Network ( http://www.genome.gov/27540473 ), the NIH Collaboratory ( https://www.nihcollaboratory.org/ ), PCORnet (http://www.pcornet.org/ ), and the MURDOCK Study (http://murdock-study.com/ ), among others [14–17] .",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"The Phenotype KnowledgeBase website ( https://phekb.org/ )i sa knowledge base of phenotypes, offering a collaborative envi- ronment to build and validate phenotype deﬁnitions.",OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"Researchers at Vanderbilt Univer- sity turned this approach on its head, developing a method known as phenome-wide association studies (PheWAS, https://phewas.mc.vanderbilt.edu/ ).",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
( http://scopeblog.stanford.edu/2014/06/30/when- ten-days-a-lifetime-rapid-whole-genome-sequencing-helps-criti-34 Genomics Proteomics Bioinformatics 14 (2016) 31 –41,Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
medical insurance companies in the United States started to offer coverage of the FoundationOne test in late 2014 (http://www.clinicalinformaticsnews.com/2014/10/17/foundation- medicine-wins-insurance-cove rage-priority-health.html ).,Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
His story was cov-ered in the Milwaukee Journal Sentinel in 2011 in a piece that was later awarded a Pulitzer Prize for explanatory reporting (http://www.jsonline.com/news/health/111641209.html ).,Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"In February 2015, it was announced that the FDA had approved 23andMe’s applicationfor a test for Bloom syndrome ( http://www.fda.gov/News Events/Newsroom/PressAnnouncements/UCM435003 ), and in October 2015 it was announced that the company would once again be offering health information in the form of carrier statusfor 36 genes [42].",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"Note that a 23andMe customer is able to down- load his or her raw genomic data and to use information from other websites to interpret the results, including Promethease (http://www.snpedia.com/index.php/Promethease ), Geneticge- nie (http://geneticgenie.org/ ), openSNP ( https://opensnp.org/ ), and Interpretome ( http://interpretome.com/ ) for health- related associations.",OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"In late 2015, the project began returning results topatients for 76 genes ( https://www.genomeweb.com/sequenc- ing-technology/geisinger-begins-returning-clinically-actionable- exome-sequencing-results ).",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
"Washington (DC): National Academies Press (US); 2009, http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
Nature 2015. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/e7/main.PMC4792852.pdf
The authors would like to apologize for any inconvenience this has caused to the reviewers of this article and readers of the journal.NeuroImage: Clinical 11 (2016) 347 –348 DOI of original article: http://dx.doi.org/10.1016/j.nicl.2015.04.007 .,Non-OADS,/arxiv_data1/oa_pdf/f7/bb/main.PMC4792853.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2016.02.0042213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/bb/main.PMC4792853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/a3/main.PMC4792854.pdf
http://dx.doi.org/10.1016/j.mgene.2015.12.006 2214-5400/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/5f/a3/main.PMC4792854.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/a3/main.PMC4792854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bottleneck Genetic diversityHeterozygote de ﬁciency Microsatellite markersTibetan sheep 1.,Non-OADS,/arxiv_data1/oa_pdf/80/51/main.PMC4792857.pdf
http://dx.doi.org/10.1016/j.mgene.2016.01.002 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/80/51/main.PMC4792857.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/51/main.PMC4792857.pdf
These two methods were applied using Bot- tleneck v1.2.02 ( http://www.ensam.inra.fr/URLB ).,OADS,/arxiv_data1/oa_pdf/80/51/main.PMC4792857.pdf
http://www.fao.org/dad-is/ .,Non-OADS,/arxiv_data1/oa_pdf/80/51/main.PMC4792857.pdf
http://dx.doi.org/10.1111/ jbg.12160.,Non-OADS,/arxiv_data1/oa_pdf/80/51/main.PMC4792857.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Keywords: Morus notabilis LBDfamily Phylogeny analysis Gene expression 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
http://dx.doi.org/10.1016/j.mgene.2014.04.0042214-5400/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
The genome of mulberry was recently sequenced and is available in theMorus database ( http://morus.swu.edu.cn/morusdb/).,OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
Identi ﬁcation of the mulberry LBD family genes TheMorus database was used ( http://morus.swu.edu.cn/morusdb/ ).,OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
"Forty-two Arabidopsis LBDs were downloaded from the Plant Transcrip- tion Factor Database ( http://planttfdb.cbi.edu.cn /) (Husbands et al., 2007 ).",OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
DUF260) was downloaded from the Pfam database ( http://www.sanger.ac.uk ).,OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
"The predicted genes obtained in two methods were examined and corrected by the Simple Modular Architecture Research Tool ( http://smart.embl-heidelberg.de /) (Letunic et al., 2012 ) and GENSCAN Web Server ( http://genes.mit.edu/GENSCAN.html )(Burge and Karlin, 1997 ).",OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
The gene annotations inTable 1 were searched using protein blast on NCBI ( http://ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
"A diagram of exon –intron structures was generated using the online Gene Structure Display Server (GSDS: http://gsds.cbi.pku.edu.cn )(Guo et al., 2007 ) with the sites of intron and exon by loading DNA and RNA sequences of mulberry LBDgene family (RNA sequences was shown in Supplementary material 1).",OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
"The conserved sequence logo was obtained using the online Weblogo platform ( http://weblogo.berkeley.edu ) (Schneider and Stephens, 1990 ).",OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
"The root, bark, bud, ﬂower, and leaf RPKM value of mulberry LBDgenes were retrieved from RNA se- quencing data ( http://morus.swu.edu.cn/morusdb/ ).",OADS,/arxiv_data1/oa_pdf/e1/66/main.PMC4792858.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC4792862.pdf
"All were treated with a non-myeloablative conditioning regimen (Fludarabine with low dose total body irradia-tion with or without anti-thymocyt e globulin (Rabbit ATG, 2 mg/kg)Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/rinimResults in Immunology http://dx.doi.org/10.1016/j.rinim.2016.01.001 2211-2839/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC4792862.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC4792862.pdf
"[2] A. Monfort, A. Wutz, Breathing-in epigenetic change with vitamin C, EMBO Rep. 14 (4) (2013) 337 –346, http://dx.doi.org/10.1038/embor.2013.29 .",Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC4792862.pdf
"96 (6) (2014) 1165 –1175, http://dx.doi.org/10.1189/jlb .",Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC4792862.pdf
"Senden-Gijsbers, M. Tilanus, et al., Ascorbic acid promotes proliferation of NK cell populations in different culture systems applicable for NK cell therapy, Cytotherapy 17 (5) (2015) 613 –620, http://dx.doi.org/10.1016/j.jcyt.2015.01.004 .",Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC4792862.pdf
"〈http://www.federa.org/ sites/default/ ﬁles/bijlagen/coreon/codepropersecondaryuseofhumantissue1_ 0.pdf 〉, Nov 2014.",Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC4792862.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 232 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.04.001 1319-0164 ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/0e/f4/main.PMC4792889.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 182 –188 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.022 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9a/12/main.PMC4792890.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/12/main.PMC4792890.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/12/main.PMC4792890.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jsps.2015.",OADS,/arxiv_data1/oa_pdf/9a/12/main.PMC4792890.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ABCA4 mutations autosomal recessive cone-rod dystrophyautosomal recessive retinitis pigmentosa Stargardt's disease 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
They include many different types with more than 238 causative genes identi ﬁed up to date (RetNet: https://sph.uth.edu/retnet/ July 2015).,OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
http://dx.doi.org/10.1016/j.mgene.2016.02.0022214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
"With the use of improved tools in routine laboratory diagnostics, such as ABCA4 microarray mutation screening and next-generation se- quencing, more than 800 mutations in ABCA4 have been reported, highlighting extreme allelic heterogeneity (HGMD Professional;http://www.biobase-international.com/product/hgmd )(Zernant et al., 2011; Jin et al., 2014; Ernest et al., 2009; Zhang et al., 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
Public genome sequence databases wereused for the design of PCR primers (NCBI: http://www.ncbi.nlim.nih.,OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
"gov,E N S E M B L : http://www.ensembl.org ).",Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
"For the inter- pretation of the results, the following databases were used: database of genomic variants ( http://projects.tcag.ca/variation/ ), DECIPHER database ( http://www.sanger.ac.uk/PostGenomics/decipher/ ), and the International Standards for Cytogenomic Arrays ( https://www.",OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
"Only one mutation was found in 4 patients; 3 of them car- ried known pathogenic mutations and one of them carried the mutation p.His423Arg, which has previously been reported ( Shroyer et al., 2001; Webster et al., 2001) and has been registered as non pathogenic in theRetina International database ( http://www.retina-international.org /).",Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
"(3) Neutral (0.545) N/A Abbreviations: N/A: non-applicable, PolyPhen-2: Polymorphism Phenotyping v2 ( http://genetics.bwh.harvard.edu/pph2/ ), SIFT: Sorting Intolerant From Tolerant ( http://sift.jcvi.org /), PROVEAN: Protein Variation Effect Analyzer ( http://provean.jcvi.org/index.php ), Mutation taster: http://www.mutationtaster.org /, Pmut: http://mmb2.pcb.ub.es:8080/PMut/ , Mutation Assessor: http://mutationassessor.org /, HSF: Human Splicing Finder ( http://www.umd.be/HSF3/HSF.html ), Prob.",Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
"Abbreviations: N/A: non-applicable, PolyPhen-2: Polymorphism Phenotyping v2 ( http://genetics.bwh.harvard.edu/pph2/ ), SIFT: Sorting Intolerant From Tolerant ( http://sift.jcvi.org /), PROVEAN: Protein Variation Effect Analyzer ( http://provean.jcvi.org/index.php ), Mutation taster: http://www.mutationtaster.org /, Pmut: http://mmb2.pcb.ub.es:8080/PMut/ , Mutation Assessor: http://mutationassessor.org /, HSF: Human Splicing Finder ( http://www.umd.be/HSF3/HSF.html ), Poss.",Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC4792891.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 176 –181 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.011 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/81/22/main.PMC4792892.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/22/main.PMC4792892.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/22/main.PMC4792892.pdf
< http://www.fda.gov/ForConsumers/ConsumerUpdates/ ucm048682.htm > (accessed 13.07.13).,Non-OADS,/arxiv_data1/oa_pdf/81/22/main.PMC4792892.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 220 –225 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.009 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/01/96/main.PMC4792893.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/96/main.PMC4792893.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/96/main.PMC4792893.pdf
http://dx.doi.org/ 10.1111/jphs.12073 .,Non-OADS,/arxiv_data1/oa_pdf/01/96/main.PMC4792893.pdf
http://dx.doi.org/10.2165/ 11538460-000000000-00000 .,Non-OADS,/arxiv_data1/oa_pdf/01/96/main.PMC4792893.pdf
http://dx.doi.org/10.1016/j.jsps.2013.12.016,OADS,/arxiv_data1/oa_pdf/ab/78/main.PMC4792894.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 226 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.017 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/cc/42/main.PMC4792895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cc/42/main.PMC4792895.pdf
http://dx.doi.org/10.1016/j.jsps.2014.04.001,OADS,/arxiv_data1/oa_pdf/e7/23/main.PMC4792897.pdf
"Drug Deliv.. http://dx.doi.org/ 10.3109/10717544.2013.838717 (posted online on October 9, 2013).",OADS,/arxiv_data1/oa_pdf/e7/23/main.PMC4792897.pdf
"Drug Target.. http://dx.doi.org/ 10.3109/1061186X.2013.831421 (posted online on September 2, 2013).",OADS,/arxiv_data1/oa_pdf/e7/23/main.PMC4792897.pdf
http://dx.doi.org/10.1155/ JBB/2006/63675 .,Non-OADS,/arxiv_data1/oa_pdf/e7/23/main.PMC4792897.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/0e/main.PMC4792898.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 213 –219 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.011 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/de/0e/main.PMC4792898.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/0e/main.PMC4792898.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 189 –196 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.003 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/58/9e/main.PMC4792899.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/9e/main.PMC4792899.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/9e/main.PMC4792899.pdf
"The second conference was the Pharmacy Education Forum with the theme ‘‘Join hands to promote RUM’’, held in May, 2012, and organized by MOH in collaboration withSharjah University ( http://www.cpdpharma.ae/index.php?",Non-OADS,/arxiv_data1/oa_pdf/58/9e/main.PMC4792899.pdf
<http://www.cpdpharma.ae/index.php?view=details&id=12% 3A2nd+Pharmacy+Educational+Forum&option=com_event- list&Itemid=84 > (accessed on 14.06.13).,Non-OADS,/arxiv_data1/oa_pdf/58/9e/main.PMC4792899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: VitiligoLiver X ReceptorPolymorphismrs11039155rs2279238 1.,Non-OADS,/arxiv_data1/oa_pdf/46/96/main.PMC4792900.pdf
http://dx.doi.org/10.1016/j.mgene.2016.02.001 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/96/main.PMC4792900.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/96/main.PMC4792900.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/a8/main.PMC4792901.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 153 –164 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.017 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ce/a8/main.PMC4792901.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/a8/main.PMC4792901.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jsps.2015.",OADS,/arxiv_data1/oa_pdf/ce/a8/main.PMC4792901.pdf
"Available at: http://www.corel- pharmachem.com/acryﬂow.htm , accessed on 8th June, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ce/a8/main.PMC4792901.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 147 –152 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.005 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4a/73/main.PMC4792902.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/73/main.PMC4792902.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/73/main.PMC4792902.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/39/main.PMC4792903.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 165 –175 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.014 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fc/39/main.PMC4792903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/39/main.PMC4792903.pdf
"7, 5. http://dx.doi.org/10.1186/1477-3155-7-5 .",Non-OADS,/arxiv_data1/oa_pdf/fc/39/main.PMC4792903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/85/main.PMC4792904.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 227 –231 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.015 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e0/85/main.PMC4792904.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/85/main.PMC4792904.pdf
http://dx.doi.org/ 10.1016/j.ijpharm .,OADS,/arxiv_data1/oa_pdf/e0/85/main.PMC4792904.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Inﬂammatory gene PolymorphismsCytokinesIschemic strokeCerebral infarctionMeta-analysis Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1016/j.mgene.2016.01.003 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1016/j.brainresbull.,OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
"2011, 179061. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1097/00004647-200207000-00001 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1161/01.STR.0000143788.87054.85 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1016/S1474- 4422(09)70025-0 .,OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1161/STROKEAHA.,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1056/NEJMra043430 .,OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1189/jlb.1109766 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
"Bull.81, 38 –42.http://dx.doi.org/10.1016/j.brainresbull.2009.09.009 .",OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
"http://dx.doi.org/10.1007/s00415-002-0726-0 .Lin, T.-M., Chen, C.-H., Wu, H.-L., Wang, C.-H., Chen, Y.-L., Eng, H.-L., 2008.",Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1371/journal.pmed.1000097 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1161/STROKEAHA.111.647446 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1038/ng1846 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1007/s11033-012- 2478-y .,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.org/10.1016/j.clineuro.2008.09.027 .,OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
"Gene 499, 61 –69.http://dx.doi.org/10.1016/j.gene.2012.02.026 .",OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
"2013, 961039. http://dx.doi.org/ 10.1155/2013/961039 .",Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
"J. Neuroin ﬂammation 9, 162. http://dx.doi.org/ 10.1186/1742-2094-9-162 .",Non-OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
"Gene 567,36–44.http://dx.doi.org/10.1016/j.gene.2015.04.054 .29 S. Misra et al.",OADS,/arxiv_data1/oa_pdf/7b/e9/main.PMC4792905.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/d5/main.PMC4792906.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 140 –146 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.008 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/af/d5/main.PMC4792906.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/d5/main.PMC4792906.pdf
"Biomol.Spectrosc., http://dxdoi.org/10.1016/j.saa.2014.10.033 (in press).Baker, S., Rakshith, D., Kavitha, K.S., Santosh, P., Kavitha, H.U., Rao, Y., Satish, S., 2013a.",OADS,/arxiv_data1/oa_pdf/af/d5/main.PMC4792906.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/34/main.PMC4792907.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 197 –212 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.012 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e1/34/main.PMC4792907.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/34/main.PMC4792907.pdf
< http://www.oecd.org/dataoecd/33/ 37/37849783.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/e1/34/main.PMC4792907.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/d1/main.PMC4792908.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/d1/main.PMC4792908.pdf
http://dx.doi.org/10.1016/j.shaw.2015.09.004Safety and Health at Work 7 (2016) 1 e5,Non-OADS,/arxiv_data1/oa_pdf/49/d1/main.PMC4792908.pdf
Supplementary data Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.shaw.2015.09.004 .,OADS,/arxiv_data1/oa_pdf/49/d1/main.PMC4792908.pdf
Available from: http://www.ilo.org/public/english/bureau/ stat/isco/docs/annex1.doc .,Non-OADS,/arxiv_data1/oa_pdf/49/d1/main.PMC4792908.pdf
Available from: http://www.statistics.gr/portal/page/portal/ESYE .,OADS,/arxiv_data1/oa_pdf/49/d1/main.PMC4792908.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/ec/main.PMC4792909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/ec/main.PMC4792909.pdf
http://dx.doi.org/10.1016/j.shaw.2015.10.004Safety and Health at Work 7 (2016) 63 e71,Non-OADS,/arxiv_data1/oa_pdf/90/ec/main.PMC4792909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/76/main.PMC4792910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/76/main.PMC4792910.pdf
http://dx.doi.org/10.1016/j.shaw.2015.09.001Safety and Health at Work 7 (2016) 78 e82,Non-OADS,/arxiv_data1/oa_pdf/74/76/main.PMC4792910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/f3/main.PMC4792911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/f3/main.PMC4792911.pdf
http://dx.doi.org/10.1016/j.shaw.2015.11.005Safety and Health at Work 7 (2016) 38 e42,Non-OADS,/arxiv_data1/oa_pdf/00/f3/main.PMC4792911.pdf
Available from: http://kostat.go.kr/e_book/kssc/ KSCO07/EBook.htm [in Korean].,Non-OADS,/arxiv_data1/oa_pdf/00/f3/main.PMC4792911.pdf
Available from: http://www.bls.gov/ooh/ transportation-and-material-moving/heavy-and-tractor-trailer-truck-drivers.,Non-OADS,/arxiv_data1/oa_pdf/00/f3/main.PMC4792911.pdf
Available from: http://www-nrd.nhtsa.dot.gov/Pubs/810646.pdf .,OADS,/arxiv_data1/oa_pdf/00/f3/main.PMC4792911.pdf
Available from: http://www.bls.gov/ opub/mlr/2015/article/workplace-hazards-of-truck-drivers-1.htm .,Non-OADS,/arxiv_data1/oa_pdf/00/f3/main.PMC4792911.pdf
Available from: http://www.fmcsa.dot.gov/regulations/title49/ section/395.1 .Saf Health Work 2016;7:38 e42 42,Non-OADS,/arxiv_data1/oa_pdf/00/f3/main.PMC4792911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/89/main.PMC4792912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/89/main.PMC4792912.pdf
http://dx.doi.org/10.1016/j.shaw.2015.08.002Safety and Health at Work 7 (2016) 12 e17,Non-OADS,/arxiv_data1/oa_pdf/74/89/main.PMC4792912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/99/main.PMC4792913.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/99/main.PMC4792913.pdf
http://dx.doi.org/10.1016/j.shaw.2015.09.002Safety and Health at Work 7 (2016) 83 e85,Non-OADS,/arxiv_data1/oa_pdf/6d/99/main.PMC4792913.pdf
[cited 2015 Aug 18] Available from: http://tinyurl.com/arbobalans2014 .,Non-OADS,/arxiv_data1/oa_pdf/6d/99/main.PMC4792913.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/fb/main.PMC4792914.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/fb/main.PMC4792914.pdf
http://dx.doi.org/10.1016/j.shaw.2015.08.001Safety and Health at Work 7 (2016) 49 e54,Non-OADS,/arxiv_data1/oa_pdf/4e/fb/main.PMC4792914.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/eb/main.PMC4792915.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/eb/main.PMC4792915.pdf
http://dx.doi.org/10.1016/j.shaw.2015.09.005Safety and Health at Work 7 (2016) 32 e37,Non-OADS,/arxiv_data1/oa_pdf/25/eb/main.PMC4792915.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/11/main.PMC4792916.pdf
http://dx.doi.org/10.1016/j.shaw.2015.06.006,OADS,/arxiv_data1/oa_pdf/c0/11/main.PMC4792916.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/10/main.PMC4792917.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/10/main.PMC4792917.pdf
http://dx.doi.org/10.1016/j.shaw.2015.08.004Safety and Health at Work 7 (2016) 18 e31,Non-OADS,/arxiv_data1/oa_pdf/55/10/main.PMC4792917.pdf
Available from: http://minderdrinken.nl [in Dutch].,Non-OADS,/arxiv_data1/oa_pdf/55/10/main.PMC4792917.pdf
Available from: http://www.testuwleefstijl.nl .,Non-OADS,/arxiv_data1/oa_pdf/55/10/main.PMC4792917.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/95/main.PMC4792918.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/95/main.PMC4792918.pdf
http://dx.doi.org/10.1016/j.shaw.2015.06.002Safety and Health at Work 7 (2016) 6 e11,Non-OADS,/arxiv_data1/oa_pdf/a8/95/main.PMC4792918.pdf
Available from: http://www.hse.,Non-OADS,/arxiv_data1/oa_pdf/a8/95/main.PMC4792918.pdf
Available from: http://www.hse.,Non-OADS,/arxiv_data1/oa_pdf/a8/95/main.PMC4792918.pdf
Available from: http://www.hse.gov.uk/ pubns/books/hsg250.htm .,Non-OADS,/arxiv_data1/oa_pdf/a8/95/main.PMC4792918.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/37/main.PMC4792919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/37/main.PMC4792919.pdf
http://dx.doi.org/10.1016/j.shaw.2015.10.005Safety and Health at Work 7 (2016) 43 e48,Non-OADS,/arxiv_data1/oa_pdf/a9/37/main.PMC4792919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/a8/main.PMC4792920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/a8/main.PMC4792920.pdf
http://dx.doi.org/10.1016/j.shaw.2015.07.006Safety and Health at Work 7 (2016) 72 e77,Non-OADS,/arxiv_data1/oa_pdf/d2/a8/main.PMC4792920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/main.PMC4792921.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/main.PMC4792921.pdf
http://dx.doi.org/10.1016/j.shaw.2015.09.003Safety and Health at Work 7 (2016) 55 e62,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/main.PMC4792921.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ab/26/jpts-28-319.PMC4792967.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a5/95/jpts-28-326.PMC4792968.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/1a/0f/jpts-28-332.PMC4792969.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b5/31/jpts-28-339.PMC4792970.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/12/34/jpts-28-347.PMC4792971.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ad/db/jpts-28-351.PMC4792972.pdf
"[Medline] 7)	 International	Physical	Activity	Questionnaires:	http://www.ipaq.ki.se/ipaq.htm	(Accessed	Aug.	10,	2015).",Non-OADS,/arxiv_data1/oa_pdf/ad/db/jpts-28-351.PMC4792972.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a3/bd/jpts-28-355.PMC4792973.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/be/02/jpts-28-360.PMC4792974.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/69/a8/jpts-28-366.PMC4792975.pdf
"[Medline]   [CrossRef] 11) Ministry of Health, Labour and Welfare: Undoukinokinoukoujyou manual: http://www.mhlw.go.jp/topics/ 2009/05/dl/tp0501-1d.pdf#search=’%E9%81%8B%E5%8B%95%E5%99%A8%E3%81%AE%E5%90%91%E4%B8%8A%E3%83%9E%E3%83%8B%E3%83%A5%E3%82%A2%E3%83%AB’.",Non-OADS,/arxiv_data1/oa_pdf/69/a8/jpts-28-366.PMC4792975.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/1f/87/jpts-28-372.PMC4792976.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/65/d0/jpts-28-378.PMC4792977.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/bb/d4/jpts-28-382.PMC4792978.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/80/2f/jpts-28-392.PMC4792979.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/cf/38/jpts-28-399.PMC4792980.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/6f/d1/jpts-28-407.PMC4792981.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a7/20/jpts-28-412.PMC4792982.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/86/8f/jpts-28-419.PMC4792983.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/3c/2b/jpts-28-426.PMC4792984.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/47/87/jpts-28-432.PMC4792985.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/61/0e/jpts-28-438.PMC4792986.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/69/04/jpts-28-442.PMC4792987.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d3/4a/jpts-28-446.PMC4792988.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b5/d7/jpts-28-450.PMC4792989.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/91/2c/jpts-28-456.PMC4792990.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/1b/99/jpts-28-460.PMC4792991.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/81/e7/jpts-28-467.PMC4792992.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/9b/66/jpts-28-473.PMC4792993.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/58/35/jpts-28-478.PMC4792994.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/66/8b/jpts-28-483.PMC4792995.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b6/41/jpts-28-488.PMC4792996.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/15/78/jpts-28-491.PMC4792997.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/50/50/jpts-28-495.PMC4792998.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/6a/55/jpts-28-500.PMC4792999.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f8/2e/jpts-28-506.PMC4793000.pdf
"(Fact Sheet, 84), 1999. http://www.who.int/occupational_health/publications/newsletter/en/gohnet1eb.pdf.",OADS,/arxiv_data1/oa_pdf/f8/2e/jpts-28-506.PMC4793000.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c2/e3/jpts-28-511.PMC4793001.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/71/27/jpts-28-515.PMC4793002.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e9/69/jpts-28-519.PMC4793003.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/6f/8a/jpts-28-525.PMC4793004.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/cc/8c/jpts-28-530.PMC4793005.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/3d/4c/jpts-28-535.PMC4793006.pdf
Retrieved from http://www.attitudefactor.com/PWItecharticle.htm.,Non-OADS,/arxiv_data1/oa_pdf/3d/4c/jpts-28-535.PMC4793006.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b0/ff/jpts-28-541.PMC4793007.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/03/4f/jpts-28-547.PMC4793008.pdf
Further information can be found at http://www2.unopar.br/sites/eelo/.,Non-OADS,/arxiv_data1/oa_pdf/03/4f/jpts-28-547.PMC4793008.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/11/d2/jpts-28-553.PMC4793009.pdf
"http://www.strokecenter.org/patients/about-stroke/stroke-statistics (Ac - cessed Aug. 6, 2015) 5) Yi TI, Han JS, Lee KE, et al.",Non-OADS,/arxiv_data1/oa_pdf/11/d2/jpts-28-553.PMC4793009.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/0f/19/jpts-28-558.PMC4793010.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d1/ef/jpts-28-563.PMC4793011.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/dc/2d/jpts-28-569.PMC4793012.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/76/c9/jpts-28-576.PMC4793013.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a7/d5/jpts-28-580.PMC4793014.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/8d/fc/jpts-28-585.PMC4793015.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/6b/a0/jpts-28-589.PMC4793016.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/bd/ce/jpts-28-596.PMC4793017.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/6c/ad/jpts-28-602.PMC4793018.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/9e/5d/jpts-28-607.PMC4793019.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/13/e4/jpts-28-613.PMC4793020.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/8f/f3/jpts-28-621.PMC4793021.pdf
"REFERENCES 1) The Statistics Bureau of Japan: http://www.stat.go.jp/data/topics/topi901.htm (Accessed Oct. 1, 2015) 2) Nishino T, Saga T: Late result of coronary artery bypass grafting in 52 patients aged 80 year and older.",OADS,/arxiv_data1/oa_pdf/8f/f3/jpts-28-621.PMC4793021.pdf
"[Medline]   [CrossRef] 17) Guidelines for Rehabilitation in Patients with Cardiovascular Disease: (JCS 2007) http://www.j-circ.or.jp/guideline/ pdf/JCS2007_nohara_h.pdf (Accessed Oct. 1, 2015) 18) Takahashi T, Sakurada K, Kumamaru M, et al.",Non-OADS,/arxiv_data1/oa_pdf/8f/f3/jpts-28-621.PMC4793021.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ee/70/jpts-28-626.PMC4793022.pdf
"http://www.seniam.org (Accessed Sep.  20, 2015) 9) Moon J, Koo D, Kim K, et al.",OADS,/arxiv_data1/oa_pdf/ee/70/jpts-28-626.PMC4793022.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/39/62/jpts-28-632.PMC4793023.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/74/06/jpts-28-635.PMC4793024.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/32/66/jpts-28-641.PMC4793025.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/2c/40/jpts-28-646.PMC4793026.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/jpts-28-654.PMC4793027.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/jpts-28-658.PMC4793028.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ea/9e/jpts-28-661.PMC4793029.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/99/5a/jpts-28-665.PMC4793030.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/7f/9a/jpts-28-671.PMC4793031.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/8e/3c/jpts-28-677.PMC4793032.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/7e/6e/jpts-28-680.PMC4793033.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e4/12/jpts-28-685.PMC4793034.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ca/b5/jpts-28-689.PMC4793035.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Review  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/fa/77/jpts-28-695.PMC4793036.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e9/09/jpts-28-701.PMC4793037.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c5/b3/jpts-28-705.PMC4793038.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/fa/d2/jpts-28-708.PMC4793039.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/aa/ad/jpts-28-711.PMC4793040.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/25/27/jpts-28-714.PMC4793041.pdf
3. http://epid.coi.waw.pl/krn/ 4.,Non-OADS,/arxiv_data1/oa_pdf/9d/82/PDIA-33-24295.PMC4793055.pdf
"Disclosure Prof. Jean-Michel Hannoun-Levi declares association  with ELEKTA, related to the patent No 8834339: Assembly  for performing brachytherapy treatment of a tumour tissue  in an animal body (http://www.google.com.au/patents/ US8834339 [1]).",Non-OADS,/arxiv_data1/oa_pdf/69/47/JCB-8-26832.PMC4793065.pdf
"Master of Sciences Thesis, Medical Radiation Physics Department, Lund University, Lund 2005. http://lup.lub.lu.se/student­papers/record/2156980/file/2157759.pdf.",Non-OADS,/arxiv_data1/oa_pdf/0f/2e/JCB-8-26891.PMC4793066.pdf
http://www.physics.carleton.ca/ clrp/seed_database/I125/ProstaSeed_125SL.,OADS,/arxiv_data1/oa_pdf/0f/2e/JCB-8-26891.PMC4793066.pdf
"09 17, 2014. http://article.wn.com/ view/2014/09/17/Partial_Breast_Irradiation_With_Intersti-tial_Brachytherapy_A_3/ (accessed 11 29, 2014).",Non-OADS,/arxiv_data1/oa_pdf/27/b0/JCB-8-26935.PMC4793068.pdf
"IBioLucent Receives FDA Clearance for SAVI Bra-chytherapy Device 2006. http://www.itnonline.com/arti- cle/biolucent-receives-fda-clearance-savi-brachytherapy-   device (accessed 11 29, 2014).",Non-OADS,/arxiv_data1/oa_pdf/27/b0/JCB-8-26935.PMC4793068.pdf
Available from: http://seer.cancer.gov/ about/overview.html.,Non-OADS,/arxiv_data1/oa_pdf/72/4b/JCB-8-27008.PMC4793071.pdf
Available from: http://seer.cancer.gov/data/ psa-values.html.,Non-OADS,/arxiv_data1/oa_pdf/72/4b/JCB-8-27008.PMC4793071.pdf
"Clinical Trials, Study Number 0413; available at: https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0413 [retrieved February 8, 2016].",Non-OADS,/arxiv_data1/oa_pdf/0f/f5/JCB-8-27011.PMC4793074.pdf
"NCCN Clinical Practice Guidelines in Oncology: Breast Can-cer; available at: http://www.nccn.org/professionals/phy-sician_gls/pdf/breast.pdf [retrieved February 8, 2016].",Non-OADS,/arxiv_data1/oa_pdf/0f/f5/JCB-8-27011.PMC4793074.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Lisdexamfetamine for binge eating disorder SL McElroy et al 1260 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/96/59/npp2015275a.PMC4793109.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Impact of ghrelin on impulsivity RH Anderberg et al 1209 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/d3/17/npp2015297a.PMC4793128.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054486.115.© 2016 Ying and Fredrick This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/499.PMC4793206.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT RNA 22:499 –505; Published by Cold Spring Harbor Laboratory Press for the RNA Society 499",Non-OADS,/arxiv_data1/oa_pdf/73/ed/499.PMC4793206.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054445.115.© 2016 Belfetmi et al.,OADS,/arxiv_data1/oa_pdf/bf/e8/506.PMC4793207.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/bf/e8/506.PMC4793207.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/bf/e8/506.PMC4793207.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055152.115.© 2016 Ziemniak et al.,OADS,/arxiv_data1/oa_pdf/65/b0/518.PMC4793208.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/65/b0/518.PMC4793208.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/65/b0/518.PMC4793208.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055046.115.© 2016 Guni šová et al.,OADS,/arxiv_data1/oa_pdf/13/0b/542.PMC4793210.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/13/0b/542.PMC4793210.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/13/0b/542.PMC4793210.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052795.115.© 2016 Sánchez-Hernández et al.,OADS,/arxiv_data1/oa_pdf/70/ae/571.PMC4793212.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/70/ae/571.PMC4793212.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommer-cial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/70/ae/571.PMC4793212.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054064.115.© 2016 Lamichhane et al.,OADS,/arxiv_data1/oa_pdf/c9/0d/583.PMC4793213.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/c9/0d/583.PMC4793213.pdf
"Our analysis was performed using AmiGO 2 (http://amigo.geneontology.org/amigo) on May 5, 2015.",OADS,/arxiv_data1/oa_pdf/c9/0d/583.PMC4793213.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055558.115.© 2016 Nottingham et al.,OADS,/arxiv_data1/oa_pdf/02/32/597.PMC4793214.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/02/32/597.PMC4793214.pdf
DATA DEPOSITION The TGIRT-seq data sets described in this manuscript have beendeposited in the National Center for Biotechnology InformationSequence Read Archive (http://www.ncbi.nlm.nih.gov/sra) underaccession number SRP066009.,OADS,/arxiv_data1/oa_pdf/02/32/597.PMC4793214.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055616.115.© 2016 Hoch et al.,OADS,/arxiv_data1/oa_pdf/7c/3b/614.PMC4793215.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/7c/3b/614.PMC4793215.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055186.115.© 2016 Na et al.,OADS,/arxiv_data1/oa_pdf/2f/4e/636.PMC4793217.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD 636 RNA 22:636 –655; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/2f/4e/636.PMC4793217.pdf
"2004); (iv) sequence conservation among 12 Drosophila species, calcu- lated based on orthologs provided on FlyBase (http://flybase.org) (using Rate4Site, see Mayrose et al.",OADS,/arxiv_data1/oa_pdf/2f/4e/636.PMC4793217.pdf
"For the estimation of evolutionary conservation, orthol-ogous sequences from 12 Drosophila species were downloaded from the FlyBase database (http://flybase.org).",OADS,/arxiv_data1/oa_pdf/2f/4e/636.PMC4793217.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053",OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"Relative labelling efficiency wasdefined as relative fluorescence intensity/ mg EV protein, and deviations of B10% between samples were considered acceptable before proceeding to cell association studies.GPI-anchored nanobodies promote EV tumour targeting Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053",OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"Nanobodies fused to GPI-anchors were hypothesized to localize to lipid rafts in cellular membranes upon expression (b).GPI-anchored nanobodies promote EV tumour targeting Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053",OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"ns /C30not signiﬁcant and *** indicates p B0.001 as determined by one-way ANOV A with Tukey post-hoc test.GPI-anchored nanobodies promote EV tumour targeting Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053",OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"GPI- anchoring may potentially be used as a versatile tool to incorporate a variety of proteins on EVs, includingantibodies, enzymes, reporter proteins and (immune-stimulatory) signalling molecules.GPI-anchored nanobodies promote EV tumour targeting Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"2015; 4:27066, doi: http://dx.doi.org/10.3402/jev.v4.27066 3. van Dommelen SM, Vader P, Lakhal S, Kooijmans SA, van Solinge WW , Wood MJ, et al.",OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"2015;4:30087, doi: http://dx.doi.org/10.3402/jev.v4.30087 11.",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"2014;3:24641, doi: http://dx.doi.org/10.3402/jev.v3.24641 19.",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053",OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"2015;4:26883, doi: http://dx.doi.org/10.3402/jev.v4.26883 43.",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"2013;2:22614, doi: http://dx.doi.org/10.3402/jev.v2i0.22614 54.",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"2015;589:1391 /C18.GPI-anchored nanobodies promote EV tumour targeting Citation: Journal of Extracellular Vesicles 2016, 5: 31053 - http://dx.doi.org/10.3402/jev.v5.31053 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/15/JEV-5-31053.PMC4793259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"The followingbiochemical and hematological parameters were mea- sured: total protein, albumin, total bilirubin, aspartate aminotransaminase (AST), alanine aminotransaminase(ALT), lactate dehydrogenase (LDH), alkaline phosphatase(ALP), g-glutamyl transpeptidase ( g-GT), total cholesterol,Regulatory effect of paraprobiotic CP2305 on gut function Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"BMI: body mass index.Regulatory effect of paraprobiotic CP2305 on gut function Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"(b) Changes in the concentrations of fecal tyrosine metabolites, which reﬂect the sum of the concentrations of phenol, 4-ethylphenol and p-cresol.Regulatory effect of paraprobiotic CP2305 on gut function Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"The solid line is the regression line, and the dotted lines indicate the bounds of the 95% conﬁdence intervals.Regulatory effect of paraprobiotic CP2305 on gut function Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"10 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
"Exp Anim 2007; 56: 301 /C17.Regulatory effect of paraprobiotic CP2305 on gut function Citation: Microbial Ecology in Health & Disease 2016, 27: 30259 - http://dx.doi.org/10.3402/mehd.v27.30259 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d4/63/MEHD-27-30259.PMC4793260.pdf
Keywords Alpha-gal; Delayed anaphylaxis; Glycan; IgE; Red meat allergy This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/d6/nihms-764046.PMC4793386.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Matrix metalloproteinases Immune recoveryLung functionHIVTB-IRISART 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/65/main.PMC4793443.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.11.040 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/65/main.PMC4793443.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/65/main.PMC4793443.pdf
Clinical infectious diseases : an of ﬁcial publicationof the Infectious Diseases So- ciety of America http://dx.doi.org/10.1093/cid/civ978 .,Non-OADS,/arxiv_data1/oa_pdf/5a/65/main.PMC4793443.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Lung cancerChronic obstructive pulmonary diseaseSmoking exposure Ethnicity Genetic susceptibility It is generally accepted that lung cancer results from a complex in- teraction between smoking exposure, chronic lung disease and genetic susceptibility ( El Zein et al., 2012 ).",Non-OADS,/arxiv_data1/oa_pdf/65/87/main.PMC4793520.pdf
We pro- pose that a greater susceptibility to COPD may be relevant in this settingEBioMedicine 4 (2016) 13 –14 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.002 .,Non-OADS,/arxiv_data1/oa_pdf/65/87/main.PMC4793520.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.005 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/87/main.PMC4793520.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/87/main.PMC4793520.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/08/rjw034.PMC4793551.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/5e/main.PMC4793559.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.10.012 2352-3964/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/c1/5e/main.PMC4793559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/5e/main.PMC4793559.pdf
http://biostat.mc.vanderbilt.edu/wiki/pub/Main/FrankHarrell/logistCal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/ec/SIM-33-517.PMC4793659.pdf
Available at: https://clinicaltrials.gov/ct2/ show/NCT01884571?term 5als1immunosuppression& rank51.,Non-OADS,/arxiv_data1/oa_pdf/ad/b5/NEUROLOGY2015670125.PMC4793781.pdf
"3-4, 84–87http://dx.doi.org/10.3109/23320885.2015.1120641 CASE REPORT ‘‘More than skin deep’’: Recurrent primary hand abscesses in a warehouse operative L. Kearneya, C. O’Connorb, F. Fitzpatrickband J.",Non-OADS,/arxiv_data1/oa_pdf/fd/ac/icrp-2-84.PMC4793786.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/ac/icrp-2-84.PMC4793786.pdf
Available from: http://webarchive.nationalarchives.gov.uk/20140714084352/ http://hpa.org.uk/webc/hpawebfile/hpaweb_c/121869941 1960 (Last accessed November 29 2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/ac/icrp-2-84.PMC4793786.pdf
Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/391168/PVL_guidance_in_ primary_care_quick_reference_guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fd/ac/icrp-2-84.PMC4793786.pdf
"3-4, 88–91http://dx.doi.org/10.3109/23320885.2015.1102640 CASE REPORT Intestinal obstruction following harvest of VRAM-flap for reconstruction of a large perineal defect Sherif Elawaa, Olof Hallbo ¨o¨kb,c,P a¨r Myrelidb,cand Johann Zdolseka aDepartment of Hand Surgery, Plastic Surgery and Burns andbDepartment of Surgery, Linko ¨ping University, Linko ¨ping, Sweden; cDepartment of Clinical and Experimental Medicine, Linko ¨ping University, Linko ¨ping, Sweden ABSTRACT A patient with locally advanced adenocarcinoma of the rectum was operated with abdominoper- ineal resection and perineal reconstruction with a vertical rectus abdominis musculocutaneous flap.Six days postoperatively, there was herniation of the small bowel, between the anterior andposterior rectus sheaths, to a subcutaneous location.ARTICLE HISTORY Received 12 May 2015 Accepted 19 September 2015 KEYWORDS Vertical rectus abdominis musculocutaneous flap,perineal defect, rectal adenocarcinoma Introduction The vertical rectus abdominis musculocutaneous flap (VRAM) is a reliable method for primary closure ofperineal skin defects up to medium size, which other-wise might have been left for healing by secondaryintention [1–18].",Non-OADS,/arxiv_data1/oa_pdf/ab/b1/icrp-2-88.PMC4793787.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/b1/icrp-2-88.PMC4793787.pdf
"3-4, 67–72http://dx.doi.org/10.3109/23320885.2015.1100967 CASE REPORT Restoration of oral competence in double free flap reconstructions of massive lower facial defects with fascia lata slings – Case series and review of the literature Dominic Henn*, Andreas Nissen*, Nathan Menon and Gordon K. Lee Stanford Division of Plastic Surgery, Stanford University Medical Center, Palo Alto, CA, USA ABSTRACT Restoration of adequate oral competence is especially challenging in double free flap reconstruc- tions of massive head and neck defects resulting from composite resections.",Non-OADS,/arxiv_data1/oa_pdf/a4/4a/icrp-2-67.PMC4793788.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/4a/icrp-2-67.PMC4793788.pdf
"3-4, 77–79http://dx.doi.org/10.3109/23320885.2015.1105724 CASE REPORT Reconstruction of a subtotally amputated auricle with a very narrow inferior pedicle Cemal Alper Kemalog ˘lu, Fatih K ılıc¸ & Galip Kemali Gu ¨ nay Department of Plastic, Reconstructive and Aesthetic Surgery, Erciyes University, Kayseri, Turkey ABSTRACT In our case study, the left ear of a 57-year-old male patient was subtotally amputated due to an iron-plate cutting accident.",Non-OADS,/arxiv_data1/oa_pdf/06/5a/icrp-2-77.PMC4793789.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/5a/icrp-2-77.PMC4793789.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0).,Non-OADS,/arxiv_data1/oa_pdf/06/7a/icrp-2-47.PMC4793790.pdf
"http://informahealthcare.com/crp ISSN: 2332-0885 (electronic) Cas Rep Plast Surg Hand Surg, 2015; 2(3-4): 47 –49 DOI: 10.3109/23320885.2015.1029483",Non-OADS,/arxiv_data1/oa_pdf/06/7a/icrp-2-47.PMC4793790.pdf
"3-4, 80–83http://dx.doi.org/10.3109/23320885.2015.1112747 CASE REPORT Episode of massive pulmonary embolism after bilateral breast augmentation Fabrizio Schonauera, Gisella Nelea, Annalena Di Martinoa, Mariangela Santoroaand Fabio Santanelli di Pompeob aPlastic Surgery Unit, School of Medicine and Surgery, University ‘‘Federico II’’, Naples, Italy;bPlastic Surgery Unit, Sant’Andrea Hospital, School of Medicine and Psychology, ‘‘Sapienza’’ University of Rome, Rome, Italy ABSTRACT Pulmonary embolism is a rare postsurgical complication, even more so following breast augmentation.",Non-OADS,/arxiv_data1/oa_pdf/7f/2e/icrp-2-80.PMC4793791.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/2e/icrp-2-80.PMC4793791.pdf
Available from: http://itunes.apple.com/it/app/ thromboembolism-risk/id889719436?I ¼en&mt¼8.,Non-OADS,/arxiv_data1/oa_pdf/7f/2e/icrp-2-80.PMC4793791.pdf
"3-4, 73–76http://dx.doi.org/10.3109/23320885.2015.1102067 CASE REPORT Use of a pedicled fillet foot flap for knee preservation in severe lower extremity trauma: A case report and literature review David Jensson, Thorir Audolfsson, Maria Mani and Andres Rodriguez-Lorenzo Department of Plastic and Maxillofacial Surgery, Institute of Surgical Sciences, Uppsala University and Uppsala University Hospital, Sweden ABSTRACT We report the sequential use of a pedicled fillet foot flap in a clinical case of complex bilateral lower extremity trauma to achieve stable wound closure, maximizing length preservation and gait rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/ac/91/icrp-2-73.PMC4793796.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non -Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/91/icrp-2-73.PMC4793796.pdf
"While budget cuts reduce  health and social care expenditures, there is, thus, a strong need for  providing high-quality care in order to maintain elderly’s quality of  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/e9/cmv106.PMC4793802.pdf
"2, 167–171 doi:10.1093/fampra/cmw007 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/3d/cmw007.PMC4793803.pdf
"To view a copy of this license, visit http://creativecommons.org/   licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/53/8d/mtm201612.PMC4793805.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/a9/af/mtm201610.PMC4793806.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/58/bbv034.PMC4793891.pdf
"Similarly, IBM and MARS have established a consortium that aims to sequence the food supply chain (http://www.research.ibm.com/client-programs/foodsafety/).",Non-OADS,/arxiv_data1/oa_pdf/04/58/bbv034.PMC4793891.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/43/bbv038.PMC4793893.pdf
"Doctoral thesis at the University of Liege, Belgium; available from http://orbi.ulg.ac.be/handle/2268/ 136086.",Non-OADS,/arxiv_data1/oa_pdf/5b/43/bbv038.PMC4793893.pdf
URL http://www.nhs.uk/Conditions/Body-odour/Pages/Treatment.aspx [accessed on 02 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/de/cf/JOCD-15-58.PMC4793925.pdf
URL http://www.mintel.com/press-centre/beauty-and-personal-care/the-only-way-is-smooth-half-of-britains-men-feel-the-pressure-to-remove- or-groom-their-body-hair [accessed on 02 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/de/cf/JOCD-15-58.PMC4793925.pdf
"Second, weexcluded sites for which read depth was less than one-third of the average read depth (representing defaultsettings in PSMC when analysing highly covered gen- omes, https://github.com/lh3/psmc).",Non-OADS,/arxiv_data1/oa_pdf/a5/4b/MEC-25-1058.PMC4793928.pdf
"The settings of the PSMC analysis(/C0p and /C0t options) were chosen manually according to suggestions given by H. Li and R. Durbin (2011,https://github.com/lh3/psmc) and based on our pre- vious experience (Nadachowska-Brzyska et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/4b/MEC-25-1058.PMC4793928.pdf
Habitat destruction is likely to underlie an ongoing decline (BirdLife International2004) and the distribution is fragmented and the specieslisted a near-threatened on the IUCN Red List (http://www.iucnredlist.org/details/full/22709319/0).,Non-OADS,/arxiv_data1/oa_pdf/a5/4b/MEC-25-1058.PMC4793928.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/5c/nihms762502.PMC4793934.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jcf.,OADS,/arxiv_data1/oa_pdf/bc/5c/nihms762502.PMC4793934.pdf
2014. http://dx.doi.org/ 10.1128/JCM.00764-14 5.,Non-OADS,/arxiv_data1/oa_pdf/bc/5c/nihms762502.PMC4793934.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/d3/jev355.PMC4793937.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/90/jev356.PMC4793938.pdf
Sao Paulo 2016;58:1 http://dx.doi.org/10.1590/S1678-9946201658001,Non-OADS,/arxiv_data1/oa_pdf/cb/a3/0036-4665-rimtsp-S1678-9946201658001.PMC4793942.pdf
Sao Paulo 2016;58:2 http://dx.doi.org/10.1590/S1678-9946201658002,Non-OADS,/arxiv_data1/oa_pdf/63/1c/0036-4665-rimtsp-S1678-9946201658002.PMC4793943.pdf
Sao Paulo 2016;58:3 http://dx.doi.org/10.1590/S1678-9946201658003,Non-OADS,/arxiv_data1/oa_pdf/70/42/0036-4665-rimtsp-S1678-9946201658003.PMC4793944.pdf
Sao Paulo 2016;58:4 http://dx.doi.org/10.1590/S1678-9946201658004,Non-OADS,/arxiv_data1/oa_pdf/16/2a/0036-4665-rimtsp-S1678-9946201658004.PMC4793945.pdf
Sao Paulo 2016;58:5 http://dx.doi.org/10.1590/S1678-994620160005,Non-OADS,/arxiv_data1/oa_pdf/dd/99/0036-4665-rimtsp-S1678-9946201658005.PMC4793946.pdf
Sao Paulo 2016;58:6 http://dx.doi.org/10.1590/S1678-9946201658006,Non-OADS,/arxiv_data1/oa_pdf/fd/5f/0036-4665-rimtsp-S1678-9946201658006.PMC4793947.pdf
Sao Paulo 2016;58:7 http://dx.doi.org/10.1590/S1678-9946201658007,Non-OADS,/arxiv_data1/oa_pdf/f7/6d/0036-4665-rimtsp-S1678-9946201658007.PMC4793948.pdf
Sao Paulo 2016;58:8 http://dx.doi.org/10.1590/S1678-9946201658008,Non-OADS,/arxiv_data1/oa_pdf/a4/9b/0036-4665-rimtsp-S1678-9946201658008.PMC4793949.pdf
Sao Paulo2016;58:9http://dx.doi.org/10.1590/S1678-994658009,Non-OADS,/arxiv_data1/oa_pdf/ec/32/0036-4665-rimtsp-S1678-9946201658009.PMC4793950.pdf
Sao Paulo 2016;58:10 http://dx.doi.org/10.1590/S1678-9946201658010,Non-OADS,/arxiv_data1/oa_pdf/70/7c/0036-4665-rimtsp-S1678-9946201658010.PMC4793951.pdf
Sao Paulo 2016;58:11 http://dx.doi.org/10.1590/S1678-9946201658011,Non-OADS,/arxiv_data1/oa_pdf/1c/d4/0036-4665-rimtsp-S1678-9946201658011.PMC4793952.pdf
Available from: <https://unstats.un.org/unsd/methods/ m49/m49regin.htm>  30.,Non-OADS,/arxiv_data1/oa_pdf/1c/d4/0036-4665-rimtsp-S1678-9946201658011.PMC4793952.pdf
Sao Paulo 2016;58:12 http://dx.doi.org/10.1590/S1678-9946201658012,Non-OADS,/arxiv_data1/oa_pdf/50/28/0036-4665-rimtsp-S1678-9946201658012.PMC4793953.pdf
"Analyses were performed using the R language and environment for statistical computing (Version2.15.3; R Core Team, Vienna, 2013, available in the publicdomain at http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/00/c8/i1552-5783-57-3-1221.PMC4794083.pdf
"Western blot bands were quantiﬁed by densitometryusing ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA [gel analysis tool]), and the signals of thetarget protein were normalized to that of b-tubulin.",OADS,/arxiv_data1/oa_pdf/5b/54/i1552-5783-57-3-877.PMC4794085.pdf
"11Nerves were traced using NeuronJ (in the public domain at http://www.imagescience.org/meijering/software/neuronj/), a plug-in for the ImageJ software (in thepublic domain at http://imagej.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/10/96/i1552-5783-57-3-1132.PMC4794090.pdf
"Additional subgroup analyses of patients who escalated to weekly dosing are shown in Supple- mentary Table 1, Supplemental Digi tal Content 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/5f/2b/ibd-22-0886.PMC4794130.pdf
"Additionally, the overallsafety pro ﬁle of patients who escalated to double-blind weekly dosing was similar to that observed when these patients were receiving treatment every other week, with the exceptions of the exposure-adjusted rates of serious adverse events and adverse events leading to discontinuation, which were numerically higher after dose escalation, and hepatic events, which were numerically higher before dose escalation (see Supplementary Table 2, Sup- plemental Digital Content 2, http://links.lww.com/IBD/B233).",Non-OADS,/arxiv_data1/oa_pdf/5f/2b/ibd-22-0886.PMC4794130.pdf
"Treatment was discontinued for conﬁrmed virologic failure/inadequate virologic response (Supplemental Digital Content 1, http://links.lww.com/QAD/A850).",Non-OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
"A Classiﬁcation and Regression Tree analysis was used to further investigate the association between week 24 CVC minimum plasma concentration ( Cmin) and virologic outcomes.Results Study population and disposition Of the 392 study participants screened, 143 were randomized to CVC or EFV , in combination with FTC/TDF (CVC100, 59; CVC200, 56; and EFV , 28) (Supplemental Digital Content 2, http://links.lww.com/ QAD/A850).",OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
"Efﬁcacy The proportion of study participants with virologic success (HIV-1 RNA <50 copies/ml) was similar in all treatment arms at weeks 24 (primary end point) and 48 (secondary end point) (all P>0.05; Table 3; Supple- mental Digital Content 3, http://links.lww.com/QAD/ A850).",Non-OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
"Mean CD4þ/CD8þcell ratio increased from baseline in all groups (Supplemental Digital Content 4, http://links.lww.com/QAD/A850).",OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
"Most laboratory abnormalities were grade 1 or 2 (Supplemental Digital Content 5, http://links.lww.- com/QAD/A850).",Non-OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
"There were no notable differences in glucose, insulin, homeostatic model assessment-insulin resistance, or hemoglobin A1c (Supplemental Digital Content 6, http://links.lww.com/ QAD/A850), and no clinically relevant ECG changes.",Non-OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
"Biomarkers of inﬂammation and immune activation CVC led to a dose-dependent, compensatory increase in MCP-1 because of CCR2 blockade, whereas no change was observed with EFV (Supplemental Digital Content 7, http://links.lww.com/QAD/A850).",Non-OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
"During the ﬁrst 12 weeks, sCD14 (a marker of monocyte activation) levels decreased and remained below baseline in the CVC arms throughout the study; whereas in the EFV arm, sCD14 levels increased and remained above baseline values (Supplemental Digital Content 7, http://links.lww.com/ QAD/A850).",OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
"CVC effects on sCD14 were independent of changes in HIV-1 RNA, in contrast to EFV , where greater viral load decline was associated with smaller changes in sCD14 levels (Supplemental Digital Content 8, http://links.lww.com/QAD/A850).",Non-OADS,/arxiv_data1/oa_pdf/7e/3d/aids-30-869.PMC4794136.pdf
Available at: http://www.inshi.umn.,Non-OADS,/arxiv_data1/oa_pdf/a7/dd/aids-30-909.PMC4794188.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bonnethead MitogenomePhylogenyHypnosqualea hypothesis 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.1016/j.mgene.2015.11.005 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
The complete mitochondrial genome of the sandbar shark Carcharhinus plumbeus .M i t o c h o n d r i a lD N A .http://dx.doi.org/10.3109/ 19401736.2014.926487 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2014.982574 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2014.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2014.919463 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/ 19401736.2014.892095 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2014.913145 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2014.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2013.873908 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2014.1003898 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/ 19401736.2014.913157.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.1371/journal.pone.0042543 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2014.892094 .54 P. Díaz-Jaimes et al.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2013.878922 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2013.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.org/10.3109/19401736.2013.878928 .,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/main.PMC4794228.pdf
"The R package, its source code and documentations are available from http://cran.r-project.org/web/packages/seqminer and http://seqminer.genomic.codes/.",OADS,/arxiv_data1/oa_pdf/b0/30/GEPI-39-619.PMC4794281.pdf
Summary association statistics were generated using RVTESTS [https://github.com/zhanxw/rvtests].,OADS,/arxiv_data1/oa_pdf/b0/30/GEPI-39-619.PMC4794281.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.S80 J Child Orthop (2016) 10 (Suppl 1):S9–S80 123",Non-OADS,/arxiv_data1/oa_pdf/ec/b1/11832_2016_Article_715.PMC4794449.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.J Child Orthop (2016) 10 (Suppl 1):S91–S137 S137 123",Non-OADS,/arxiv_data1/oa_pdf/a7/0d/11832_2016_Article_714.PMC4794452.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2d/b8/jcs-5-1.PMC4794540.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/d2/jcs-5-11.PMC4794541.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/48/e7/jcs-5-23.PMC4794542.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/ce/jcs-5-33.PMC4794543.pdf
Available from:   http://www.tandfebooks.com/ isbn/97802 03759745 .,Non-OADS,/arxiv_data1/oa_pdf/42/ce/jcs-5-33.PMC4794543.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under the terms of  the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/71/b6/jcs-5-43.PMC4794544.pdf
Available  from:  http://www.who.int/cancer/ detec   tion/ brea st cancer/en.,Non-OADS,/arxiv_data1/oa_pdf/71/b6/jcs-5-43.PMC4794544.pdf
Available from: http://www.ircancer.,Non-OADS,/arxiv_data1/oa_pdf/71/b6/jcs-5-43.PMC4794544.pdf
This work is published by Journal of Caring Sciences as an  open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/24/jcs-5-57.PMC4794545.pdf
This work is published by Journal of Caring Sciences as an open access article distribute d  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/53/8e/jcs-5-67.PMC4794546.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/74/jcs-5-75.PMC4794547.pdf
This work is  published by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/bc/jcs-5-85.PMC4794548.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/30/omv072.PMC4794555.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/ee/omw012.PMC4794556.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/50/omw010.PMC4794557.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/e9/omw013.PMC4794558.pdf
"Cells 2016; 39(3): 169-178  http://dx.doi.org/10.14348/molcells.2016.2329                    N-Terminal Acetylation-Targeted N-End Rule   Proteolytic System: The Ac/N-End Rule Pathway    Kang-Eun Lee1,2, Ji-Eun Heo1,2, Jeong-Mok Kim1, and Cheol-Sang Hwang1,*      Although N α-terminal acetylation (Nt-acetylation) is a per- vasive protein modification in eukaryotes, its general func-tions in a majority of proteins are poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
"NatA consists of a catalytic subunit Naa10 (Ard1) and an  auxiliary subunit Naa15 (Nat1) (Mullen et al., 1989; Park and  Szostak, 1992), and acetylates Ser, Ala, Cys, Gly, Thr, and Val  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
"Cells http://molcells.org     N-termini (Aksnes et al., 2015b) (Fig.",OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
"Cells http://molcells.org     acetylated Nt-Met, Ala, Ser, Cys, Thr, and Val, rather than  their non-acetylated counterparts.",Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
"Cells http://molcells.org     dosages and a subsequent increase in unassembled or mis- folded proteins (Hwang et al., 2010b).",OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
A ll information  about cancer-related mutations was acquired and analyzed from dat asets of The Cancer Genome Atlas (https://tcga-data.nci.nih.go v/tcga).,OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
"Cells http://molcells.org     pathway will set the stage for new therapeutic approaches  based on inhibitors or activators of MetAPs, specific Nt- acetylases, and other components of the Ac/N-end rule path- way, including Ac/N-recognins (Hwang et al., 2010a; Lee et al., 2015; Park et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
"Cells http://molcells.org     Piatkov, K.I., Vu, T.M., Hwang, C.S., and Varshavsky, A.",Non-OADS,/arxiv_data1/oa_pdf/36/e8/molce-39-3-169.PMC4794598.pdf
"Cells 2016; 39(3): 179-185  http://dx.doi.org/10.14348/molcells.2016.2359                    Emerging Roles of RNA-Binding Proteins in   Plant Growth, Development, and Stress Responses    Kwanuk Lee, and Hunseung Kang*      Posttranscriptional regulation of RNA metabolism, includ- ing RNA processing, intron sp licing, editing, RNA export,  and decay, is increasingly regarded as an essential step  for fine-tuning the regulation of gene expression in eukar- yotes.",Non-OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
"GRPs harboring an addition- al CCHC-type zinc finger in the glycine-rich region, referred to  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
"Cells http://molcells.org     as RZs, have been found in Arabidopsis and rice (Kim et al.,  2010a; 2010b; Mangeon et al., 2010).",OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
RNA-Binding Protein in Plant Development and Stress Response  Kwanuk Lee & Hunseung Kang     http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
"Cells http://molcells.org     lism in living organisms (Jankowsky, 2011).",OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
RNA-Binding Protein in Plant Development and Stress Response  Kwanuk Lee & Hunseung Kang     http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
Cells http://molcells.org     (2013).,OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
RNA-Binding Protein in Plant Development and Stress Response  Kwanuk Lee & Hunseung Kang     http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/03/87/molce-39-3-179.PMC4794599.pdf
"Cells 2016; 39(3): 186-194  http://dx.doi.org/10.14348/molcells.2016.2159                    Human Amnion-Derived Mesenchymal Stem Cells  Protect Human Bone Marrow Mesenchymal Stem Cells against Oxidative Stress-Mediated  Dysfunction via ERK1/2 MAPK Signaling    Yuli Wang1,2, Junchi Ma1,2, Yifei Du1, Jing Miao1, and Ning Chen1,*      Epidemiological evidence suggests that bone is especially  sensitive to oxidative stress, causing bone loss in the el-derly.",Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
"We showed that HAMSCs were not only capa- ble of promoting osteogenic differentiation, but also reversing  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
"Cells http://molcells.org     Assessment of ALP activity and mineralized matrix for- mation  Fourteen days after co-culturing, Transwells containing HAMSCs  were removed.",Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
Cells http://molcells.org     HAMSCs ratio (Fig.3B).,OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
Cells http://molcells.org     with HAMSCs significantly promoted ALP activity and mineral- ized matrix formation in H 2O2-induced HBMSCs.,Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
Cells http://molcells.org     tation with beta-tricalcium phosphate and autologous osteo- blasts in canine mandible.,Non-OADS,/arxiv_data1/oa_pdf/d4/83/molce-39-3-186.PMC4794600.pdf
"Cells 2016; 39(3): 195-203  http://dx.doi.org/10.14348/molcells.2016.2198                    Copper Ion from Cu 2O Crystal Induces AMPK- Mediated Autophagy via Superoxide in Endothelial Cells    Youngsik Seo1, Young-Sik Cho2, Young-Duk Huh2, and Heonyong Park1,*      Copper is an essential element required for a variety of  functions exerted by cuproproteins.",OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
"Additionally, BCL2 is known to inhibit the interaction between Beclin  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
"Cells http://molcells.org     1 and VPS 34, inhibiting autophagy (He et al., 2012).",OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
"Cells http://molcells.org     To examine the effects of cuprous oxide (Cu 2O) or cupric ox- ide (CuO) crystals on endothelial cell death, BAECs were treat-ed with cuprous oxide or cupric oxide crystals in dose curve  experiments.",OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
Cells http://molcells.org     Cu+ and Cu2+ to characterize effects in endothelial cells and  better understand roles of the two types of crystals.,OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
Cells http://molcells.org     characterized.,Non-OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/90/88/molce-39-3-195.PMC4794601.pdf
"Cells 2016; 39(3): 204-210  http://dx.doi.org/10.14348/molcells.2016.2206                    DNA Strand Breaks in Mitotic Germ Cells of  Caenorhabditis elegans  Evaluated by Comet  Assay    Sojin Park1,2, Seoyun Choi1, and Byungchan Ahn1,*      DNA damage responses are im portant for the maintenance  of genome stability and the su rvival of organisms.",OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
In this  Molecules and Cells http://molcells.org  Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
"Cells http://molcells.org     Boulton, S.J.",Non-OADS,/arxiv_data1/oa_pdf/ed/bb/molce-39-3-204.PMC4794602.pdf
"Cells 2016; 39(3): 211-216  http://dx.doi.org/10.14348/molcells.2016.2226                    Structural Analysis of the Streptomyces avermitilis   CYP107W1-Oligomycin A Complex and Role of the Tryptophan 178 Residue    Songhee Han1,4, Tan-Viet Pham1,4, Joo-Hwan Kim1, Young-Ran Lim1, Hyoung-Goo Park1, Gun-Su Cha2,  Chul-Ho Yun2, Young-Jin Chun3, Lin-Woo Kang1, *, and Donghak Kim1,*      CYP107W1 from Streptomyces avermitilis  is a cytochrome  P450 enzyme involved in the biosynthesis of macrolide  oligomycin A.",OADS,/arxiv_data1/oa_pdf/32/36/molce-39-3-211.PMC4794603.pdf
"Briefly, the sitting-drop vapor-diffusion  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/32/36/molce-39-3-211.PMC4794603.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/32/36/molce-39-3-211.PMC4794603.pdf
"Cells http://molcells.org     method was employed for the initial crystallization at 14 °C,  using a Hydra II e-Drop automated pipetting system (Matrix)  and the Index, Crystal Screen, Crystal Screen Cryo, Crystal  Screen Lite, PEGRx, SaltRx, PEG/Ion, Wizard, and Wizard precipitant synergy screening kits.",OADS,/arxiv_data1/oa_pdf/32/36/molce-39-3-211.PMC4794603.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/32/36/molce-39-3-211.PMC4794603.pdf
"Cells http://molcells.org     lar orientation of the macrolide ligand in the active site of the  P450 enzyme was previously reported in MycG (Li et al., 2012).",OADS,/arxiv_data1/oa_pdf/32/36/molce-39-3-211.PMC4794603.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/32/36/molce-39-3-211.PMC4794603.pdf
Cells http://molcells.org     indicates the affinities to the substrate.,Non-OADS,/arxiv_data1/oa_pdf/32/36/molce-39-3-211.PMC4794603.pdf
"Cells 2016; 39(3): 217-228  http://dx.doi.org/10.14348/molcells.2016.2235                    Substitution of Heavy Complementarity Determining  Region 3 (CDR-H3) Resi dues Can Synergistically  Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen    Seung Kee Moon1,2,4, So Ra Park1,4, Ami Park1, Hyun Mi Oh1, Hyun Jung Shin1, Eun Ju Jeon1, Seiwhan Kim1,  Hyun June Park2, Young Joo Yeon3, and Young Je Yoo2,*      To generate a biobetter that has improved therapeutic activity, we constructed scFv libraries via random mu- tagenesis of several residu es of CDR-H3 and -L3 of  hu4D5.",Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
A popular strategy to  improve the binding affinity and efficacy of the antibody is  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Cells http://molcells.org     mutagenesis, and particularly, substitution of the residues at  some positions of CDR-H and CDR-L would be considered.",Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Phagemids extracted from the selected clones were ana- lyzed by DNA sequencing, and then CDR were identified using  NCBI IgBLAST (http://www.ncbi.nlm.nih.gov/igblast/).",OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Cells http://molcells.org     with Fc (R&D system, USA) as coating antigens.",OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Computing the stability and analyzing antibody-antigen  interaction To analyze the molecular interactions between the antibody  and HER2 (P04626, UniProtKB), we obtained the structural  information for HER2 and hu4D5 from the PDB (code: 1N8Z; web site: http://www.rcsb.org/pdb/home/home.do).",OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"The effects  of mutations in the antibody variable regions on stability, force  field and charges were estimated using CHARMm module and Momany-Rone, respectively (Discovery Studio 3.5, Accelrys  Inc., USA, http://accelrys.com/).",OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Data on intraprotein interac- tions were obtained from the Protein Interactions Calculator (http://pic.mbu.iisc.ernet.in/), and the binding energy between  the antibody and HER2 molecule was calculated by equation 1  below.",OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Cells http://molcells.org     cal to antigen binding key residues, were excluded from ran- domization.",OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Cells http://molcells.org     Analysis of the binding affinity and binding energy of the  CDR-H3 variants indicates that the 3 residues F100c, A101 and L102 of AH06 can enhance the binding affinity to HER2 (by  additional hydrophobic interactions) approximately 3-fold; how- ever, W98 of CDR-H3 has the greatest impact.",Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
Cells http://molcells.org           Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Cells http://molcells.org     11, 117-127.",Non-OADS,/arxiv_data1/oa_pdf/ee/2a/molce-39-3-217.PMC4794604.pdf
"Cells 2016; 39(3): 229-241  http://dx.doi.org/10.14348/molcells.2016.2244                    Histone Deacetylase-3/CAGE Axis Targets   EGFR Signaling and Regulates the Response to Anti-Cancer Drugs    Hyuna Kim1,2, Youngmi Kim1,2, Hyeonjung Goh1, and Dooil Jeoung1,*      We have previously reported the role of miR-326-HDAC3  loop in anti-cancer drug-resistance.",Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
EGFR signaling  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
"Cells http://molcells.org     regulates the multi drug-resistant phenotypes (Shi et al., 2009).",OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
Cells http://molcells.org     10% fetal bovine serum was placed in the lower chamber and  cells were incubated at 37°C for 16 h. The cells were fixed with  methanol and the invaded cells were stained and counted.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
Cells http://molcells.org     expression of MDR1 in Malme3MR cells transfected with  HDAC3 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
Cells http://molcells.org     decreasing the expression of CAGE and pEGFRY845 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
Cells http://molcells.org     DISCUSSION     Celastrol and taxol increase the expression of pEGFRY845 in  SNU387 and Malme3M cells (personal observations).,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
Cells http://molcells.org     activity toward EGFR.,OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5f/41/molce-39-3-229.PMC4794605.pdf
"Cells 2016; 39(3): 242-249  http://dx.doi.org/10.14348/molcells.2016.2271                    Cloning, Purification, and Characterization of  Recombinant Human Extracellular Superoxide Dismutase in SF9 Insect Cells    Pravesh Shrestha1, Ji-Hye Yun1, Woo Taek Kim2, Tae-Yoon Kim3,*, and Weontae Lee1,*      A balance between production and degradation of reactive  oxygen species (ROS) is critical for maintaining cellular homeostasis.",OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
Cells http://molcells.org     and the spots were transferred into each 1.5 ml tube.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
Cells http://molcells.org     Table 2.,OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/molce-39-3-242.PMC4794606.pdf
"Cells 2016; 39(3): 250-257  http://dx.doi.org/10.14348/molcells.2016.2290                    CaPUB1, a Hot Pepper U-box  E3 Ubiquitin Ligase,  Confers Enhanced Cold Stress Tolerance and Decreased Drought Stress To lerance in Transgenic  Rice ( Oryza sativa L.)    Hye Jo Min1, Ye Jin Jung1, Bin Goo Kang2, and Woo Taek Kim1,*      Abiotic stresses such as drought and low temperature  critically restrict plant growth, reproduction, and produc-tivity.",Non-OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
Cells http://molcells.org     al.,OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
Cells http://molcells.org     observed.,OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
"Cells http://molcells.org     to cold stress (Wang et al., 2013).",OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/a4/molce-39-3-250.PMC4794607.pdf
"Cells 2016; 39(3): 258-265  http://dx.doi.org/10.14348/molcells.2016.2310                    TrkB Promotes Breast Cancer Metastasis via   Suppression of Runx3 and Keap1 Expression    Min Soo Kim1,3, Won Sung Lee1,3, and Wook Jin1,2,*       In metastatic breast cancer, the acquisition of malignant  traits has been associated with the increased rate of cell growth and division, mobility,  resistance to chemotherapy,  and invasiveness.",Non-OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
Cells http://molcells.org     Statistical analysis  All data are expressed as mean ± SEM.,OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
Cells http://molcells.org     cells.,OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
Cells http://molcells.org     ies suggest that the activation or expression of tumor suppres- sors in cancer cells needs to be inhibited in order for a cancer  cell to acquire the ability to initiate the invasion-metastasis cas- cade.,Non-OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6f/88/molce-39-3-258.PMC4794608.pdf
"Cells 2016; 39(3): 266-279  http://dx.doi.org/10.14348/molcells.2016.2362                    Regulations of Reversal of Senescence by PKC  Isozymes in Response to 12- O-Tetradecanoylphorbol-  13-Acetate via Nuclear Translocation of pErk1/2     Yun Yeong Lee1, Min Sook Ryu1, Hong Seok Kim4, Masami Suganuma2, Kye Yong Song3, and  In Kyoung Lim1,*      The mechanism by which 12- O-tetradecanoylphorbol-13- acetate (TPA) bypasses cellular senescence was investigat- ed using human diploid fibrob last (HDF) cell replicative se- nescence as a model.",OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
"Moreover, we investigated the reversal of gene ex- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
"Cells http://molcells.org     at 12,000 × g for 5 min and the supernatant was collected as  cytoplasmic fraction.",OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
"MAPK docking motif in the regulatory and catalytic domains of PKC α was predicted and searched by  using website http://elm.eu.or g and based on the published  reports (Bardwell et al., 2001; Yang et al., 1998).",OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
"Th e functional category analyses of  the differentially expressed genes (DEGs) were performed by DAVID (http://david.abcc.ncifcrf.gov), Enrichr (http://amp.pharm.",OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
mssm.edu/Enrichr/) or PANTHE R (http://pantherdb.org/) tools.,OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
Cells http://molcells.org      A                          B                      C                          D                         E                          F                      sented by % of total cells (lower panel).,OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
"Cells http://molcells.org      A                               C              B                 D                                F                      E                           ICC was performed with anti-pErk1/2 and anti-PKC α antibodies and counted the cells with nuclear pErk1/2 and PKC α; TPA-induced pErk1/2  translocation was signi ficantly reduced by overexpression of mt(R159,161G)-PKC α compared with that of the wt-PKC α (p < 0.01).",Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
Cells http://molcells.org                                                  Fig.,Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
Cells http://molcells.org     Table 3.,OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
"Cells http://molcells.org     higher affinity of PKC β1 for PEA-15 S104 than for PKC α  (Nishikawa et al., 1997).",OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/4e/6f/molce-39-3-266.PMC4794609.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/ab/gyv170.PMC4794610.pdf
US  Geological Survey Data Series 800. http://pubs.usgs.gov/ds/800/ .,OADS,/arxiv_data1/oa_pdf/0c/ab/gyv170.PMC4794610.pdf
"The finite element analyses were performed in Abaqus.2 The meshes  1http://www.image.hudsonalpha.org/ , last accessed February 2011.Nowlan et al.",OADS,/arxiv_data1/oa_pdf/ff/3b/emss-67290.PMC4794622.pdf
"After verifying that the same muscle bodies are  present at TS22 and TS24 as at TS23, it was assumed that the muscle attachment sites  2©, http://www.simulia.com/ , last accessed February 2011.3©, http://www.rhino3d.com/ , last accessed February 2011.4©, http://www.cubit.sandia.gov/ , last accessed February 2011.Nowlan et al.",OADS,/arxiv_data1/oa_pdf/ff/3b/emss-67290.PMC4794622.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2016, 7: 29605 - http://dx.doi.org/10.3402/dfa.v7.29605 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/38/6c/DFA-7-29605.PMC4794731.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 29605 - http://dx.doi.org/10.3402/dfa.v7.29605",Non-OADS,/arxiv_data1/oa_pdf/38/6c/DFA-7-29605.PMC4794731.pdf
"Factors that affect diabetic patients to develop diabetic foot ParameterDM patients with DF N/C3054DM patients without DF N/C3025 P Medication used Oral antidiabetics (%) 24 (44%) 20 (80%) 0.009 Insulin (%) 11 (20%) 3 (12%)Both (%) 19 (36%) 2 (8%) Presence of home glucose meter Yes available (%) 33 (61%) 16 (64%) 0.804 Not available (%) 21 (39%) 9 (36%) Measuring blood glucose level Daily (%) 11 (20%) 5 (20%) 0.930 Weekly (%) 13 (24%) 7 (28%)Rarely (%) 30 (56%) 13 (52%) Regular physician visit Yes (%) 10 (19%) 8 (32%) 0.184 No (%) 44 (81%) 17 (68%) Therapy compliance and adherence Yes (%) 32 (59%) 10 (40%) 0.110 No (%) 22 (41%) 15 (60%) Source of used medications Public diabetic centers (free of charge) (%)23 (43%) 7 (28%) 0.213 Private community pharmacies (with fee) (%)31 (57%) 18 (72%) Knowledge about disease and its complication Yes (%) 22 (41%) 7 (28%) 0.274 No (%) 32 (59%) 18 (72%) Knowledge about hyperglycemia symptoms Yes (%) 11 (20%) 7 (28%) 0.452 No (%) 43 (80%) 18 (72%) Anyone helps you in your treatment Yes (%) 24 (44%) 10 (40%) 0.710 No (%) 30 (56%) 15 (60%) Availability of prescribed medication in public centers Yes (%) 3 (13%) 5 (72%) 0.002 No (%) 20 (87%) 2 (28%) Patients who stop treatment if medications are not available freelyYes (%) 6 (30%) 2 (33%) 0.876 No (%) 14 (70%) 4 (67%) Regular foot inspection Yes (%) 27 (50%) 8 (32%) 0.134 No (%) 27 (50%) 17 (68%) Physical activity Yes (%) 41 (76%) 11 (44%) 0.005 No (%) 13 (24%) 14 (56%) DM: diabetes mellitus; DF: diabetic foot.Risk factors for diabetic foot ulcers Citation: Diabetic Foot & Ankle 2016, 7: 29605 - http://dx.doi.org/10.3402/dfa.v7.29605 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/38/6c/DFA-7-29605.PMC4794731.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 29605 - http://dx.doi.org/10.3402/dfa.v7.29605",Non-OADS,/arxiv_data1/oa_pdf/38/6c/DFA-7-29605.PMC4794731.pdf
"(a) Yes (b) NoRisk factors for diabetic foot ulcers Citation: Diabetic Foot & Ankle 2016, 7: 29605 - http://dx.doi.org/10.3402/dfa.v7.29605 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/38/6c/DFA-7-29605.PMC4794731.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 29605 - http://dx.doi.org/10.3402/dfa.v7.29605",Non-OADS,/arxiv_data1/oa_pdf/38/6c/DFA-7-29605.PMC4794731.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"Discussion Oral microbiota contained within endodontic abscessesFor the current study, we examined endodontic abscesses for the presence of 280 oral bacterial species (425 taxa-specific probes) using microarray determinations con-ducted by the Human Oral Microbial IdentificationLaboratory at the Forsyth Institute (Cambridge, MA).Our findings confirmed and provided new informationsupporting the earlier research by Siqueira and Ro ˆcas (6), describing the microbiota of endodontic abscesses ob- tained from the demographic region in Rio de Janeiro,Oral microbiota species in acute apical endodontic abscesses Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"Using the log base 2 scale, the range of transformed intensity values in the horizontal axis is 0 /C116.Oral microbiota species in acute apical endodontic abscesses Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"Through these mechanisms, S. cristatusOral microbiota species in acute apical endodontic abscesses Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
Available from: http://www.R-project.org/ [cited 17 August2015].,Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"FEMS Microbiol Lett 1996; 143: 13 /C118.Oral microbiota species in acute apical endodontic abscesses Citation: Journal of Oral Microbiology 2016, 8: 30989 - http://dx.doi.org/10.3402/jom.v8.30989 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b3/97/JOM-8-30989.PMC4794734.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Schmid, A. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/48/59/srep22736.PMC4794761.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/48/59/srep22736.PMC4794761.pdf
Statistical analysis Statistical analysis was performed using   Review Manager  5.2 software (Available at http://ims.cochrane.org/reman).,OADS,/arxiv_data1/oa_pdf/85/a7/CMJ-128-3219.PMC4794866.pdf
[3] It has been suggested that nearly 90% physicians spent more than 8 hours per  day on their work (http://health.sohu.com/s2008/yisheng/.,Non-OADS,/arxiv_data1/oa_pdf/5e/08/CMJ-128-3251.PMC4794877.pdf
"(a and b) The cross‑section of the thoracolumbar vertebral body  is kidney‑shaped, so the anterior border of the vertebral canal does  not fully match the posterior border of the vertebral body (the original  vector images were copied from: http://smart.servier.info/UK/images/ Bones/08.gif, the last time to visit the page was July 28, 2015).",Non-OADS,/arxiv_data1/oa_pdf/d0/01/CMJ-128-3158.PMC4794894.pdf
Available at: http://www.auburn.edu/~deruija/endo_ diabetesoralagents.,Non-OADS,/arxiv_data1/oa_pdf/a1/f6/RPS-11-23.PMC4794934.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/d5/rjw037.PMC4794942.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/ba/ofw032.PMC4794943.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/09/ofw028.PMC4794945.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/60/ofw030.PMC4794946.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/b6/ofw026.PMC4794947.pdf
"METHODS Literature Search A literature search for pediatric cases of GDPU associated with RV and NoV gastroenteritis was conducted from September1974 until October 2015 using the PubMed and Google Scholardatabase for Chinese-, Croatian-, Czech-, Danish-, English-, French-, German-, Hungarian-, Italian-, Korean-, Polish-, Portu- guese-, Russian-, Spanish-, and Turkish-language publications aswell as using Ichushi Web database ( http://www.jamas.or.jp )f o r Japanese-language publicati ons.",Non-OADS,/arxiv_data1/oa_pdf/dc/b6/ofw026.PMC4794947.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/0d/ofw029.PMC4794948.pdf
See http://www.ifs.org.uk/publications/7591 (last checked 22 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/10.1177_0141076816632215.PMC4794969.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/1a/5a/10.1177_2325967116634074.PMC4794976.pdf
"Developmental  Cognitive  Neuroscience  14  (2015)  50–61 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Development  of the uncinate  fasciculus:  Implications  for  theory  and developmental  disorders Ingrid  R.  Olson∗,  Rebecca  J.",Non-OADS,/arxiv_data1/oa_pdf/0c/1c/main.PMC4795006.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/1c/main.PMC4795006.pdf
"Olson).1994;  Yakovlel  &  Lecours,  1967 ),  MRI  (Courchesne  et  al.,  2000; Durston  et  al.,  2001;  Giedd  et  al.,  1999a;  Giedd  et  al.,  1999b;  Gogtay et  al.,  2004;  Good  et  al.,  2001;  Matsuzawa  et  al.,  2001;  Paus  et  al., 1999;  Sowell  et  al.,  2003 ),  and  diffusion  tensor  imaging  (DTI)  stud- ies  (Barnea-Goraly  et  al.,  2005;  Bava  et  al.,  2010;  Giorgio  et  al., 2008; Hasan et al.,  2007;  Lebel  &  Beaulieu,  2011;  Lebel  et  al.,  2012; McKinstry et  al.,  2002;  Mukherjee  &  McKinstry,  2006;  Mukherjee et al.,  2001;  Schmithorst  &  Yuan,  2010;  Schneider  et  al.,  2004;  Snook et  al.,  2007;  Yap  et  al.,  2013 )  suggest  that  concurrent  changes  in  gray and white  matter  are  two  important  events  that  follow  distinct http://dx.doi.org/10.1016/j.dcn.2015.06.003 1878-9293/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/0c/1c/main.PMC4795006.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/0c/1c/main.PMC4795006.pdf
"9, 343,  http://dx.doi.org/10.3389/fnhum.2015.00343 Alm,  K.H.,  Unger,  A.,  Nugiel,  T.,  Zhang,  H.R.,  Rolheiser,  T.,  Troiani,  V.,  Olson,  I.R., 2015.",Non-OADS,/arxiv_data1/oa_pdf/0c/1c/main.PMC4795006.pdf
"72  (1),  16–25,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/0c/1c/main.PMC4795006.pdf
"Cortex,  1–10,  http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/0c/1c/main.PMC4795006.pdf
"Datasharing of personal data is a form of data ‘processing ’,i na c c o r d a n c e with National and International Regulation such as the EU directive 95/46/EC on personal data protection or in the US, HHS Regulationsfor the Protection of Human Subjects (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.102) and the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, 45 CFR 164.514(b).",Non-OADS,/arxiv_data1/oa_pdf/d8/e2/ejhg2014197a.PMC4795058.pdf
’ Further information on BRIF can be found on the P3G website at http://www.p3g.org/brif-bioshare-pilot-study.,Non-OADS,/arxiv_data1/oa_pdf/d8/e2/ejhg2014197a.PMC4795058.pdf
http://oicr.on.ca/oicr-programs-and-platforms/global-alli- ance/white-paper.,Non-OADS,/arxiv_data1/oa_pdf/d8/e2/ejhg2014197a.PMC4795058.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Charter of principles for international sharing D Mascalzoni et al 728 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/d8/e2/ejhg2014197a.PMC4795058.pdf
"To view a copy of this license, visit http://creative commons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Prioritizing clinical genetic testing services FS e v e r i n et al 735 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/c1/ef/ejhg2014190a.PMC4795066.pdf
"1As a consequence, lifespan is reduced for most affected individuals.Heterozygous missense or splice-site mutations account for about95% of identi ﬁed variants (Ehlers –Danlos Syndrome variant databases: https://eds.gene.le.ac.uk/home.php?select_db =COL3A1; unpublished data from the Collagen Diagnostic Laboratory, Department ofPathology, University of Washington).",Non-OADS,/arxiv_data1/oa_pdf/32/95/ejhg2014181a.PMC4795069.pdf
"He had normal results on cardiologic examination.The 85-year-old paternal grandmother (I-2) was healthy except forangina pectoris.DNA studies The proband (III-2) and his sister (III-3) were each heterozygous for twoCOL3A1 sequence variants: c.1786C 4T, p.(Arg596*) in exon 26, which encodes part of the triple helical domain of pro α1(III), and c.3851G4A, p.(Gly1284Glu) in exon 50, which encodes a portion of the carboxyl-terminal propeptide (submitted to https://eds.gene.le.ac.uk/home.php?select_db =COL3A1 as AN_003368 (DB-ID COL3A1_ 00451 and DB-ID COL3A1_00585 5,10; Figure 2a).",Non-OADS,/arxiv_data1/oa_pdf/32/95/ejhg2014181a.PMC4795069.pdf
"About 2/3rds of the described sequence variants result in substitutions for the glycine residues in the 342 uninterrupted Gly-X-Y triplets of the triple helicaldomain and most of the rest alter splice sites (unpublished data from the Collagen Diagnostic Laboratory, Department of Pathology, University of Washington; Ehlers –Danlos Syndrome variant databases https://eds.gene.le.ac.uk/home.php?select_db =COL3A1).",Non-OADS,/arxiv_data1/oa_pdf/32/95/ejhg2014181a.PMC4795069.pdf
"Close to half thevariants identi ﬁed in COL1A1 result in the creation of premature termination codons and a mild phenotype of osteogenesis imperfecta (OI), OI type I (see Database of Collagen Mutations https://oi.gene.le.ac.uk/home.php?select_db =COL1A1, and unpublished data from the Collagen Diagnostic Laboratory, Department of Pathology, University of Washington).",Non-OADS,/arxiv_data1/oa_pdf/32/95/ejhg2014181a.PMC4795069.pdf
"Video Abstract  available for more insights from the author (see Video,  Supplemental Digital Content 1, http://links.lww.com/JNPT/A124).",Non-OADS,/arxiv_data1/oa_pdf/36/e1/jnpt-40-124.PMC4795094.pdf
"Level of Evidencea I Evidence obtained from high-quality ( ≥50% criti - cal appraisal score) diagnostic studies, prospective  studies, or randomized controlled trials II Evidence obtained from lesser quality (<50% criti - cal appraisal score) diagnostic studies, prospective  studies, or randomized controlled trials III Case-controlled studies or retrospective studies IV Case study or case series  V Expert opinion aBased on information from the Centre for Evidence Based  Medicine  website: http://www.cebm.net/oxford-centre-evidence-based-medicine-   levels-evidence-march-2009/ TABLE 2.",Non-OADS,/arxiv_data1/oa_pdf/36/e1/jnpt-40-124.PMC4795094.pdf
The vestibular outcome measure rec - ommendations are available online at http://www.neuropt.,OADS,/arxiv_data1/oa_pdf/36/e1/jnpt-40-124.PMC4795094.pdf
Details regarding recommendations are available online at http://www.neuropt.org/professional-resources/ neurology-section-outcome-measures-recommendations/vestibular-disorders.,Non-OADS,/arxiv_data1/oa_pdf/36/e1/jnpt-40-124.PMC4795094.pdf
http://www.cdc.gov/HomeandRecreationalSafety/ Falls/index.html.,OADS,/arxiv_data1/oa_pdf/36/e1/jnpt-40-124.PMC4795094.pdf
"1, Supplemental Digital Content 1, http://links.lww.com/MLR/B95).",Non-OADS,/arxiv_data1/oa_pdf/52/c7/mlr-54-343.PMC4795096.pdf
"RESULTS Population Counts and Utilization Supplementary Materials Figure 2, Supplemental Digital Content 1, http://links.lww.com/MLR/B95 shows theoverall DLBCL, FL, and CLL total population counts, as well as the R+Chemo populations over time.",OADS,/arxiv_data1/oa_pdf/52/c7/mlr-54-343.PMC4795096.pdf
"In CLL, the range was narrower, between 0.8 and 0.9years (Supplementary Materials, Supplemental Digital Con- tent 1, http://links.lww.com/MLR/B95).Medical Care /C15Volume 54, Number 4, April 2016 Population Benefits and Costs of Rituximab Copyright r2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/52/c7/mlr-54-343.PMC4795096.pdf
"When extrapolated to 10 years based on the mean increase over year 6, the in- cremental cost of R+Chemo increased to $43,899, $28,211,and $38,289, respectively (Supplementary Materials, Sup- plemental Digital Content 1, http://links.lww.com/MLR/ B95).",Non-OADS,/arxiv_data1/oa_pdf/52/c7/mlr-54-343.PMC4795096.pdf
Available at: http://www.gao.gov/ products/GAO-13-46R.,OADS,/arxiv_data1/oa_pdf/52/c7/mlr-54-343.PMC4795096.pdf
"Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, http://links.lww.com/JNPT/A122).",Non-OADS,/arxiv_data1/oa_pdf/a1/83/jnpt-40-071.PMC4795097.pdf
"This has been adapted from the ENGAGE-HD trial protocol paper (open access article distributed under the terms of the Creative Commons Attribution License, http://creativecommons.org/licenses/by/4.0,16to provide additional detail with respect to methods for implementation evaluation).",Non-OADS,/arxiv_data1/oa_pdf/a1/83/jnpt-40-071.PMC4795097.pdf
"(Competencies can be found at Skills for Life, accessed May 29, 2015: https://tools.skillsforhealth.org.",Non-OADS,/arxiv_data1/oa_pdf/a1/83/jnpt-40-071.PMC4795097.pdf
"Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, http://links.lww.com/JNPT/A127).",Non-OADS,/arxiv_data1/oa_pdf/80/a7/jnpt-40-081.PMC4795099.pdf
"App Identiﬁcation and Selection The investigators identiﬁed an initial set of 18 com- mercially available apps that might support knowledge trans- lation (see Supplemental Digital Content 2, http://links.lww.",OADS,/arxiv_data1/oa_pdf/80/a7/jnpt-40-081.PMC4795099.pdf
The authors have compiled a list ofneurology-speciﬁc apps (though not endorsed by the authors) available as of May 2015 in Supplemental Digital Content 3 (http://links.lww.com/JNPT/A129).,Non-OADS,/arxiv_data1/oa_pdf/80/a7/jnpt-40-081.PMC4795099.pdf
Apple Press Info 2010; http://www.apple.com/pr/ library/2010/01/27Apple-Launches-iPad.html.,Non-OADS,/arxiv_data1/oa_pdf/80/a7/jnpt-40-081.PMC4795099.pdf
Gene expression results are publicly available at the Gene Expression Omnibus data repository (http://www.ncbi.nlm.nih.gov/geo/) with accession number GSE61849.,OADS,/arxiv_data1/oa_pdf/71/09/ejhg2014244a.PMC4795102.pdf
"We conducted searches in different databases available online, such as Haploreg(http://www.broadinstitute.org/mammals/haploreg/haploreg.php), 13 Ensembl (http://www.ensembl.org)14and the UCSC Genome browser (http://genome.ucsc.edu).15As expected, elements affected by the potentially regulatory SNPs included open chromatin regions, novelprotein-coding sequences, processed antisense transcripts, pseudo- genes, microRNAs, novel lincRNAs and altered protein-binding motifs.",OADS,/arxiv_data1/oa_pdf/71/09/ejhg2014244a.PMC4795102.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Gene relations under association peaks in CD LP l a z a - I z u r i e t a et al 1105 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/71/09/ejhg2014244a.PMC4795102.pdf
Supplemental Material The online supplemental material is available at http://pspb.sage-pub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/e8/ed/10.1177_0146167216636624.PMC4795148.pdf
Sequence variants were deposited at http://databases.LOVD.nl/.,OADS,/arxiv_data1/oa_pdf/89/37/ejhg201538a.PMC4795202.pdf
VAST: http://structure.ncbi.nlm.nih.gov/Structure/VAST/.,OADS,/arxiv_data1/oa_pdf/89/37/ejhg201538a.PMC4795202.pdf
"To view a copy of this license, visit http://creativecom mons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Brachydactyly type A1 LR a c a c h o et al 1645 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/89/37/ejhg201538a.PMC4795202.pdf
Sample size calculations were performed using the POWER program(from EPITOME software available on the US NCI website http://dceg.cancer.gov/tools/design/power).,OADS,/arxiv_data1/oa_pdf/4d/71/ejhg201572a.PMC4795220.pdf
Data are available at: http://www.gwascentral.org/study/HGVST1828.,OADS,/arxiv_data1/oa_pdf/4d/71/ejhg201572a.PMC4795220.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Baseline attitudes of the HealthSeq cohort SC Sanderson et al 20 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/29/11/ejhg2015118a.PMC4795230.pdf
Available from: http://www.iarc.fr/en/ publications/pdfs‑online/wrk/wrk8/index.php.,Non-OADS,/arxiv_data1/oa_pdf/b8/32/CMJ-128-3101.PMC4795268.pdf
"Trial Registration:  ClinicalTrials.gov, NCT01933880; https://clinicaltrials.gov/ct2/show/NCT01933880?term=CONCERTAATT4099&rank=1 Key words:  Academic Performance; Attention‑deficit  Hyperactivity Disorder; Cognitive Function; Osmotic‑release  Oral System‑methylphenidate Access this article online Quick Response Code: Website:    www.cmj.org DOI:    10.4103/0366‑6999.168948Abstract Address for correspondence:  Dr. Yi Zheng,   Beijing Anding Hospital, Capital Medical University, Beijing 100088, China  E‑Mail: yizheng@ccmu.edu.cn This is an open access article distributed under the terms of the Creative Commons  Attribution‑NonCommercial‑ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non‑commercially, as long as the author is credited  and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/28/f5/CMJ-128-2988.PMC4795269.pdf
Available from:  http://www.effectivehealthcare.ahrq.gov/ehc/products/191/818/ CER44‑ADHD_20111021.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/f5/CMJ-128-2988.PMC4795269.pdf
"The average rainfall figures were obtained from previous  reports ( http://www.weather-and-climate.com/average-monthly- Rainfall-Temperature-Sunshine , Katmandu, Nepal; accessed on  April 15, 2014) and plotted in the graph.",OADS,/arxiv_data1/oa_pdf/d4/dd/IJMR-142-1.PMC4795338.pdf
"Available from: http://nvbdcp.gov.in/chik-cd.html , accessed  on November 25, 2013.",OADS,/arxiv_data1/oa_pdf/6e/03/IJMR-142-108.PMC4795340.pdf
"Available from: http://www.censusindia.gov.in/vital_ statistics/SRS_Reports_2012.html , accessed on November 25,  2013.",OADS,/arxiv_data1/oa_pdf/6e/03/IJMR-142-108.PMC4795340.pdf
"Available  from: http://nvbdcp.gov.in/Chikun-Guidelines.html , accessed  on November 25, 2013.110  INDIAN J MED RES, DECEMBER (SUPPL.)",Non-OADS,/arxiv_data1/oa_pdf/6e/03/IJMR-142-108.PMC4795340.pdf
"Available from:  http://nvbdcp.gov.in/chik-cd.html , accessed on October 14,  2014.",OADS,/arxiv_data1/oa_pdf/2a/91/IJMR-142-111.PMC4795341.pdf
Available from: http://www.tritripura.in/tri/Tribes/Index.,Non-OADS,/arxiv_data1/oa_pdf/04/95/IJMR-142-12.PMC4795342.pdf
"Available from: http://www.nvbdcp.gov.in/malaria11.html ,  accessed on May 20, 2012.",Non-OADS,/arxiv_data1/oa_pdf/04/95/IJMR-142-12.PMC4795342.pdf
"Available from: http://www.nvbdcp.gov.in , accessed  on May 20, 2012.",OADS,/arxiv_data1/oa_pdf/04/95/IJMR-142-12.PMC4795342.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/65918/1/WHO_MAL_  84.1013. pdf?,OADS,/arxiv_data1/oa_pdf/04/95/IJMR-142-12.PMC4795342.pdf
"Available from: http://www.nvbdcp.gov.in/malaria3.html ,  accessed on May 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/04/95/IJMR-142-12.PMC4795342.pdf
Available from: http://www.nvbdcp.gov.,Non-OADS,/arxiv_data1/oa_pdf/74/ab/IJMR-142-30.PMC4795344.pdf
"Available from: http://www.nvbdcp.gov.in/den- cd.html , accessed on January 10, 2014.",OADS,/arxiv_data1/oa_pdf/7c/1c/IJMR-142-7.PMC4795350.pdf
"Available from:  http://www.cdc.gov/dengue/clinicalLab/laboratory.html , accessed  on January 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7c/1c/IJMR-142-7.PMC4795350.pdf
"Available  from: http://nvbdcp.gov.in/malaria-new.html; 2014 , accessed  on June 30, 2015 .",Non-OADS,/arxiv_data1/oa_pdf/50/83/IJMR-142-71.PMC4795351.pdf
"Available  from:  http://who.int/WHOPES/recommendations/en/ , accessed  on May 18, 2015.",OADS,/arxiv_data1/oa_pdf/50/83/IJMR-142-71.PMC4795351.pdf
Available from: http://www.vestergaard.com/.,Non-OADS,/arxiv_data1/oa_pdf/50/83/IJMR-142-71.PMC4795351.pdf
Available from: http://nvbdcp.gov.in/Doc/malaria- operational-manual-2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/50/83/IJMR-142-71.PMC4795351.pdf
"Available from: http://www.who.int/ malaria/publications/atoz/who_guidance_longevity_llins.pdf ,  accessed on May 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/50/83/IJMR-142-71.PMC4795351.pdf
"Available  from: http://nigerianbioscientist.com , accessed on December  8, 201 5.",Non-OADS,/arxiv_data1/oa_pdf/89/0d/IJMR-142-95.PMC4795354.pdf
Available from: http://users.rcn.com/jkimball.,Non-OADS,/arxiv_data1/oa_pdf/89/0d/IJMR-142-95.PMC4795354.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/38/b0/IJMPO-37-1.PMC4795367.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/38/b0/IJMPO-37-1.PMC4795367.pdf
Available from: http://www.medscape.org/ vie warticle/  580631.,Non-OADS,/arxiv_data1/oa_pdf/b9/25/IJMPO-37-20.PMC4795369.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b9/25/IJMPO-37-20.PMC4795369.pdf
Available from:  http://www.who.int/hpvcentre.,OADS,/arxiv_data1/oa_pdf/e6/5b/IJMPO-37-25.PMC4795370.pdf
Available from: http://www.ncrpindia.org/ALL_NCRP_ REPORTS/PBCR_REPORT_2009_2011/ALL_CONTENT/ Printed_Version.htm.,Non-OADS,/arxiv_data1/oa_pdf/2a/ef/IJMPO-37-32.PMC4795372.pdf
Available from: http://www.ncrpindia.org/Cancer_Atlas_ India/chapter6_Report.aspx.,Non-OADS,/arxiv_data1/oa_pdf/35/86/IJMPO-37-47.PMC4795376.pdf
Available from:  http://www.en.wikipedia.org/wiki/Pahang.,Non-OADS,/arxiv_data1/oa_pdf/53/91/JOVR-10-375.PMC4795386.pdf
Available from: http://www.acrm.org.my/ned/ cataractSurgeryRegistry.html.,Non-OADS,/arxiv_data1/oa_pdf/53/91/JOVR-10-375.PMC4795386.pdf
Available from: http://www.aao.org/ ppp.,Non-OADS,/arxiv_data1/oa_pdf/53/91/JOVR-10-375.PMC4795386.pdf
Available from: http://www.aao.org/ about/policy/upload/Amblyopia_2006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/80/JOVR-10-408.PMC4795390.pdf
Available from : http://tabby.vision.mcgill.ca.,Non-OADS,/arxiv_data1/oa_pdf/d6/cb/JOVR-10-433.PMC4795394.pdf
Available from: http://www.who.int/uv/sun_ protection/en/.,OADS,/arxiv_data1/oa_pdf/c2/c1/JOVR-10-441.PMC4795395.pdf
Available from:  http://www.optometrists.asn.au/LinkClick.aspx?fileticket=L zIMeZULAnY%3d&tabid=81&language=en‑US.,Non-OADS,/arxiv_data1/oa_pdf/c2/c1/JOVR-10-441.PMC4795395.pdf
Available from: http://www.who.int/uv/ health/en/index.html.,OADS,/arxiv_data1/oa_pdf/c2/c1/JOVR-10-441.PMC4795395.pdf
Available from: http://www.iso.org/iso/home/standards.,Non-OADS,/arxiv_data1/oa_pdf/c2/c1/JOVR-10-441.PMC4795395.pdf
Available from: http://www.acuvue.ca/site_en/ uv_protection.htm.,OADS,/arxiv_data1/oa_pdf/c2/c1/JOVR-10-441.PMC4795395.pdf
Available from: http://www.janach.it/newsdett.,Non-OADS,/arxiv_data1/oa_pdf/8f/ec/JOVR-10-461.PMC4795397.pdf
Available  from: http://www.angioedupro.com/Sharpoint/?seek=394.,Non-OADS,/arxiv_data1/oa_pdf/8f/ec/JOVR-10-461.PMC4795397.pdf
Available from: http://www.accessdata.fda.gov/ scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=36541.,OADS,/arxiv_data1/oa_pdf/8f/ec/JOVR-10-461.PMC4795397.pdf
Available from:  http://www.fischersurgical.com/NCIAnimation Video  3‑31‑09.wmv.,Non-OADS,/arxiv_data1/oa_pdf/8f/ec/JOVR-10-461.PMC4795397.pdf
"Keramed, “Endoinjector.” Available from: http://www.keramed.",Non-OADS,/arxiv_data1/oa_pdf/8f/ec/JOVR-10-461.PMC4795397.pdf
Available from: http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfpcd/classification.cfm?ID=3982.,OADS,/arxiv_data1/oa_pdf/8f/ec/JOVR-10-461.PMC4795397.pdf
"Systems, “Endoserter by Ocular Systems.” Available  from: http://www.us.ocularsystemsinc.com/physicians/ the‑endoserter/.",Non-OADS,/arxiv_data1/oa_pdf/8f/ec/JOVR-10-461.PMC4795397.pdf
Available  from: http://www.eyeworld.org/ewsupplementarticle.php?id=281.,Non-OADS,/arxiv_data1/oa_pdf/12/a1/JOVR-10-498.PMC4795405.pdf
Available from:   http://www.medical.philips.com/co_es/about/news/publications/ medicamundi/zhang-roa-sehgal-he-al-ghazi-martin.wpd.,Non-OADS,/arxiv_data1/oa_pdf/1a/d4/JMP-41-45.PMC4795417.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/56/ppa-10-313.PMC4795447.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 313–319Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  313OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9558 8interleukin-18 and mir-130a in severe sepsis  patients with thrombocytopenia Yao-li cui1,2 Bing Wang2 hong-Mei gao2 Ying-hong Xing2 Jian li2 hong-Jie li2 Zhu lin2 Y ong-Qiang Wang2 1Department of lymphoma and Key  laboratory of cancer Prevention and  Therapy, Tianjin Medical University  cancer institute and hospital,   national clinical research center  for cancer, 2Department of intensive  care Unit and Key lab for critical  care Medicine of the Ministry of  health, emergency Medicine research  institute, Tianjin First center hospital,   Tianjin, People’s republic of chinaBackground:  Thrombocytopenia is one of the most common laboratory abnormalities  encountered in patients with severe sepsis.",Non-OADS,/arxiv_data1/oa_pdf/a1/56/ppa-10-313.PMC4795447.pdf
"Interleukin (IL)-18, a proinflammatory cytokine, correspondence: Yong-Qiang Wang Department of intensive care Unit  and Key lab for critical care Medicine  of the Ministry of health, emergency  Medicine research institute, Tianjin First  center hospital, Tianjin 300192, People’s  republic of china Tel +86 22 2334 1405 Fax +86 22 2334 4105 email yaoli-cui@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Cui et al Running head recto: IL-18 and miR-130a in sepsis patients with thrombocytopenia DOI: http://dx.doi.org/10.2147/PPA.S95588",Non-OADS,/arxiv_data1/oa_pdf/a1/56/ppa-10-313.PMC4795447.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a1/56/ppa-10-313.PMC4795447.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 413–426Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  413ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10201 3antibiotic prescribing and resistance: knowledge  level of medical students of clinical years of  University sultan Zainal abidin, Malaysia Mainul haque nor iza a Rahman Zainal Zulkifli salwani ismail Faculty of Medicine, Universiti sultan  Zainal abidin, Kuala T erengganu,   T erengganu, MalaysiaAbstract:  The innovation of penicillin by Dr Alexander Fleming in 1928 and its use in clinical  practice saved many lives, especially during the Second World War.",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Therefore, this outstanding achievement led to the belief that “infec - tious diseases would be conquered shortly.”5 Although the history of clinical uses of  antimicrobials is quite recent, the antibiotic tetracycline has been identified as far back Correspondence: Mainul haque Faculty of Medicine, Universiti sultan  Zainal abidin, Medical Campus, Jalan  sultan Mahmud, 20400 Kuala Terengganu,  Terengganu, Malaysia Tel +60 10 926 5543 email runurono@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Haque et al Running head recto: Antibiotic prescribing and resistance DOI: http://dx.doi.org/10.2147/TCRM.S102013 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
Or use: http://youtu.be/JOe-G0AKCF YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
Available from: http://www.who.int/ mediacentre /factsheets/fs194/en /.,Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Available  from: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564 748_eng.pd f. Accessed November 10, 2015.",OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Available from: http://apps.who.int/iris/bitstream/10665/44812/   1/9789241503181_eng.pd f. Accessed November 10, 2015.",OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Available: http://www.reactgroup.org/uploads/react/ resources/260/Medical%20students%E2%80%99%20views%20on%20 the%20current%20and%20future%20antibiotic%20resistance% 20 situation .en.319.pd f. Accessed November 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Available  from: http://www.who.int/medicines/publications/policyperspectives/ ppm05en.pd f. Accessed November 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Available from: http://ecdc.europa.eu/en/ publications / Publications/0909_TER_The_Bacterial_Challenge_Time_to_ React.pd f. Accessed November 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Available from: https://www.rcplondon.ac.uk/sites/ default/files/documents/women-and-medicine-future-full-report.pd f.  Accessed November 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"Available from: https://www.hpsc.ie/A-Z/Gastroenteric/ Handwashing/Publications/File,1047,en.pd f. Accessed November 10,  2015.",Non-OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
Available: http://www.cdc.gov/mmwr/PDF/rr/rr5116 pdf.,OADS,/arxiv_data1/oa_pdf/00/85/tcrm-12-413.PMC4795448.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 401–412Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  401ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8074 9Methylnaltrexone for opioid-induced constipation:  review and meta-analyses for objective plus  subjective efficacy and safety outcomes Waldemar siemens gerhild Becker Clinic for Palliative Care, Medical  Center, University of Freiburg, Faculty  of Medicine, University of Freiburg,   Freiburg, germanyIntroduction:  Opioid-induced constipation (OIC) is a frequent adverse event that impairs  patients’ quality of life.",Non-OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
"This may result in additional costs to the health care system as well as society.9,10Correspondence: gerhild Becker Clinic for Palliative Care, Medical  Center, University of Freiburg, Faculty of  Medicine, University of Freiburg, Robert- Koch-straße 3, 79106 Freiburg, germany Tel +49 761 2709 5412 Fax +49 761 2709 5414 email gerhild.becker@uniklinik-freiburg.d eJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Siemens and Becker Running head recto: Methylnaltrexone for opioid-induced constipation – efficacy and safety DOI: http://dx.doi.org/10.2147/TCRM.S80749",Non-OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
"Available from: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/2008/ucm116885.ht m.  Accessed January 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
Available from: http://handbook.cochrane.org /.,OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
Available from: http://www.medscape.com/viewcollection/3246 3.,Non-OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/9e/tcrm-12-401.PMC4795449.pdf
"Pathophysiology The brain requires iron for many of its essential activities including transport of oxygen, energy generation , development of oligodendrocytes,Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"H, Heavy Subunit; L, Light Subunit.Kumar N, Rizek P, Jog M Neuroferritinopathy Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"in GP NCerebral atrophyDecr.Neuroferritinopathy Kumar N, Rizek P, Jog M Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"CSF ferritin Abbreviations: A, Adenine Base; Asymp., Asymptomatic; At, Ataxia; BG, Basal Ganglia; C, Cytosine Base; Ch, Chorea; CN, Caudate Nucleus; Co, Cogniti ve Impairment; CSF, Cerebrospinal Fluid; D, Dystonia; Decr., Decreased; DN, Dentate Nucleus; Dup, Duplication; GP, Globus Pallidus; Incl., Including; Incr., Inc reased; Ins, Insertion; LN, Lenticular Nuclei; Np, Neuropsychiatric Manifestations; O, Orofacial Dyskinesia; P, Putamen; Pk, Parkinsonism; Prev., Previously; RN, Red Nucle us; SN, Substantia Nigra; SWI, Susceptibility-weighted Imaging; T, Thymine Base; Th, Thalamus; Tr, Tremor; T/S, Tics/Stereotypy.Kumar N, Rizek P, Jog M Neuroferritinopathy Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"The associated mutations are listed alongside thesymptoms.Neuroferritinopathy Kumar N, Rizek P, Jog M Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"While isolated defects in complex I 2and complex III14were seen in three and one patient respectively, three other patients had a combined defect involving multiple respiratory chain complexes.2,16A generalized deficiency was reported in a sample of post-mortem cerebellar tissue.16These respiratory chain defects suggest mitochon- drial dysfunction in NF.Kumar N, Rizek P, Jog M Neuroferritinopathy Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"serum ceruloplasminand increased24-hour urinarycopper Chorea-acanthocytosis 39NChorea NOrofacial dyskinesia NDystonia NTics NParkinsonismNBG atrophy NNeuronal loss and gliosis inthe striatum,GP and SNNAR NYoung adult onset NSeizures NTics more common NSelf-mutilation NOculomotor abnormalities NMyopathy NNeuropathyNCaudate atrophy(predilectionfor the head of CN)NAcanthocytes in peripheralblood smearNElevated CKNeuroferritinopathy Kumar N, Rizek P, Jog M Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"1In successive generations, there may be an increase in the number of trinucleotide repeats in the affected gene leading to earlier age of onset.Kumar N, Rizek P, Jog M Neuroferritinopathy Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"doi: 10.1016/j.bbagen.2011.10.016.Neuroferritinopathy Kumar N, Rizek P, Jog M Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"doi: 10.1007/s00401- 012-1013-5.Kumar N, Rizek P, Jog M Neuroferritinopathy Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/b1/74/tre-06-355-7522-1.PMC4795517.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/fe/kev347.PMC4795536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/2c/kev388.PMC4795537.pdf
"Trial registration: ClinicalTrials.gov, http://www.clinicaltrials.gov, NCT01877278 Key words: OA, pain, pain threshold, knee, clinical trial.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/kev426.PMC4795538.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/kev426.PMC4795538.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 45 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/45/dyu137.PMC4795556.pdf
For furtherdetails please visit: [http://www.haramaya.edu.et/research/projects/kds-hrc/].,Non-OADS,/arxiv_data1/oa_pdf/b0/cd/dyv284.PMC4795560.pdf
The relevant data collection instruments can be accessed at: [http://www.haramaya.edu.et/research/projects/kds-hrc].,OADS,/arxiv_data1/oa_pdf/b0/cd/dyv284.PMC4795560.pdf
The data sharing policy of Kersa HDSS can be accessed at: [http://www.haramaya.,Non-OADS,/arxiv_data1/oa_pdf/b0/cd/dyv284.PMC4795560.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 73 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/71/dyv305.PMC4795561.pdf
http://www.socialstyrelsen.se/register/halsodatar egister/lakemedelsregistret.,OADS,/arxiv_data1/oa_pdf/07/71/dyv305.PMC4795561.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 102 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/8d/dyv307.PMC4795563.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/49/opth-10-431.PMC4795568.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 431–436submit your manuscript | www.dovepress.co m Dove press  431 http: //dx.doi.org/10.2147/OPTH.S10217 1Dove press Original researChopen access to scientific and medical research Open access Full T ext article Three-year results of a modified photodynamic  therapy procedure (ironing PDT) for age-related  macular degeneration patients with large lesions Tsuyoshi Otsuji1 Kenichiro sho2 akiko Tsumura1 naoko Koike1 T etsuya nishimura1 Kanji Takahashi2 1Department of Ophthalmology,   Kansai Medical University,   Takii hospital, 2Department of  Ophthalmology, Kansai Medical  University, hirakata hospital,   Osaka, JapanBackground:  To evaluate the effect of photodynamic therapy (PDT) using a modified procedure  on exudative age-related macular degeneration having been conventionally difficult to treat.",Non-OADS,/arxiv_data1/oa_pdf/9a/49/opth-10-431.PMC4795568.pdf
"This procedure was designated “Ironing PDT.” In the Correspondence: Tsuyoshi Otsuji Department of Ophthalmology, Kansai  Medical University, Takii hospital,  10-15 Fumizono-cho, Moriguchi,  Osaka 570-8507, Japan Tel +81 66 6992 1001 Fax +81 66 6992 8263 email otsuji@takii.kmu.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Otsuji et al Running head recto: Ironing PDT for AMD DOI: http://dx.doi.org/10.2147/OPTH.S102171",Non-OADS,/arxiv_data1/oa_pdf/9a/49/opth-10-431.PMC4795568.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9a/49/opth-10-431.PMC4795568.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/49/opth-10-431.PMC4795568.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/a1/ott-9-1415.PMC4795569.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1415–1423OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1415Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9916 6The effect of antagonizing rgD-binding integrin  activity in papillary thyroid cancer cell lines Weiwei cheng Fang Feng chao Ma hui Wang Department of n uclear Medicine,   shanghai Xin hua hospital, shanghai  Jiao Tong University school of  Medicine, shanghai, People’s republic  of chinaAbstract:  Patients with papillary thyroid cancer (PTC) generally have good prognosis, but inoper - able and radioactive iodine–refractory PTC still poses significant clinical challenges due to lack of  effective treatment and higher mortality rates.",Non-OADS,/arxiv_data1/oa_pdf/af/a1/ott-9-1415.PMC4795569.pdf
"Among the large subfamily of integrin heterodimers,  some of them have been found to bind to ECM through the Arg-Gly-Asp (RGD) motif,  and therefore, peptides containing RGD structure usually have a high affinity and specific - ity for these integrin heterodimers, particularly for αvβ3 and αvβ5.6 This characteristic  enables pharmacologic disruption of integrin–ECM binding to achieve antitumor effect,   and thus many small molecules containing the RGD sequence have been manufactured correspondence: hui Wang Department of nuclear Medicine,  shanghai Xin hua hospital, shanghai  Jiao Tong University school of Medicine,  Medical Technology Building 702, 1665  Kongjiang road, 200092 shanghai,  People’s republic of china email wanghuishanghai@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cheng et al Running head recto: Effect of antagonizing integrin activity in PTC cells DOI: http://dx.doi.org/10.2147/OTT.S99166",Non-OADS,/arxiv_data1/oa_pdf/af/a1/ott-9-1415.PMC4795569.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/af/a1/ott-9-1415.PMC4795569.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/a1/ott-9-1415.PMC4795569.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ba/c7/ott-9-1389.PMC4795570.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1389–1398OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1389Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9586 2a dried blood spot mass spectrometry metabolomic  approach for rapid breast cancer detection Qingjun Wang1,2,* Tao sun3,* Yunfeng cao1,2,4,5 Peng gao2,4,6 Jun Dong2,4 Yanhua Fang2 Zhongze Fang2 Xiaoyu sun2 Zhitu Zhu1,2 1Oncology Department 2, The  First affiliated hospital of liaoning  Medical University, 2Personalized  Treatment and Diagnosis research  center, The First affiliated hospital  of liaoning Medical University and  Dalian institute of chemical Physics,   chinese academy of sciences,   Jinzhou, 3Department of internal  Medicine 1, cancer hospital of china  Medical University, liaoning cancer  hospital & insititute, shenyang, 4cas  Key laboratory of separation science  for analytical chemistry, Dalian  institute of chemical Physics, chinese  academy of sciences, Dalian, 5Key  laboratory of contraceptives and  Devices research (n PFPc), shanghai  engineer and Technology research  center of reproductive health  Drug and Devices, shanghai institute  of Planned Parenthood research,   shanghai, 6clinical laboratory, Dalian  sixth People’s hospital, Dalian,   People’s republic of china *These authors contributed equally  to this workObjective:  Breast cancer (BC) is still a lethal threat to women worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ba/c7/ott-9-1389.PMC4795570.pdf
"Additionally, utility of solely genetic information for early  BC detection is not fully convincing.4 Currently, BC screening largely relies on radiologic and serum protein marker  detection strategies.5,6 Magnetic resonance imaging and computed tomography are rela - tively reliable tactics that help BC diagnosis clinically, but they are not cost-effective  and are not easily accessed by citizens living in the undeveloped regions.7 Although  mammography checking has claimed to reduce BC-related deaths from 13% to 25%, it correspondence: Zhitu Zhu The First Affiliated Hospital of Liaoning  Medical University, Jinzhou 121000,  People’s republic of china Fax +86 416 460 5049 email kez_dicp@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Dried blood spot MS metabolomic analysis for BC detection DOI: http://dx.doi.org/10.2147/OTT.S95862",Non-OADS,/arxiv_data1/oa_pdf/ba/c7/ott-9-1389.PMC4795570.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ba/c7/ott-9-1389.PMC4795570.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c7/ott-9-1389.PMC4795570.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/fa/copd-11-515.PMC4795571.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 515–525submit your manuscript | www.dovepress.co m Dove press  515 http: //dx.doi.org/10.2147/COPD.S9833 3Dove press ExPErt O PInIO nopen access to scientific and medical research Open Access Full text Article treatment of patients with COPD and recurrent  exacerbations: the role of infection and  inflammation Salud Santos1,2 Alicia Marin2,3 Joan Serra-Batlles4 David de la rosa5 Ingrid Solanes6 xavier Pomares7 Marta López-Sánchez1 Mariana Muñoz-Esquerre1 Marc Miravitlles2,8 1Pneumology Department,   Hospital Universitari de Bellvitge,   Universidad de Barcelona, Bellvitge  Biomedical research Institute  (IDIBELL), Hospitalet de Llobregat,   Barcelona, 2Centro de Investigación  Biomédica en red de Enfermedades  respiratorias (CIBErES), Madrid,   3Pneumology Department, Hospital  Universitari Germans trias i Pujol,   Badalona, 4Pneumology Department,   Hospital Universitari de Vic,   5Pneumology Unit, Hospital Plató,   6Pneumology Department, Biomedical  research Institute Sant Pau,   Hospital de la Santa Creu i Sant Pau,   Universidad Autónoma, Barcelona,   7Pneumology Department , Hospital  Universitari Parc taulí, Sabadell,   8Pneumology Department, Hospital  Universitari Vall d’Hebron, Barcelona,   SpainAbstract:  Exacerbations of COPD represent an important medical and health care problem.",Non-OADS,/arxiv_data1/oa_pdf/29/fa/copd-11-515.PMC4795571.pdf
"It is not known why  certain patients exhibit the frequent exacerbator phenotype, nor has it been established  how far recurrent infections, defects in the individual’s own immune system, or the  inflammatory nature of COPD may cause the presence of repeated exacerbations.3 The involvement of viruses and bacteria in exacerbations of COPD, and the  possible roles of systemic and bronchial inflammation, and of the individual’s Correspondence: Marc Miravitlles Pneumology Department, Hospital  Universitari Vall d’Hebron,  Passeig de la Vall d’Hebron 119-129,  08035 Barcelona, Spain tel/fax +34 93 274 6083 Email mmiravitlles@vhebron.ne t Journal name: International Journal of COPD Article Designation: Expert Opinion Y ear: 2016 Volume: 11 Running head verso: Santos et al Running head recto: COPD and recurrent exacerbations DOI: http://dx.doi.org/10.2147/COPD.S98333",Non-OADS,/arxiv_data1/oa_pdf/29/fa/copd-11-515.PMC4795571.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/29/fa/copd-11-515.PMC4795571.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/fa/copd-11-515.PMC4795571.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/74/e3/btt-10-053.PMC4795572.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/74/e3/btt-10-053.PMC4795572.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Biologics: Targets and Therapy 2016:10 53–58Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  53Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BTT .S9723 4correlations between immunogenicity, drug  levels, and disease activity in an italian cohort  of rheumatoid arthritis patients treated with  tocilizumab Maurizio Benucci1 Francesca Meacci2 Valentina grossi2 Maria infantino2 Mariangela Manfredi2 emanuele Bellio2 Valerio Bellio2 Francesca li gobbi1 laura Bazzichi3 Paolo Moscato4 Dario caputo4 gianantonio saviola5 rossella Talotta6 Piercarlo sarzi-Puttini6 Fabiola atzeni7 1rheumatology Unit, Ospedale  san giovanni di Dio, Florence,   italy; 2allergology and immunology  laboratory, Ospedale san giovanni  di Dio, Florence, italy; 3rheumatology  Unit, University of Pisa, Pisa, italy;   4internal Medicine and rheumatology  Unit, University of salerno, salerno,   italy; 5rheumatology Unit, salvatore  Maugeri Foundation, Mantua, italy;   6rheumatology Unit, Ospedale luigi  sacco, Milan, italy; 7irccs  galeazzi  Orthopedic institute, Milan, italy correspondence: Maurizio Benucci   rheumatology Unit, Ospedale  san giovanni di Dio, asl 10 Florence,  Via di T orregalli 3, 50143 Florence, italy   T el +39 05 5693 2636   Fax +39 05 5693 2099   email maurizio.benucci@uslcentro.",Non-OADS,/arxiv_data1/oa_pdf/74/e3/btt-10-053.PMC4795572.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/74/e3/btt-10-053.PMC4795572.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/74/e3/btt-10-053.PMC4795572.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/d6/dddt-10-1147.PMC4795573.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1147–1157Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1147Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9704 3T oward antituberculosis drugs: in silico screening  of synthetic compounds against Mycobacterium  tuberculosis  l,d-transpeptidase 2 Junie B Billones1,2 Maria constancia O  carrillo1 Voltaire g Organo1 stephani Joy Y Macalino1 Jamie Bernadette a sy1 inno a emnacen1 nina abigail B clavio1 gisela P concepcion3 1Office of the Vice President for  academic affairs – emerging  interdisciplinary research Program:   “computer-aided Discovery of  compounds for the treatment of  T uberculosis in the Philippines,”  Department of Physical sciences and  Mathematics, college of arts and  sciences, 2institute of Pharmaceutical  sciences, national institutes of health,   University of the Philippines Manila,   Manila, 3Marine science institute,   University of the Philippines Diliman,   Diliman, Quezon city, PhilippinesAbstract:  Mycobacterium tuberculosis  (Mtb) the main causative agent of tuberculosis, is  the main reason why this disease continues to be a global public health threat.",Non-OADS,/arxiv_data1/oa_pdf/82/d6/dddt-10-1147.PMC4795573.pdf
"l,d-transpeptidases catalyze the  formation of 3 →3 cross-linkages, one type of which is the l,d-transpeptidase 2 (LdtMt2;  MT2594, product of gene Rv2518c ), a protein that was observed to be pertinent for  Mtb’s virulence and growth during the chronic phase of the disease.2,3 While the com - bination of clavulanate and meropenem shows potential in treating patients with TB  by inhibiting Mtb’s  mycobacterial β-lactamase (BlaC) and LdtMt2, respectively, the  short half-life of meropenem forestalls its use as an anti-TB agent.4 Furthermore, both  imipenem, another carbapenem that has shown activity against LdtMt2, and meropenem,  are compounds that are currently being tested for the treatment of a wide range of  infections other than TB.5 Nonetheless, this may later lead to resistance, as the drug  is not specific for TB.correspondence: Junie B Billones eiDr computer laboratory, second  Floor, Damian hall, Old neDa complex,  University of the Philippines Manila, Padre  Faura corner Maria Orosa street, ermita,  Manila 1000, Philippines Tel +63 2 708 5571 Fax +63 2 708 5571 email jbbillones@up.edu.p h Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Billones et al Running head recto: Virtual screening of compounds against Mtb LdtMt2  DOI: http://dx.doi.org/10.2147/DDDT.S97043",Non-OADS,/arxiv_data1/oa_pdf/82/d6/dddt-10-1147.PMC4795573.pdf
Available from: http://apps.who.int/ iris/bitstream/ 10665/191102/1/9789241565059_eng.pdf?ua =1.,OADS,/arxiv_data1/oa_pdf/82/d6/dddt-10-1147.PMC4795573.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/82/d6/dddt-10-1147.PMC4795573.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/d6/dddt-10-1147.PMC4795573.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/1b/ott-9-1425.PMC4795574.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1425–1436OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1425ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9758 7Antitumor activity of pluripotent cell-engineered  vaccines and their potential to treat lung cancer  in relation to different levels of irradiation Yan-na Zhang Xiao-gang Duan Wen-hui Zhang Ai-ling Wu Huan-Huan Yang Dong-ming Wu Yu-Quan Wei Xian-cheng Chen State Key Laboratory of Biotherapy/ Collaborative Innovation Center  for Biotherapy, West China Hospital,   West China Medical School, Sichuan  University, Chengdu, Sichuan Province,   People’s Republic of ChinaAbstract:  Cancer stem cells (CSCs) are critical for tumor initiation/maintenance and recurrence  or metastasis, so they may serve as a potential therapeutic target.",Non-OADS,/arxiv_data1/oa_pdf/1d/1b/ott-9-1425.PMC4795574.pdf
"Anticancer vaccines might  provide an avenue for generating specific antitumor immunity with reduced toxicity  and prolonged immune memory and reactivity,2 compared with traditional therapies Correspondence: Xian-cheng Chen State Key Laboratory of Biotherapy/ Collaborative Innovation Center for  Biotherapy, West China Hospital,  West China Medical School, Sichuan  University, No 17, South Ren Min  Road Third Section, Wu Hou Zone,  Chengdu, Sichuan Province 610041,  People’s Republic of China Tel +86 189 8008 3598 Email chenwcrs@126.co mJournal name: OncoTargets and Therapy Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Different irradiation-level vaccines versus lung cancer DOI: http://dx.doi.org/10.2147/OTT.S97587",Non-OADS,/arxiv_data1/oa_pdf/1d/1b/ott-9-1425.PMC4795574.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1d/1b/ott-9-1425.PMC4795574.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/1b/ott-9-1425.PMC4795574.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/59/ott-9-1437.PMC4795576.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1437–1448OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1437Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9826 8increased expression of the long noncoding  rna crnDe-h indicates a poor prognosis in  colorectal cancer, and is positively correlated with  irX5 mrna expression T ong liu* Xin Zhang* Y ong-mei Yang lu-tao Du chuan-xin Wang Department of clinical laboratory,   Qilu hospital, shandong University,   Jinan, People’s republic of china *These authors contributed equally  to this workBackground:  The long noncoding RNA (lncRNA) colorectal neoplasia differentially  expressed – h (CRNDE-h) plays important roles in the early stages of human development  and cancer progression.",Non-OADS,/arxiv_data1/oa_pdf/e6/59/ott-9-1437.PMC4795576.pdf
"Keywords:  colorectal cancer, long noncoding RNA, CRNDE-h, diagnosis, prognosis, IRX5 Introduction Colorectal cancer (CRC) is one of the most common malignant tumors and the third  leading cause of cancer deaths worldwide.1 Although current detection methods, such  as fecal occult blood testing and fiber-optic colonoscopy, have significantly improved  outcomes for patients with CRC, more than half of those at an advanced stage of  disease die of carcinoma recurrence after undergoing radical resection.2 Therefore,  to provide better treatment strategies, there is an urgent need to further understand correspondence: chuan-xin Wang Department of clinical laboratory,  Qilu hospital, shandong University,  107 Wenhua West road, Jinan, shandong  250012, People’s republic of china Tel +86 531 82166801 Fax +86 531 86927544 email cxwang@sdu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Increased expression of lncRNA CRNDE-h indicates poor prognosis in CRC DOI: http://dx.doi.org/10.2147/OTT.S9826 8",Non-OADS,/arxiv_data1/oa_pdf/e6/59/ott-9-1437.PMC4795576.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/59/ott-9-1437.PMC4795576.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/59/ott-9-1437.PMC4795576.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/92/e4/cia-11-299.PMC4795580.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 299–306Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  299OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9541 1The clinical outcomes of oldest old patients with   tuberculosis treated by regimens containing  rifampicin, isoniazid, and pyrazinamide huang-shen lin1,2 Chun-Wen Cheng3 Ming-shyan lin4 Yen-li Chou5 Pey-Jium Chang2 Jing-Chi lin6 Jung-Jr Ye3 1Division of Infectious Diseases,   Department of Internal Medicine,   Chang gung Memorial hospital,   Chia-Yi, 2graduate Institute of Clinical  Medical sciences, College of Medicine,   Chang gung University, Taoyuan,   3Division of Infectious Diseases,   Department of Internal Medicine,   Chang gung Memorial hospital  at linkou, Chang gung University  College of Medicine, Taoyuan,   4Division of Cardiology, Chang gung  Memorial hospital, Yunlin, 5Division  of Pulmonary and Critical Care  Medicine, Department of Internal  Medicine, Chang gung Memorial  hospital, Chia-Yi, 6Division of Allergy  and Immunology and rheumatology,   Department of Internal Medicine,   Chang gung Memorial hospital,   Chia-Yi, TaiwanObjectives:  To investigate the clinical characteristics, adverse drug reactions, and outcomes  of the oldest old patients (aged $80 years) with tuberculosis (TB) treated with rifampicin,  isoniazid, and pyrazinamide (RIP)-containing regimens.",Non-OADS,/arxiv_data1/oa_pdf/92/e4/cia-11-299.PMC4795580.pdf
"In 2004, the oldest old comprised 18% of the  world’s older people and 24% of people in more developed countries, and the pro - portion of the oldest old people will continue to increase during the next 2 decades.3 Correspondence: Jung-Jr Ye Division of Infectious Diseases,  Department of Internal Medicine, Chang  gung Memorial hospital at linkou,  Chang gung University College of  Medicine, 5 Fu-shin street, gueishan 333,  Taoyuan, Taiwan Tel +886 3 328 1200 ext 8450 Fax +886 3 328 9410 email loyalwise@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lin et al Running head recto: Clinical outcomes of oldest old patients with tuberculosis DOI: http://dx.doi.org/10.2147/CIA.S95411",Non-OADS,/arxiv_data1/oa_pdf/92/e4/cia-11-299.PMC4795580.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/92/e4/cia-11-299.PMC4795580.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/92/e4/cia-11-299.PMC4795580.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a2/f6/ott-9-1409.PMC4795582.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1409–1414OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1409Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9717 0Ovarian small-cell carcinoma hypercalcemic type  successfully treated: a case report and literature  review Jian-jun Wang1,* Qi Liu2,* Nan Wu1 Xiao-die Zhou1 Hai Wang1 Xuan Wang1 pin T u1 Xiao-jun Zhou1 Qun-li shi1 1Department of p athology,   2Department of Obstetrics and  Gynecology, Jinling Hospital, Medical  school of Nanjing University, Nanjing  University, Nanjing, Jiangsu, people’s  republic of China *These authors contributed equally  to this workAbstract:  Ovarian small-cell carcinoma hypercalcemic type (OSCCHT) is a relatively rare and  highly fatal gynecological malignancy.",Non-OADS,/arxiv_data1/oa_pdf/a2/f6/ott-9-1409.PMC4795582.pdf
"The patient was then referred to another Correspondence: Qun-li shi Department of pathology, Jinling Hospital,  Medical school of Nanjing University,  Nanjing University, 305 east Zhongshan  road, Nanjing, Jiangsu 210002, people’s  republic of China Tel +86 025 8086 1291 email shiqunli2005@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Diagnosis and treatment of OSCCHT DOI: http://dx.doi.org/10.2147/OTT.S97170",Non-OADS,/arxiv_data1/oa_pdf/a2/f6/ott-9-1409.PMC4795582.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a2/f6/ott-9-1409.PMC4795582.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/f6/ott-9-1409.PMC4795582.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/60/20/cia-11-293.PMC4795583.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 293–298Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  293OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9954 2Changes of deceleration and acceleration capacity  of heart rate in patients with acute hemispheric  ischemic stroke Yan-hong Xu1 Xing-De Wang2 Jia-Jun Yang1 li Zhou2 Y ong-Chao Pan1 1Department of n eurology,   2Department of Cardiology, shanghai  Jiao Tong University Affiliated sixth  People’s hospital, shanghai, People’s  republic of ChinaBackground and purpose:  Autonomic dysfunction is common after stroke, which is correlated  with unfavorable outcome.",Non-OADS,/arxiv_data1/oa_pdf/60/20/cia-11-293.PMC4795583.pdf
"Phase-rectified signal averaging Correspondence: Jia-Jun Yang Department of neurology, shanghai Jiao  Tong University Affiliated Sixth People’s  hospital, 600 Yishan road, shanghai  200233, People’s republic of China Tel/fax +86 21 3829 7763 email yangjiajunfzy@sina.co m  Xing-De Wang Department of Cardiology, shanghai Jiao  Tong University Affiliated Sixth People’s  hospital, 600 Yishan road, shanghai  200233, People’s republic of China Tel +86 21 3829 7277 email wxdwsz8@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Xu et al Running head recto: Changes of DC and AC of heart rate in patients with stroke DOI: http://dx.doi.org/10.2147/CIA.S99542",Non-OADS,/arxiv_data1/oa_pdf/60/20/cia-11-293.PMC4795583.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/60/20/cia-11-293.PMC4795583.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/60/20/cia-11-293.PMC4795583.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1119–1131Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1119Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8297 2Selective use of sorafenib in the treatment  of thyroid cancer Fabián Pitoia Fernando Jerkovich Division of endocrinology, Hospital de  Clinicas – University of Buenos Aires,   Buenos Aires, ArgentinaAbstract:  Sorafenib is a multiple kinase inhibitor (MKI) approved for the treatment of  primary advanced renal cell carcinoma and advanced primary liver cancer.",Non-OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
"Currently, there is  a selective approach for the use of remnant ablation: it is not routinely indicated in  low-risk patients, may be considered in intermediate-risk patients, and is an absolute  indication in those with high risk of recurrence.4Correspondence: Fabián Pitoia División endocrinología, Hospital de  Clínicas – University of Buenos Aires,  Córdoba 2351, Fifth Floor, Buenos  Aires 1001, Argentina Tel/fax +54 011 5950 8828 email fpitoia@intramed.ne t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Pitoia and Jerkovich Running head recto: Sorafenib in thyroid cancer DOI: http://dx.doi.org/10.2147/DDDT.S82972",Non-OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT00984282?term =NCT009842 82&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
Available from: http://ctep.cancer.,Non-OADS,/arxiv_data1/oa_pdf/af/3d/dddt-10-1119.PMC4795584.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/10/73/ott-9-1399.PMC4795585.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1399–1407OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1399Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9752 0comparison of preoperative neutrophil–lymphocyte,  lymphocyte–monocyte, and platelet–lymphocyte  ratios in patients with upper urinary tract urothelial  carcinoma undergoing radical nephroureterectomy Xin song* gui-Ming Zhang* Xiao-cheng Ma lei luo Bin li Dong-Yue chai li-Jiang sun Department of Urology, The affiliated  hospital of Qingdao University,   Qingdao, shandong, People’s republic  of china *These authors contributed equally  to this workPurpose:  The aim of this study was to investigate the prognostic value of preoperative  neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), and lymphocyte–monocyte  ratio (LMR) in patients with upper urinary tract urothelial carcinoma (UUTUC).",Non-OADS,/arxiv_data1/oa_pdf/10/73/ott-9-1399.PMC4795585.pdf
"For patients with  UUTUC with local muscular invasion, the 5-year disease-free survival (DFS) rate was  50%, and for those who had advanced disease, the rate decreased to 10%.4 Currently, recognized independent prognostic factors include tumor stage, tumor  grade, extensive tumor necrosis, sessile tumor architecture, and lymphovascular inva - sion (LVI), which are mostly derived from postoperative data.5–8 Some preoperative  biomarkers, including serum creatinine and hemoglobin levels and Eastern Cooperative  Oncology Group performance status, are recognized as independent prognostic factors correspondence: li-Jiang sun Department of Urology, The Affiliated  hospital of Qingdao University, no 16  Jiangsu road, Qingdao 266003, shandong,  People’s republic of china Tel +86 532 8291 1330 email slijiang999@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Song et al Running head recto: NLR, PLR, and LMR in patients with UUTUC DOI: http://dx.doi.org/10.2147/OTT.S97520",Non-OADS,/arxiv_data1/oa_pdf/10/73/ott-9-1399.PMC4795585.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/10/73/ott-9-1399.PMC4795585.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/73/ott-9-1399.PMC4795585.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f9/e9/dddt-10-1133.PMC4795586.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1133–1146Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1133Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10212 8synthesis, antimicrobial, and antiproliferative  activities of substituted phenylfuranylnicotinamidines Magdy M Y oussef1,2 reem K arafa3,4 Mohamed a ismail1,2 1Department of chemistry, college  of science, King Faisal University,   hofuf, saudi arabia; 2Department  of chemistry, Faculty of science,   Mansoura University, Mansoura,   3Department of Pharmaceutical  chemistry, Faculty of Pharmacy, cairo  University, cairo, 4Biomedical sciences  Program, University of science and  Technology, Zewail city of science  and T echnology, cairo, egyptAbstract:  This research work deals with the design and synthesis of a series of substituted  phenylfuranylnicotinamidines 4a–i.",Non-OADS,/arxiv_data1/oa_pdf/f9/e9/dddt-10-1133.PMC4795586.pdf
"Keywords:  substituted phenylfuranylnicotinamidines, Suzuki coupling, antiproliferative,  antibacterial, antioxidant Introduction Over the past few years, the development of bacterial resistance to antibiotics has been  reported and resistance to multiple antimicrobial agents has become a major health  problem.1 A continuous discovery of new anti-infectious agents is urgently needed owing  to the progress of antibiotic resistance in almost all clinically significant pathogens.2  Cancer is a disease that still intrigues the scientific community stimulating their interest  in finding novel chemotherapeutic agents effective for the management and remediation  of this life-threatening ailment.3 Many factors compromise the rate of success of cancer  chemotherapy, with the emergence of drug resistance to currently clinically useful agents  being the most worrisome in the fight against cancer.4 Heterocycle-based chemical enti - ties have been explored as backbone scaffolds for the design of novel antiproliferative correspondence: Mohamed a ismail Department of chemistry, Faculty of  science, Mansoura University, Mansoura  35516, egypt Tel +20 10 9684 9505 email mabouelenan@kfu.edu.s a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y oussef et al Running head recto: Activities of substituted phenylfuranylnicotinamidines DOI: http://dx.doi.org/10.2147/DDDT.S102128",Non-OADS,/arxiv_data1/oa_pdf/f9/e9/dddt-10-1133.PMC4795586.pdf
Available from: http://apps.who.int/iris/bitstream/10665/112738/ 1/9789240692671_eng.pdf.,OADS,/arxiv_data1/oa_pdf/f9/e9/dddt-10-1133.PMC4795586.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f9/e9/dddt-10-1133.PMC4795586.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/e9/dddt-10-1133.PMC4795586.pdf
Availability and implementation: The method is implemented as an online web tool publicly avail- able at http://dsea.tigem.it.,OADS,/arxiv_data1/oa_pdf/31/ab/btv536.PMC4795590.pdf
"235 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/ab/btv536.PMC4795590.pdf
"Note that a P-value for the KS test can be computed analytically without resorting to random permutations.In particular, we used our signed variant (available online at https://github.com/franapoli/signed-ks-test) of the R function ks.test toFig.",Non-OADS,/arxiv_data1/oa_pdf/31/ab/btv536.PMC4795590.pdf
"4 Conclusions We introduced DSEA, a computational approach to help elucidatingthe mechanism of action of a set of drugs resulting from automatedscreening techniques, also available online at http://dsea.tigem.it.",Non-OADS,/arxiv_data1/oa_pdf/31/ab/btv536.PMC4795590.pdf
"Moreover, relevant code ismaintained on GitHub (https://github.com/franapoli/signed-ks-test).These resources are meant to facilitate the expansion of the DSEAdatabase of pathways and profiles, to encourage further develop- ment of the methods and to ensure replicability of our results.",Non-OADS,/arxiv_data1/oa_pdf/31/ab/btv536.PMC4795590.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/09/41/ndt-12-611.PMC4795591.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 611–615Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  611OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10210 0No association between BDNF  Val66Met  polymorphism and treatment response in   obsessive-compulsive disorder in the  Japanese population hidehiro Umehara1 shusuke Numata1 Makoto Kinoshita1 shinya Watanabe1 shutaro Nakaaki2 satsuki sumitani1,3 T etsuro Ohmori1 1Department of Psychiatry, institute  of Biomedical sciences, T okushima  University graduate school,   T okushima, 2laboratory of aging,   Behavior and cognition, Department  of Neuropsychiatry, Keio University  school of Medicine, T okyo, 3academic  support Office for students with  special Needs, T okushima University,   T okushima, JapanAim:  Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family, and  it promotes the development and function of dopaminergic and serotonergic neurons.",Non-OADS,/arxiv_data1/oa_pdf/09/41/ndt-12-611.PMC4795591.pdf
"Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family,  which is known to regulate many aspects of neural circuit development and function,  including cell proliferation and differentiation, axon and dendrite growth, synaptogenesis,  and synaptic function and plasticity.4,5 Substantial evidence suggests that BDNF promotes  the development and function of dopaminergic and serotonergic neurons.6,7 Several  studies have demonstrated that patients with OCD had significantly decreased plasma  and serum BDNF levels compared with controls,8–12 and the administration of selective  SRIs (SSRIs) and atypical antipsychotics enhances BDNF  gene expression.6,13correspondence: shusuke Numata Department of Psychiatry, institute  of Biomedical sciences, Tokushima  University graduate school, 3-8-15  Kuramoto-cho, Tokushima 770-8503,  Japan Tel +81 88 633 7130 Fax +81 88 633 7131 email shu-numata@umin.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Umehara et al Running head recto: Association between BDNF and clinical response in OCD DOI: http://dx.doi.org/10.2147/NDT.S102100",Non-OADS,/arxiv_data1/oa_pdf/09/41/ndt-12-611.PMC4795591.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/09/41/ndt-12-611.PMC4795591.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/41/ndt-12-611.PMC4795591.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/5e/ijn-11-991.PMC4795592.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 991–1002International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  991OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10187 2Insights into the therapeutic potential of hypoxia- inducible factor-1 α small interfering rNa  in malignant melanoma delivered via folate- decorated cationic liposomes Zhongjian chen1,* Tianpeng Zhang2,* Baojian Wu2 Xingwang Zhang2 1Department of Pharmaceutics,   shanghai Dermatology hospital,   2Division of Pharmaceutics, college  of Pharmacy, Jinan University,   gangzhou, People’s republic of china *These authors contributed equally  to this workAbstract:  Malignant melanoma (MM) represents the most dangerous form of skin cancer,  and its incidence is expected to rise in the coming time.",Non-OADS,/arxiv_data1/oa_pdf/77/5e/ijn-11-991.PMC4795592.pdf
"This results in high correspondence: Xingwang Zhang Division of Pharmaceutics, college of  Pharmacy, Jinan University, 601 West  huangpu avenue, guangzhou 510632,  People’s republic of china Tel +86 20 8522 0482 email pharmazxw@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chen et al Running head recto: Therapeutic potential of HIF-1 α siRNA DOI: http://dx.doi.org/10.2147/IJN.S101872",Non-OADS,/arxiv_data1/oa_pdf/77/5e/ijn-11-991.PMC4795592.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/77/5e/ijn-11-991.PMC4795592.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/5e/ijn-11-991.PMC4795592.pdf
Availability and implementation: Our DNN-HMM method and three additional algorithms can be freely accessed at https://github.com/wenjiegroup/DNN-HMM.,Non-OADS,/arxiv_data1/oa_pdf/53/c4/btv643.PMC4795613.pdf
"641 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/c4/btv643.PMC4795613.pdf
"According to the visualization of the Repli-Seq data through UCSC Genome Browser (http://genome.ucsc.edu/), we independ-ently constructed the training and test sets by manually labelling the14 states on chr1 and chr20 of BJ cell line of Replicate 1, respect-ively ( Supplementary Fig.",OADS,/arxiv_data1/oa_pdf/53/c4/btv643.PMC4795613.pdf
"697 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/ef/btv635.PMC4795614.pdf
Availability and implementation: Source code is available under the GNU General Public License at https://github.com/mpgerstl/networkRobustnessToolbox.,OADS,/arxiv_data1/oa_pdf/ca/cf/btv649.PMC4795620.pdf
"730 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/cf/btv649.PMC4795620.pdf
Algorithm 1 was implemented as multi-threaded C program which is available at https://github.com/mpgerstl/networkRobustnessToolbox.,OADS,/arxiv_data1/oa_pdf/ca/cf/btv649.PMC4795620.pdf
"The magnetization as measured by MOKE was calibrated by setting thesaturated value of the MOKE signal to this average saturated spin moment, m. SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/3/e1501492/DC1Fig.",OADS,/arxiv_data1/oa_pdf/53/e7/1501492.PMC4795654.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/3/e1501671/DC1Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/5a/59/1501671.PMC4795657.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/5d/ott-9-1371.PMC4795660.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1371–1379OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1371Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9796 9Prognostic role of microRNA-150 in various  carcinomas: a meta-analysis wei wang Xinshuai wang Yali Zhang Dan wang Hui Gao Lijuan wang Shegan Gao Henan Key Laboratory of Cancer  epigenetics, Cancer institute, The First  Affiliated Hospital, and College of  Clinical Medicine of Henan University  of Science and T echnology, Luoyang,   Henan, People’s Republic of ChinaObjective:  MicroRNA-150 (miR-150) was revealed to be an attractive prognostic biomarker in  recent studies.",Non-OADS,/arxiv_data1/oa_pdf/c6/5d/ott-9-1371.PMC4795660.pdf
"In chronic lymphocytic leukemia, it has been observed to be significantly  downregulated in cases with unfavorable clinicobiological markers and a worse  prognosis.6 Abnormal expression of miR-150 has also been found in various other solid Correspondence: Shegan Gao Henan Key Laboratory of Cancer  epigenetics, Cancer institute, The First  Affiliated Hospital, and College of Clinical  Medicine of Henan University of Science  and Technology, Luoyang, Henan 471003,  People’s Republic of China Tel +86 379 6481 3628 email gsg112258@163.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: MicroRNA-150  in various carcinomas DOI: http://dx.doi.org/10.2147/OTT.S97969",Non-OADS,/arxiv_data1/oa_pdf/c6/5d/ott-9-1371.PMC4795660.pdf
"If HRs were not  reported in the article, we used Engauge Digitizer Version 4.1  (free software downloaded from http://sourceforge.ne t)16 to  read the Kaplan–Meier survival curves to obtain the HRs and  their 95% CIs.",OADS,/arxiv_data1/oa_pdf/c6/5d/ott-9-1371.PMC4795660.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c6/5d/ott-9-1371.PMC4795660.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/5d/ott-9-1371.PMC4795660.pdf
"NGS was performed on theIllumina MiSeq platform with a MiSeq Reagent Kit V32 × 300 bp paired-end (Illumina MS-102-3003), using an input concentration of 16 pM with 2 to 5% PhiX (better results were obtained using 5% PhiX).Raw FASTQ data is publicly available at http://www.ncbi .nlm.nih.gov/ bioproject/311999.",OADS,/arxiv_data1/oa_pdf/89/61/1501371.PMC4795664.pdf
Thecomplete code of our pipeline and CLC Genomics Workbench workflow files are freely available (https://sissource.ethz.ch/sis/maf_scripts).,OADS,/arxiv_data1/oa_pdf/89/61/1501371.PMC4795664.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/3/e1501371/DC1Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/89/61/1501371.PMC4795664.pdf
The source code for MAF bioinformatics processing is publicly availa-ble at https://sissource.ethz.ch/sis/maf_scripts.,OADS,/arxiv_data1/oa_pdf/89/61/1501371.PMC4795664.pdf
Contact angles are the average of three independent mea-surements on each sample.SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/3/e1501496/DC1TextFig.,Non-OADS,/arxiv_data1/oa_pdf/72/b9/1501496.PMC4795665.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/3/e1501349/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/14/90/1501349.PMC4795672.pdf
(http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/bb/b2/1501145.PMC4795673.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1501145/DC1 Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/1501145.PMC4795673.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/3/e1501574/DC1Section S1.,Non-OADS,/arxiv_data1/oa_pdf/b6/a3/1501574.PMC4795678.pdf
See demo movies of stimuli at http://ruccs.rutgers.,Non-OADS,/arxiv_data1/oa_pdf/db/7d/i1534-7362-16-5-15.PMC4795806.pdf
"See demo movies of stimuli at http://ruccs.rutgers.edu/ ~manish/demos/RotatingColumns/RotColDemos.html (arrows are not shown in the demo movies).Journal of Vision (2016) 16(5):15, 1–15 Tanr ıkulu, Froyen, Feldman, & Singh 6",Non-OADS,/arxiv_data1/oa_pdf/db/7d/i1534-7362-16-5-15.PMC4795806.pdf
http://www.who.int/workforcealliance/knowledge/ resources/aaah_review/en/ 9.,OADS,/arxiv_data1/oa_pdf/95/d9/nihms765837.PMC4795807.pdf
http://www.cdc.gov/nchs/data/nhanes/ nhanes_13_14/2013-14_overview_brochure.pdf 21.,OADS,/arxiv_data1/oa_pdf/95/d9/nihms765837.PMC4795807.pdf
2003. http://www.mrc.ac.za/bod/sadhs.htm 22.,Non-OADS,/arxiv_data1/oa_pdf/95/d9/nihms765837.PMC4795807.pdf
"(2012)  ( tefA : JN886775;  tubB  : JN886778), using Primer3    ( Untergasser et al., 2012 ) as implemented in NCBI/Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).",OADS,/arxiv_data1/oa_pdf/63/e4/apps.1500078.PMC4795914.pdf
Website   http://www.generunner.net/  [accessed 10 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/88/29/apps.1500093.PMC4795915.pdf
Website http://www.unil.ch/popgen/softwares/fstat.htm [accessed 11 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/2c/b0/apps.1500099.PMC4795916.pdf
"It includes weeds ( Parker, 2013 ), as well as species listed on na-tional and regional catalogs of endangered plants (e.g.,  López Udías and Fábregat Llueca, 2010 ), registered on the International Union for the Conservation of Nature Red List ( http://www.iucnredlist.org/ ), or with narrow distribution areas ( Bolliger, 1996 ).",Non-OADS,/arxiv_data1/oa_pdf/f3/b8/apps.1500111.PMC4795918.pdf
"The data set is freely available from the Dryad Digital Repository ( http://dx.doi.org/10.5061/dryad.2d95h ;  Campbell et al., 2016   ).",OADS,/arxiv_data1/oa_pdf/87/a8/apps.1500114.PMC4795919.pdf
"meeting protection goals associated with genetic integrity for  endangered wild species (e.g., Cartagena Protocol on Biosafety to the Convention on Biological Diversity, 29 January 2000;  http://bch.cbd.int/protocol/parties/ ).",Non-OADS,/arxiv_data1/oa_pdf/87/a8/apps.1500114.PMC4795919.pdf
Website  http://arxiv.org/abs/1408.2863  [accessed 2 February 2016].,Non-OADS,/arxiv_data1/oa_pdf/87/a8/apps.1500114.PMC4795919.pdf
http://dx.doi.org/10.5061/dryad.2d95h .,Non-OADS,/arxiv_data1/oa_pdf/87/a8/apps.1500114.PMC4795919.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/f6/gzv067.PMC4795942.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/17/rrv055.PMC4795943.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/1a/rrv073.PMC4795945.pdf
"http://www.meti.go.jp/earthquake/nuclear/pdf/131009/131009_ 02a.pdf (18 August 2015, date last accessed).4.",OADS,/arxiv_data1/oa_pdf/da/1a/rrv073.PMC4795945.pdf
"Switzerland: World Health Organization (WHO) Press, 2013 http://apps.who .int/iris/bitstream/10665/78218/1/9789241505130_eng.pdf (11 November 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/da/1a/rrv073.PMC4795945.pdf
"Areas to which Evacuation Orders have been Issued .http://www.meti.go.jp/english/earthquake/ nuclear/roadmap/pdf/141001MapOfAreas.pdf (18 August 2015, date last accessed).External effective radiation dose in Fukushima NPP area 181",Non-OADS,/arxiv_data1/oa_pdf/da/1a/rrv073.PMC4795945.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/cf/rrv075.PMC4795946.pdf
The partially sequenced 16S rRNA gene (814 bp) was identi ﬁed and deposited in Gene Bank at NCBI ( http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/00/cf/rrv075.PMC4795946.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/29/rrv077.PMC4795947.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/77/rrv078.PMC4795948.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/d7/rrv083.PMC4795950.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/ee/rrv086.PMC4795952.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/4a/rrv093.PMC4795953.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/89/rrv097.PMC4795954.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/32/rrv098.PMC4795955.pdf
The MS/MS data we obtained were submitted to the Mascot Server to search against the mouse entries of the Mascot protein database ( http://www.matrixscience.com/ ).,OADS,/arxiv_data1/oa_pdf/81/32/rrv098.PMC4795955.pdf
"For protein identi ﬁcation, we used the obtained data to search against the mouse FASTA protein sequence database ( http://www.genome.jp/ tools/fasta/ ).",OADS,/arxiv_data1/oa_pdf/81/32/rrv098.PMC4795955.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/a9/rrv099.PMC4795956.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/aa/rrv103.PMC4795957.pdf
http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm6043a4.htm.,OADS,/arxiv_data1/oa_pdf/36/d2/adm-10-091.PMC4795974.pdf
Original  Article Obstet Gynecol Sci 2016;59(2):103-109 http://dx.doi.org/10.5468/ogs.2016.59.2.103 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 103Introduction Placenta previa occurs when the placenta totally or partially  covers the opening of the cervix or when the placenta is at - tached in the vicinity of the cervix.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/ogs-59-103.PMC4796079.pdf
"Corresponding author: Eun-Hwan Jeong Department of Obstetrics and Gynecology, Chungbuk National  University Hospital, Chungbuk National University College of Medicine,  776 1-Sunhwan-ro, Seowon-gu, Cheongju 28644, Korea Tel: +82-43-269-6052  Fax: +82-43-275-7359 E-mail: jeongmed@chungbuk.ac.kr http://orcid.org/ 0000-0002-0384-4589",Non-OADS,/arxiv_data1/oa_pdf/2e/5b/ogs-59-103.PMC4796079.pdf
"Original  Article Obstet Gynecol Sci 2016;59(2):110-115 http://dx.doi.org/10.5468/ogs.2016.59.2.110 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 110Introduction Hypertensive disorder of pregnancy is one of the most im - portant cause of maternal and neonatal morbidity and mor - tality, accounting for about 5% to 10% of pregnancies [1,2].",Non-OADS,/arxiv_data1/oa_pdf/83/4d/ogs-59-110.PMC4796080.pdf
"Corresponding author: Yun Sook Kim  Department of Obstetrics and Gynecology, Soonchunhyang University  Cheonan Hospital, 31 Sooncheonhyang 6-gil, Dongnam-gu, Cheonan  31151, Korea Tel: +82-41-570-2150   Fax: +82-41-571-7887 E-mail: drsook@schmc.ac.kr http://orcid.org/ 0000-0001-8427-4006",Non-OADS,/arxiv_data1/oa_pdf/83/4d/ogs-59-110.PMC4796080.pdf
Original  Article Obstet Gynecol Sci 2016;59(2):116-122 http://dx.doi.org/10.5468/ogs.2016.59.2.116 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 116Introduction Neuroendocrine cervical carcinoma (NECC) is a rare form of  cervical cancer representing 0.5% to 5% of all cervical cancer  cases.,Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ogs-59-116.PMC4796081.pdf
"Corresponding author: Maria Lee Department of Obstetrics and Gynecology, Seoul National University  Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-2842  Fax: +82-2-762-3599 E-mail: marialeemd@gmail.com http://orcid.org/ 0000-0002-8017-3176",Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ogs-59-116.PMC4796081.pdf
"Original  Article Obstet Gynecol Sci 2016;59(2):123-129 http://dx.doi.org/10.5468/ogs.2016.59.2.123 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 123Introduction Adenomyosis is a common benign gynecologic disease in  which endometrial glands and stroma are present within  myometrium, inducing myometrial inflammation and hyper - trophy.",Non-OADS,/arxiv_data1/oa_pdf/e4/ac/ogs-59-123.PMC4796082.pdf
"Corresponding author: Sung Hoon Kim Department of Obstetrics and Gynecology, University of Ulsan College of  Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul  05505, Korea Tel: +82-2-3010-3647   Fax: +82-2-476-7331 E-mail: kimsung@amc.seoul.kr http://orcid.org/ 0000-0003-2567-2092",Non-OADS,/arxiv_data1/oa_pdf/e4/ac/ogs-59-123.PMC4796082.pdf
"Original  Article Obstet Gynecol Sci 2016;59(2):130-136 http://dx.doi.org/10.5468/ogs.2016.59.2.130 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 130Introduction Inflammation of the vulvar and vaginal epithelium, vulvo - vaginitis, is frequently reported in prepubertal girls.",Non-OADS,/arxiv_data1/oa_pdf/30/5b/ogs-59-130.PMC4796083.pdf
"Corresponding author: Mee-Hwa Lee Department of Obstetrics and Gynecology, CHA Bundang Medical  Center, CHA University, 59 Y atap-ro, Bundang-gu, Seongnam 13496,  Korea Tel: +82-31-780-5290   Fax: +82-31-780-1947 E-mail: yeegen@cha.ac.kr http://orcid.org/ 0000-0001-9159-3961",Non-OADS,/arxiv_data1/oa_pdf/30/5b/ogs-59-130.PMC4796083.pdf
Original  Article Obstet Gynecol Sci 2016;59(2):137-143 http://dx.doi.org/10.5468/ogs.2016.59.2.137 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 137Introduction Pelvic organ prolapse is a common disease in women’s later  life and surgical procedure is needed for correcting most of  the symptomatic and/or severe prolapse.,Non-OADS,/arxiv_data1/oa_pdf/d1/2b/ogs-59-137.PMC4796084.pdf
"Corresponding author: Byung Chul Jee  Department of Obstetrics and Gynecology, Seoul National  University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang- gu, Seongnam 13620, Korea Tel: +82-31-787-7254  Fax: +82-31-787-4054 E-mail: blasto@snubh.org http://orcid.org/ 0000-0003-2289-6090",Non-OADS,/arxiv_data1/oa_pdf/d1/2b/ogs-59-137.PMC4796084.pdf
"Correlation analysis of age, opera - tion time, postoperative day of catheter removal and dura - tion of hospital stay (Spearman rho: ρ) This material can be found via http://ogscience.org/src/sm/ ogs-59-137-s001.pdf .",OADS,/arxiv_data1/oa_pdf/d1/2b/ogs-59-137.PMC4796084.pdf
Comparisons of clinicopathologic  characteristics between surgeons for the patients undergoing  vaginal hysterectomy with anterior posterior colporrhaphy  for pelvic organ prolapse This material can be found via http://ogscience.org/src/sm/ ogs-59-137-s002.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d1/2b/ogs-59-137.PMC4796084.pdf
Case Report Obstet Gynecol Sci 2016;59(2):144-147 http://dx.doi.org/10.5468/ogs.2016.59.2.144 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 144Introduction Complete chorioamniotic membrane separation (CMS) oc - curs extremely rarely without invasive fetal procedure.,Non-OADS,/arxiv_data1/oa_pdf/6d/37/ogs-59-144.PMC4796085.pdf
"Corresponding author: Ji Y eon Lee Department of Obstetrics and Gynecology, Inha University Hospital,  Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon  22332, Korea Tel: +82-32-890-2271  Fax: +82-32-890-2274 E-mail: lenna@hanmail.net http://orcid.org/ 0000-0002-6610-0245",Non-OADS,/arxiv_data1/oa_pdf/6d/37/ogs-59-144.PMC4796085.pdf
Case Report Obstet Gynecol Sci 2016;59(2):148-151 http://dx.doi.org/10.5468/ogs.2016.59.2.148 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 148Introduction Acute pancreatitis occurring in pregnancy is a rare but dan - gerous disease [1].,Non-OADS,/arxiv_data1/oa_pdf/ea/8a/ogs-59-148.PMC4796086.pdf
"Corresponding author: Suk Y oung Kim Department Obstetrics and Gynecology, Gil Hospital, Gachon  University Graduate School of Medicine, 21 Namdong-daero  774beon-gil, Namdong-gu, Incheon 21565, Korea Tel: +82-32-460-3261  Fax: +82-32-460-3290 E-mail: ksyob@gilhospital.com http://orcid.org/ 0000-0003-3600-9691",Non-OADS,/arxiv_data1/oa_pdf/ea/8a/ogs-59-148.PMC4796086.pdf
Case Report Obstet Gynecol Sci 2016;59(2):152-156 http://dx.doi.org/10.5468/ogs.2016.59.2.152 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 152Introduction Endometrial cancer is the third most common gynecologic  cancer in the Korea following cervical and ovarian cancers.,Non-OADS,/arxiv_data1/oa_pdf/79/d0/ogs-59-152.PMC4796087.pdf
"Corresponding author: Jeong Ho Rhee Department of Obstetrics and Gynecology, Keimyung University  Dongsan Medical Center, 56 Dalseong-ro, Jung-gu, Daegu 41931, Korea Tel: +82-53-250-7871   Fax: +82-53-250-7599   E-mail: r1670416@dsmc.or.kr  http://orcid.org/ 0000-0002-9280-4561",Non-OADS,/arxiv_data1/oa_pdf/79/d0/ogs-59-152.PMC4796087.pdf
Case Report Obstet Gynecol Sci 2016;59(2):157-162 http://dx.doi.org/10.5468/ogs.2016.59.2.157 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 157Introduction Microcystic stromal tumor (MCST) of the ovary is a rare sub - type of ovarian tumor with less than 30 cases reported world - wide [1-6].,Non-OADS,/arxiv_data1/oa_pdf/60/8b/ogs-59-157.PMC4796088.pdf
"Corresponding author: Eun Ji Nam Department of Obstetrics and Gynecology, Y onsei University College of  Medicine, 50-1 Y onsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-2250  Fax: +82-2-313-8357 E-mail: nahmej6@yuhs.ac  http://orcid.org/ 0000-0003-0189-3560 *These two authors contributed equally to this work",Non-OADS,/arxiv_data1/oa_pdf/60/8b/ogs-59-157.PMC4796088.pdf
Case Report Obstet Gynecol Sci 2016;59(2):163-167 http://dx.doi.org/10.5468/ogs.2016.59.2.163 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 163Introduction Urinary incontinence is a worldwide problem that affects the  millions of women.,Non-OADS,/arxiv_data1/oa_pdf/8d/07/ogs-59-163.PMC4796089.pdf
"Corresponding author: Hee-Dong Chae  Department of Obstetrics and Gynecology, University of Ulsan College of  Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul  05505, Korea  Tel: +82-2-3010-3628   Fax: +82-2-3010-8064 E-mail: hschae@amc.seoul.kr http://orcid.org/ 0000-0002-6601-6174",Non-OADS,/arxiv_data1/oa_pdf/8d/07/ogs-59-163.PMC4796089.pdf
Review Article Obstet Gynecol Sci 2016;59(2):79-84 http://dx.doi.org/10.5468/ogs.2016.59.2.79 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 79Introduction Fetal heart rate (FHR) monitoring is one of the most important  procedures for preventing perinatal morbidity and mortal - ity in the field of obstetrics.,Non-OADS,/arxiv_data1/oa_pdf/4a/7d/ogs-59-79.PMC4796090.pdf
"Corresponding author: In Y ang Park  Department of Obstetrics and Gynecology, The Catholic University of  Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 06591,  Korea  Tel: +82-2-2258-2813  Fax: +82-2-595-1549 E-mail: ooooobbbbb@catholic.ac.kr http://orcid.org/ 0000-0002-9458-2886",Non-OADS,/arxiv_data1/oa_pdf/4a/7d/ogs-59-79.PMC4796090.pdf
"Original  Article Obstet Gynecol Sci 2016;59(2):85-90 http://dx.doi.org/10.5468/ogs.2016.59.2.85 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 85Introduction In many developing and developed countries, a high cesarean  delivery rate has become a public health problem.",Non-OADS,/arxiv_data1/oa_pdf/fb/4d/ogs-59-85.PMC4796091.pdf
Available from: http://www.cdc.gov/nchs/fastats/ delivery.htm .,OADS,/arxiv_data1/oa_pdf/fb/4d/ogs-59-85.PMC4796091.pdf
http://dx.doi.org/10.1002/ jcu.22212 .,Non-OADS,/arxiv_data1/oa_pdf/fb/4d/ogs-59-85.PMC4796091.pdf
Original  Article Obstet Gynecol Sci 2016;59(2):91-96 http://dx.doi.org/10.5468/ogs.2016.59.2.91 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 91Introduction Ultrasound has become the essential tool of modern obstetric  practice [1].,Non-OADS,/arxiv_data1/oa_pdf/10/e1/ogs-59-91.PMC4796092.pdf
"Corresponding author: Joon-Seok Hong Department of Obstetrics and Gynecology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  13620, Korea Tel: +82-31-787-7256  Fax: +82-31-787-4054 E-mail: hjsobgy@gmail.com http://orcid.org/ 0000-0002-3832-8445",Non-OADS,/arxiv_data1/oa_pdf/10/e1/ogs-59-91.PMC4796092.pdf
Original  Article Obstet Gynecol Sci 2016;59(2):97-102 http://dx.doi.org/10.5468/ogs.2016.59.2.97 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 97Introduction C-reactive protein (CRP) is a widely used marker which reflect  inflammation and tissue damage [1].,Non-OADS,/arxiv_data1/oa_pdf/ff/c6/ogs-59-97.PMC4796093.pdf
"Corresponding author: Ji Eun Song Department of Obstetrics and Gynecology, Kangnam Sacred Heart  Hospital, Hallym University Medical Center, 1 Singil-ro, Y eongdeungpo- gu, Seoul 07441, Korea Tel: +82-2-829-5151  Fax: +82-2-833-5323 E-mail: guittool@hallym.or.kr http://orcid.org/ 0000-0002-1030-0096",Non-OADS,/arxiv_data1/oa_pdf/ff/c6/ogs-59-97.PMC4796093.pdf
Available from: http://www.uptodate.com.,Non-OADS,/arxiv_data1/oa_pdf/ff/c6/ogs-59-97.PMC4796093.pdf
"Membership of thePIDM is based on the existence of a designated national PV centre, a spontaneous adverse drug reaction (ADR) reporting system, and the demonstration of technicalcompetence in managing individual case safety reports (ICSRs) by submitting at least 20 ICSRs to the global ICSR database, VigiBase /C210, maintained by the Uppsala Moni- toring Centre (UMC), Sweden, on behalf of the World Health Organization (WHO) [ http://who-umc.org/graphics/ 24730.pdf ].",Non-OADS,/arxiv_data1/oa_pdf/bc/ae/40264_2015_Article_387.PMC4796322.pdf
"who-umc.org ), and the population of each country per year was obtained from the United Nations ( http://www.unfpa.",OADS,/arxiv_data1/oa_pdf/bc/ae/40264_2015_Article_387.PMC4796322.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bc/ae/40264_2015_Article_387.PMC4796322.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.Antipsychotics in Schizophrenia in France 379",Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs397/en/ .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
https://www.orpha.net/data/patho/FR/fr-schizo.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
